<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006208.pub3" GROUP_ID="EPOC" ID="674806022708035806" MERGED_FROM="" MODIFIED="2015-03-03 19:51:35 +0000" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2015-02-23 12:03:07 -0500" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2015-02-23 08:19:16 -0500" MODIFIED_BY="Sharlini Yogasingam">
<TITLE>Interventions for reducing medication errors in children in hospital</TITLE>
<CONTACT>
<PERSON ID="91919788162404270353120202212848" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Jolanda</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Maaskant</LAST_NAME>
<SUFFIX>MSc</SUFFIX>
<POSITION>Lecturer</POSITION>
<EMAIL_1>j.m.maaskant@amc.uva.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+31 6 45 55 80 02</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Emma Children's Hospital</DEPARTMENT>
<ORGANISATION>Academic Medical Center, University of Amsterdam</ORGANISATION>
<ADDRESS_1>Meibergdreef 9</ADDRESS_1>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP>1105 AZ</ZIP>
<REGION>Noord Holland</REGION>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 20 566 81 73</PHONE_1>
<PHONE_2/>
<FAX_1>+31 20 691 77 35</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2015-02-23 08:19:16 -0500" MODIFIED_BY="Sharlini Yogasingam">
<PERSON ID="91919788162404270353120202212848" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Jolanda</FIRST_NAME>
<MIDDLE_INITIALS>M</MIDDLE_INITIALS>
<LAST_NAME>Maaskant</LAST_NAME>
<SUFFIX>MSc</SUFFIX>
<POSITION>Lecturer</POSITION>
<EMAIL_1>j.m.maaskant@amc.uva.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+31 6 45 55 80 02</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Emma Children's Hospital</DEPARTMENT>
<ORGANISATION>Academic Medical Center, University of Amsterdam</ORGANISATION>
<ADDRESS_1>Meibergdreef 9</ADDRESS_1>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP>1105 AZ</ZIP>
<REGION>Noord Holland</REGION>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 20 566 81 73</PHONE_1>
<PHONE_2/>
<FAX_1>+31 20 691 77 35</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15812" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Hester</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Vermeulen</LAST_NAME>
<SUFFIX/>
<POSITION>Associate Professor</POSITION>
<EMAIL_1>h.vermeulen@amc.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Faculty of Nursing</DEPARTMENT>
<ORGANISATION>Amsterdam School of Health Professions, University of Applied Sciences Amsterdam</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="2354B0A382E26AA200D5E26B217D9E87" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Bugewa</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Apampa</LAST_NAME>
<SUFFIX/>
<POSITION>Director of Pharmacy Development</POSITION>
<EMAIL_1>b.apampa@sussex.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Life Sciences</DEPARTMENT>
<ORGANISATION>University of Sussex</ORGANISATION>
<ADDRESS_1>Falmer</ADDRESS_1>
<ADDRESS_2/>
<CITY>Brighton</CITY>
<ZIP>BN1 9QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0044-1634- 883 481</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="2354B1FB82E26AA200D5E26B9D1B3A27" ROLE="AUTHOR">
<PREFIX>DR</PREFIX>
<FIRST_NAME>Bernard</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Fernando</LAST_NAME>
<SUFFIX/>
<POSITION>General Practitioner and Honorary Research Fellow</POSITION>
<EMAIL_1>b21fern@aol.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Community Health Sciences - General Practice</DEPARTMENT>
<ORGANISATION>University of Edinburgh</ORGANISATION>
<ADDRESS_1>Thames Avenue Surgery</ADDRESS_1>
<ADDRESS_2>2 Thames Avenue</ADDRESS_2>
<CITY>Rainham</CITY>
<ZIP>ME8 9BW</ZIP>
<REGION>Kent</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0044-1634-377817</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="A3CADABD82E26AA2005387935CA50A82" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Maisoon</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Ghaleb</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Lecturer in Pharmacy Practice/Patient safety</POSITION>
<EMAIL_1>m.ghaleb@herts.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pharmacy, School of Life and Medical Sciences</DEPARTMENT>
<ORGANISATION>University of Hertfordshire</ORGANISATION>
<ADDRESS_1>College Lane Campus</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hatfield</CITY>
<ZIP>AL10 9AB</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 (0) 1797 285 087</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="A3C67E2982E26AA200538793316B71FC" ROLE="AUTHOR">
<PREFIX>A/Prof</PREFIX>
<FIRST_NAME>Antje</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Neubert</LAST_NAME>
<SUFFIX/>
<POSITION>Head Paediatric Clinical Study Centre</POSITION>
<EMAIL_1>antje.neubert@uk-erlangen.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pediatrics</DEPARTMENT>
<ORGANISATION>University Hospital Erlangen</ORGANISATION>
<ADDRESS_1>Loschgestr. 15</ADDRESS_1>
<ADDRESS_2/>
<CITY>Erlangen</CITY>
<ZIP>91054</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>0049 9131 8541237</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15336" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Sudhin</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Thayyil</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Clinical Lecturer and Honorary Consultant Neonatologist</POSITION>
<EMAIL_1>s.thayyil@ucl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Academic Neonatology</DEPARTMENT>
<ORGANISATION>Imperial College London</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>WC1N 1EH</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+ 44 (0) 20 7242 9789 Ext. 5616</PHONE_1>
<PHONE_2/>
<FAX_1>+ 44 (0) 20 7831 0488</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="2354AECE82E26AA200D5E26B100368AF" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Aung</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Soe</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Neonatologist</POSITION>
<EMAIL_1>Aung.Soe@medway.nhs.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Oliver Fisher Neonatal Unit</DEPARTMENT>
<ORGANISATION>Medway Maritime Hospital</ORGANISATION>
<ADDRESS_1>Windmill Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Gillingham</CITY>
<ZIP>ME7 5NY</ZIP>
<REGION>Kent</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0044-1634-830000</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2014-11-30 08:08:45 -0500" MODIFIED_BY="Julia Worswick" NOTES="&lt;p&gt;Minor update: 3/11/06&lt;/p&gt;" NOTES_MODIFIED="2014-11-30 08:08:45 -0500" NOTES_MODIFIED_BY="Julia Worswick">
<UP_TO_DATE>
<DATE DAY="30" MONTH="11" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="11" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="2" MONTH="12" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2015"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2014-11-04 14:27:34 -0500" MODIFIED_BY="Julia Worswick"/>
<HISTORY MODIFIED="2013-02-22 12:22:38 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_MAJOR" MODIFIED="2013-02-22 12:22:38 -0500" MODIFIED_BY="Alain Mayhew">
<DATE DAY="22" MONTH="1" YEAR="2013"/>
<DESCRIPTION>
<P>New authors added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-02-22 12:22:33 -0500" MODIFIED_BY="Alain Mayhew">
<DATE DAY="22" MONTH="1" YEAR="2013"/>
<DESCRIPTION>
<P>New authors added, methods updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2012-03-09 03:32:22 -0500" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2012-03-09 03:32:22 -0500" MODIFIED_BY="Jolanda Maaskant">
<SOURCE>
<NAME>Medway Maritime Hospital</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-03-09 03:32:22 -0500" MODIFIED_BY="Jolanda Maaskant">
<NAME>Academic Medical Center, Amsterdam</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2009-03-16 08:20:46 -0400" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-03-16 08:20:46 -0400" MODIFIED_BY="[Empty name]">
<NAME>Cochrane Child Health Field</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-02-23 08:22:30 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2015-02-17 10:50:55 -0500" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-02-02 06:13:09 -0500" MODIFIED_BY="[Empty name]">Interventions for reducing medication errors in children in hospital</TITLE>
<SUMMARY_BODY MODIFIED="2015-02-17 10:50:55 -0500" MODIFIED_BY="[Empty name]">
<P>Medication safety is important for hospitalised children, as they are at risk of experiencing unintended harm as a result of medication errors. Hospitals implement various interventions to reduce medication errors. This review examines the effectiveness of these interventions. We included seven studies describing five different interventions. The clinical pharmacist, the computerised prescribing system and the barcode medication administration system are interventions at the organisational level. The check and control checklist and a preprinted order sheet are categorised as professional interventions.</P>
<P>The introduction of a clinical pharmacist resulted in a significant decrease in serious medication errors in an intensive care setting, but these results were not seen on a medical and surgical ward. Also introduction of a computerised prescribing system and a check and control checklist did not result in conclusive results. The introduction of a barcode medication administration system and a preprinted order sheet resulted in a significant decrease in medication errors, but the benefits for paediatric patients in terms of less harm remain unclear.</P>
<P>Despite extensive searching, we identified only seven studies for inclusion. Our assessment of the quality and strength of evidence from these studies is low. This review shows that only a handful of medication safety strategies are studied in robust study designs. When the vulnerability of paediatric patients in hospital is considered, more research of high quality should be included on every research agenda.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-02-17 10:48:53 -0500" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2015-02-15 23:31:57 -0500" MODIFIED_BY="[Empty name]">
<P>Many hospitalised patients are affected by medication errors (MEs) that may cause discomfort, harm and even death. Children are at especially high risk of harm as the result of MEs because such errors are potentially more hazardous to them than to adults. Until now, interventions to reduce MEs have led to only limited improvements.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2015-02-15 23:32:12 -0500" MODIFIED_BY="[Empty name]">
<P>To determine the effectiveness of interventions aimed at reducing MEs and related harm in hospitalised children.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-02-17 10:47:45 -0500" MODIFIED_BY="[Empty name]">
<P>The Effective Practice and Organisation of Care Group (EPOC) Trials Search Co-ordinator searched the following sources for primary studies: <I>The Cochrane Library</I>, including the Cochrane Central Register of Controlled Trials (CENTRAL), the Economic Evaluation Database (EED) and the Health Technology Assessments (HTA) database; MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, Proquest Dissertations &amp; Theses, Web of Science (citation indexes and conference proceedings) and the EPOC Register of Studies. Related reviews were identified by searching the Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effects (DARE). Review authors searched grey literature sources and trial registries. They handsearched selected journals, contacted researchers in the field and scanned reference lists of relevant reviews. They conducted searches in November 2013 and November 2014. They applied neither language nor date limits.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-02-15 23:37:45 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials, controlled before-after studies and interrupted time series investigating interventions to improve medication safety in hospitalised children (&#8804; 18 years). Participants were healthcare professionals authorised to prescribe, dispense or administer medications. Outcome measures included MEs, (potential) patient harm, resource utilisation and unintended consequences of the interventions.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-02-17 02:40:52 -0500" MODIFIED_BY="[Empty name]">
<P>Two review authors independently selected studies, extracted data and assessed study quality using the EPOC data collection checklist. We evaluated the risk of bias of included studies and used the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach to assess the quality of the body of evidence. We described results narratively and presented them using GRADE tables.<BR/>
</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-02-17 10:48:53 -0500" MODIFIED_BY="[Empty name]">
<P>We included seven studies describing five different interventions: participation of a clinical pharmacist in a clinical team (n = 2), introduction of a computerised physician order entry system (n = 2), implementation of a barcode medication administration system (n = 1), use of a structured prescribing form (n = 1) and implementation of a check and control checklist in combination with feedback (n = 1).</P>
<P>Clinical and methodological heterogeneity between studies precluded meta-analyses. Although some interventions described in this review show a decrease in MEs, the results are not consistent, and none of the studies resulted in a significant reduction in patient harm. Based on the GRADE approach, the overall quality and strengfh of the evidence are low.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-02-15 23:40:48 -0500" MODIFIED_BY="[Empty name]">
<P>Current evidence on effective interventions to prevent MEs in a paediatric population in hospital is limited. Comparative studies with robust study designs are needed to investigate interventions including components that focus on specific paediatric safety issues.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-02-17 11:39:43 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2015-02-17 10:52:48 -0500" MODIFIED_BY="[Empty name]">
<P>An adverse drug event (ADE) is an unwanted occurrence after exposure to a drug that is not necessarily caused by the drug itself (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>). Adverse drug events include adverse drug reactions (ADRs) and medication errors (MEs). An ADR is defined as any response to a drug that is noxious and unintended and that occurs at doses normally used for prevention, diagnosis or therapy of a disease (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>). Adverse drug reactions may result from an exaggerated response to a drug (e.g. bronchospasm with beta blockers) or from an idiosyncratic reaction to a drug (e.g. penicillin allergy) (<LINK REF="REF-Oren-2003" TYPE="REFERENCE">Oren 2003</LINK>). No uniform definition of an ME is currently being used, despite efforts to develop an international definition (<LINK REF="REF-Lisby-2012" TYPE="REFERENCE">Lisby 2012</LINK>; <LINK REF="REF-Miller-2007" TYPE="REFERENCE">Miller 2007</LINK>; <LINK REF="REF-Yu-2005" TYPE="REFERENCE">Yu 2005</LINK>), but most studies use the definition of the US National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) (<LINK REF="REF-Lisby-2010" TYPE="REFERENCE">Lisby 2010</LINK>). The NCC MERP defines an ME as &#8220;any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional, patient or consumer&#8221; (<LINK REF="REF-NCC-MERP" TYPE="REFERENCE">NCC MERP</LINK>).</P>
<P>Medication errors are one of the most frequent causes of adverse events in hospitalised patients (<LINK REF="REF-Tam-2005" TYPE="REFERENCE">Tam 2005</LINK>; <LINK REF="REF-Vries-de-2008" TYPE="REFERENCE">Vries de 2008</LINK>). The Institute of Medicine estimates that, on average, hospitalised patients are subject to at least one ME per day (<LINK REF="REF-Aspden-2007" TYPE="REFERENCE">Aspden 2007</LINK>). Although human error is often the immediate cause of MEs, most errors are due to system failures precipitated by the increasing complexity of patient care (<LINK REF="REF-Davidhizar-2002" TYPE="REFERENCE">Davidhizar 2002</LINK>; <LINK REF="REF-Stucky-2003" TYPE="REFERENCE">Stucky 2003</LINK>). In fact, ADEs can be described as an emergent property of a particularly complex healthcare system such as a hospital or a paediatric ward within a hospital (<LINK REF="REF-Tam-2005" TYPE="REFERENCE">Tam 2005</LINK>). A systematic review of the incidence and nature of MEs in paediatric patients shows a wide distribution in results (<LINK REF="REF-Ghaleb-2006" TYPE="REFERENCE">Ghaleb 2006</LINK>). These results might be explained by variation in definitions, choice of denominator, study population or study design and the error detection method used (<LINK REF="REF-Franklin-2005" TYPE="REFERENCE">Franklin 2005</LINK>; <LINK REF="REF-Garfield-2013" TYPE="REFERENCE">Garfield 2013</LINK>; <LINK REF="REF-Lisby-2010" TYPE="REFERENCE">Lisby 2010</LINK>; <LINK REF="REF-Meyer_x002d_Massetti-2011" TYPE="REFERENCE">Meyer-Massetti 2011</LINK>; <LINK REF="REF-Morimoto-2004" TYPE="REFERENCE">Morimoto 2004</LINK>). Despite variability in the incidence of MEs, children still are considered to be at higher risk of experiencing an ADE. Kaushal et al found that the frequency of potentially harmful MEs was three times higher in paediatric patients than in adults (<LINK REF="REF-Kaushal-2001" TYPE="REFERENCE">Kaushal 2001</LINK>). Pharmacological factors such as age-based variability in absorption, metabolism and excretion of drugs pose special vulnerabilities to the risk of overdosing among children as compared with adults. Dosage calculations in children are much more prone to human error because of the constant need for weight- and surface area-based dosing and unit conversion to reflect the very small doses required (<LINK REF="REF-Santell-2003" TYPE="REFERENCE">Santell 2003</LINK>). Therefore, types of paediatric MEs and the interventions necessary to prevent them are different from those involving adults.</P>
<P>In a primary care setting, the processes involved in medication use can be quite different from those seen in a hospital setting. For example, prescribing in primary care may involve diverse personnel operating from different sites with differing accountabilities. This review, therefore, examined MEs in children in a hospital setting only.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-02-15 23:32:32 -0500" MODIFIED_BY="[Empty name]">
<P>To determine the effectiveness of interventions aimed at reducing MEs and related harm in hospitalised children.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-02-17 11:01:59 -0500" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2015-02-17 10:56:35 -0500" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2015-02-17 10:55:02 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs), controlled clinical trials (CCTs), controlled before-after studies (CBAs) and interrupted time series studies (ITSs).</P>
<P>We used the definitions in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-Cochrane-Handbook-2011" TYPE="REFERENCE">Higgins Cochrane Handbook 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Randomised controlled trial (RCT)</HEADING>
<P>A study in which &#8220;the author(s) state explicitly (usually by some variant of the term &#8216;random&#8217; to describe the allocation procedure used) that the groups compared in the trial were established by random allocation&#8221; (Box 6.3.a).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Controlled clinical trial (CCT)</HEADING>
<P>A study in which the intervention&#8217;s assignment is quasi-random (e.g. when assignment is based on date of birth or medical record number) or a trial that &#8220;does not state explicitly that the trial was randomized, but randomization cannot be ruled out&#8221; (Box 6.3.a).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Controlled before-after study (CBA)</HEADING>
<P>&#8220;A study in which observations are made before and after the implementation of an intervention, both in a group that receives the intervention and in a control group that does not&#8221; (Box 13.1.a).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interrupted time series study (ITS)</HEADING>
<P>&#8220;A study that uses observations at multiple time points before and after an intervention (the interruption). The design attempts to detect whether the intervention has had an effect significantly greater than any underlying trend over time&#8221; (Box 13.1.a).</P>
<P>We included CBA studies only if they involved contemporaneous data collection, appropriate choice of control site and a minimum of two intervention and two control sites (<LINK REF="REF-EPOC-2002" TYPE="REFERENCE">EPOC 2002</LINK>). Interrupted time series studies were included only when they described a clearly defined point in time when the intervention occurred and presented at least three data points before and three data points after the intervention (<LINK REF="REF-EPOC-2002" TYPE="REFERENCE">EPOC 2002</LINK>). We included unpublished studies, and we imposed no limitations on language or date of publication.</P>
</SUBSECTION>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2015-02-17 10:55:30 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Healthcare professionals</HEADING>
<P>We included studies of healthcare professionals who are authorised to prescribe, dispense or administer medications, and who are involved in the provision of hospital care to children (&#8804; 18 years). We excluded studies reporting misuse of medication by participants (e.g. suicide with use of medication, compliance issues).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Setting</HEADING>
<P>Studies based in all settings that provide clinical care to children in hospital: inpatient care (in secondary or tertiary units, intensive care units, operation theatres), outpatient care and accident and emergency department care.</P>
</SUBSECTION>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2015-02-17 01:17:32 -0500" MODIFIED_BY="[Empty name]">
<P>We included interventions applied in hospital care to improve patient safety in terms of MEs. Studies might describe one intervention or a package of interventions that we refer to as multi-faceted. We did not include interventions designed solely to change the volume of prescribing (e.g. reducing vancomycin dosage in neonatal units, increasing surfactant dosage in neonatal respiratory distress syndrome). We categorised interventions according to the Cochrane Effective Practice and Organisation of Care Group (EPOC) taxonomy of interventions: professional, financial, organisational or regulatory interventions (<LINK REF="REF-EPOC-2002" TYPE="REFERENCE">EPOC 2002</LINK>).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-02-17 10:56:35 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measures</HEADING>
<UL>
<LI>Occurence of MEs as proportions of participants, admission days, prescriptions and administrations.</LI>
<LI>Occurrence of (potentially) harmful MEs as proportions of participants, admission days, prescriptions and administrations, defined as categories E t/m I (NCC MERP). MEs can cause serious harm and are potentially lethal (<LINK REF="REF-Cousins-2002" TYPE="REFERENCE">Cousins 2002</LINK>; <LINK REF="REF-Kale-2012" TYPE="REFERENCE">Kale 2012</LINK>). Reduction in (potential) harm is therefore also an important outcome measure for this review.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<UL>
<LI>Resource utilisation (costs and length of stay in hospital). Medication errors are associated with extended length of admission and higher associated costs (<LINK REF="REF-Hug-2012" TYPE="REFERENCE">Hug 2012</LINK>; <LINK REF="REF-Samp-2014" TYPE="REFERENCE">Samp 2014</LINK>; <LINK REF="REF-Weingart--2000" TYPE="REFERENCE">Weingart 2000</LINK>). We therefore reviewed resource utilisation in terms of length of stay in hospital and costs.</LI>
<LI>Unintended consequences of the intervention. It is possible that whilst overall MEs may be reduced by the use of various technological interventions, especially with computerised ordering, serious adverse effects may not be reduced and could even be increased by elimination of the human barrier. Therefore, these outcomes were examined separately.</LI>
</UL>
<P>Comparison groups were given any other intervention, no intervention or usual care. Because different definitions were used to describe MEs, we explicitly cite the definitions used in the studies included in this review.</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-02-17 10:58:51 -0500" MODIFIED_BY="[Empty name]">
<P>Michelle Fiander, Trials Search Co-ordinator (TSC) for the EPOC Group, developed search strategies in consultation with the review authors. The TSC searched the Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effects (DARE) for related systematic reviews, and the databases listed below for primary studies. Searches were conducted in November 2013, and an update of searches in the main databases was conducted in November 2014; exact search dates for each database are included with the search strategies (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>; <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>; <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>; <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>; <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>; <LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>; <LINK REF="APP-08" TYPE="APPENDIX">Appendix 8</LINK>). Two methodological search filters were used to limit retrieval to appropriate study designs: the Cochrane Highly Sensitive Search Strategy (sensitivity- and precision-maximising version, 2008 revision) to identify randomised trials, and an EPOC methodology filter to identify non-RCT designs. Neither date nor language restrictions were used. Duplicates were removed from the databases electronically.</P>
<SUBSECTION>
<HEADING LEVEL="3">Databases</HEADING>
<UL>
<LI>Evidence-Based Medicine (EBM) Reviews, Cochrane Central Register of Controlled Trials (November 2014), Ovid SP.</LI>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 11), Wiley.</LI>
<LI>EBM Reviews, Health Technology Assessment (3rd Quarter 2014), Ovid SP.</LI>
<LI>EBM Reviews, National Health Service (NHS) Economic Evaluation Database (3rd Quarter 2014), Ovid SP.</LI>
<LI>MEDLINE (1947-), In-Process and other non-indexed citations (1946-2014), Ovid SP.</LI>
<LI>MEDLINE Daily Update (November 2014), Ovid SP.</LI>
<LI>EMBASE (1947 -2014), Ovid SP.</LI>
<LI>CINAHL (Cumulative Index to Nursing and Allied Health Literature) (1980-), EbscoHost.</LI>
<LI>EPOC Group, Specialised Register.</LI>
<LI>ProQuest Dissertations &amp; Theses Full Text.</LI>
<LI>ProQuest Nursing &amp; Allied Health database.</LI>
<LI>PsycInfo (1806-), Ovid SP.</LI>
<LI>Conference Proceedings Citation Index-Science (CPCI-S) (1990-2014), Web of Science.        </LI>
<LI>Conference Proceedings Citation Index-Social Science &amp; Humanities (CPCI-SSH) (1990-2014), Web of Science.</LI>
</UL>
<P> </P>
</SUBSECTION>
<OTHER_SEARCHES MODIFIED="2015-02-17 02:04:06 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Grey literature</HEADING>
<P>We conducted a grey literature search to identify studies not indexed in the databases listed above. Sources included the sites listed below.</P>
<UL>
<LI>Agency for Healthcare Research and Quality (AHRQ) at <A HREF="http://www.ahrq.gov/">www.ahrq.gov/</A>.</LI>
<LI>Grey Literature Report (New York Academy of Medicine) at <A HREF="http://greylit.org/">http://greylit.org/</A>.</LI>
<LI>Joanna Briggs Institute at <A HREF="http://www.joannabriggs.edu.au/Search.aspx">http://www.joannabriggs.edu.au/Search.aspx</A>.</LI>
<LI>National Institute for Health and Clinical Excellence (NICE) at <A HREF="http://www.nice.org.uk/">www.nice.org.uk/</A>.</LI>
<LI>National Research Register (NRR) Archive (up to 2007) at <A HREF="http://www.nihr.ac.uk/Pages/NRRArchive.aspx">http://www.nihr.ac.uk/Pages/NRRArchive.aspx</A>.</LI>
<LI>Open Grey at <A HREF="http://www.opengrey.eu/">http://www.opengrey.eu/</A>.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Trial registries</HEADING>
<P>We searched the following registries.</P>
<UL>
<LI>ClinicalTrials.gov, US National Institutes of Health (NIH), at <A HREF="http://clinicaltrials.gov/">http://clinicaltrials.gov/</A>.</LI>
<LI>International Clinical Trials Registry Platform (ICTRP), World Health Organization (WHO), at <A HREF="http://www.who.int/ictrp/en/">http://www.who.int/ictrp/en/</A>.</LI>
</UL>
<P>We also:</P>
<UL>
<LI>handsearched reference lists of all included studies, relevant systematic reviews and other relevant publications; and</LI>
<LI>contacted authors of relevant studies or reviews to clarify reported published information and to seek unpublished data.</LI>
</UL>
<P>We present details of these searches in <LINK REF="APP-09" TYPE="APPENDIX">Appendix 9</LINK>.</P>
</SUBSECTION>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-02-17 11:01:59 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Screening</HEADING>
<P>Two review authors (JM and HV) independently screened the search results at three levels: titles, abstracts to assess which studies satisfied the inclusion criteria and full-text copies of papers that were potentially relevant. If we could not assess the paper for relevance based on title or abstract, we obtained the full text. JM and HV also examined grey literature and trial registries independently. We resolved discrepancies in the process of screening by discussion or referred to the arbitrator (AS). Data from research published in duplicate were included only once.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data abstraction</HEADING>
<P>Two review authors (JM and HV) working independently extracted data from each article using the EPOC data collection checklist (<LINK REF="REF-EPOC-2002" TYPE="REFERENCE">EPOC 2002</LINK>). We resolved discrepancies by discussion or referred to the arbitrator (AS). We contacted investigators for missing data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Quality</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Assessment of risk of bias in included studies</HEADING>
<P>Quality assessment for included studies was supported by suggested risk of bias criteria for EPOC reviews (<LINK REF="REF-EPOC-2014" TYPE="REFERENCE">EPOC 2014</LINK>). For included RCTs and CBAs, we used the following criteria: allocation sequence, concealment of allocation, similar baseline outcome measurements, similar baseline characteristics, completeness of outcome data, blinding, protection against contamination, freedom from selective outcome reporting and anything else that might underestimate or overestimate the results. For ITS studies, we used the following criteria: protection against secular changes, prespecification of the shape of the intervention, data collection independent of the intervention, blinding, completeness of the dataset, freedom from selective outcome reporting and any other factors that might have underestimated or overestimated the results (e.g. an explicit rationale for the number and spacing of data points, appropriate time-series analysis) (<LINK REF="REF-Ramsay-2003" TYPE="REFERENCE">Ramsay 2003</LINK>).</P>
<P>For all included studies, we explicitly evaluated the reliability of outcomes. Obtaining reliable outcome measure(s) for medication errors is dependent on the method used. Full review of participant files is considered more sensitive than, for example, voluntary incident reports (<LINK REF="REF-Meyer_x002d_Massetti-2011" TYPE="REFERENCE">Meyer-Massetti 2011</LINK>; <LINK REF="REF-Morimoto-2004" TYPE="REFERENCE">Morimoto 2004</LINK>). In the literature, a multi-faceted approach is recommended (<LINK REF="REF-Olsen-2007" TYPE="REFERENCE">Olsen 2007</LINK>). In the included studies, we found full review of participant records, voluntary incident reports and a combination. This might have influenced the study findings. A different way to assess the reliability of the outcome is the inter-rater reliability expressed in kappa&#8217;s. EPOC defines a threshold of 0.80. In this systematic review, we combined these two elements. When a study reported full review of participant records or a combination of full review and voluntary incident reports, plus a kappa &gt; 0.80, we considered this study as having low risk of bias for this criterion. When a study reported full review of participant records or a combination of full review and voluntary incident reports, plus a kappa &#8804; 0.80, we considered this criterion as showing high risk of bias. When a study used only voluntary incident reports to assess outcome measures, we considered this study always as having high risk of bias for this criterion.</P>
<P>Two review authors (JM and HV) assessed risk of bias independently and resolved discrepancies by discussion. An arbitrator (AS) was available for consultation in the case of persistent disagreement.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Assessment of reporting bias</HEADING>
<P>A thorough search of the grey literature and contact with known experts in the field reduced the influence of publication bias on our review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Reporting</HEADING>
<P>We tabulated data in natural units for each study. We report (pre-intervention and post-intervention) means or proportions when results were available for both intervention and control groups from RCTs and CBAs. We calculated the absolute change from baseline with the 95% confidence limit. For ITS studies, we report the main outcomes in natural units with two indicators of effects of the intervention: change in the level of outcome immediately after the intervention, and change in the slope of the regression lines.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Analytical approach</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary analyses</HEADING>
<P>We based the primary analyses on consideration of outcome measures. When studies reported more than one measure for each endpoint, we extracted the outcome measures meeting the aims of our review. We present the results for all comparisons using a standard method of presentation, when possible. For comparisons of RCTs and CBAs, we planned to report for each study design the median, the interquartile range and/or the range of effect sizes across included studies. However, the studies were heterogeneous in terms of methods of analysis used. Therefore, we present the results as presented by study authors. We contacted the first study author for clarification or additional information, when necessary.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary analyses</HEADING>
<P>We planned secondary analyses to explore the consistency of the primary analyses with other types of endpoints. We planned to standardise effect sizes for continuous measures by dividing the difference in mean scores between intervention and control groups in each study through an estimate of the (pooled) standard deviation. However, this was never appropriate in the included studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Methods for reanalysis</HEADING>
<P>We aimed to present the results in a comparable way and therefore reanalysed included RCTs and CBAs, when possible, by recalculating results using the appropriate unit of analysis. We contacted the authors of such studies for clarification, when necessary. We reported heterogeneity of included studies in terms of settings, interventions, outcome assessments and outcome measures. We considered statistical meta-analysis only for studies that were similar in these terms. We examined data from ITS studies with unit of analysis errors according to EPOC guidelines.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Summary of findings</HEADING>
<P>We used the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach (<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>; <LINK REF="REF-Schunemann-2011" TYPE="REFERENCE">Schunemann 2011</LINK>) to assess the quality of the body of evidence for outcomes, to interpret results and to draw conclusions about the effects (benefits, potential harms and costs) of different interventions, including size of effect and quality of the evidence for outcomes for which evidence was found. We present evidence summaries for the main comparisons of the review in a 'Summary of findings' table.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Ongoing studies</HEADING>
<P>We describe ongoing studies, detailing the primary author, research question(s), methods and outcome measures, and provide an estimate of the reporting date.</P>
</SUBSECTION>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-02-17 11:22:42 -0500" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2015-02-17 11:14:31 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Results of the search</HEADING>
<P>Searches of the main electronic databases led to identification of 5182 titles. After independent examination of titles and abstracts by JM and HV, 90 titles and abstracts were left for further discussion. We decided on 28 articles potentially eligible for the review, given the predefined inclusion criteria. We excluded 18 studies after full-text assessment and found that seven studies met the inclusion criteria of the review and of the Cochrane EPOC group. We contacted the authors of three remaining studies for additional information, resulting in exclusion of all three studies. The full-text studies that were excluded are listed in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
<P>Handsearching of the references listed in the seven included studies, as well as of systematic reviews, reviews and overviews that we found in searches of the main electronic databases, did not yield new studies. A search of the grey literature and of trials registries also did not yield new articles, but we included one ongoing study that is potentially eligible for the review in the future (<LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>).</P>
<P>We present search strategies for the main databases in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. We describe search strategies for the grey literature and for trial registries in <LINK REF="APP-09" TYPE="APPENDIX">Appendix 9</LINK>. We provide an overview of the selection process in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Included studies</HEADING>
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Methods (design)</HEADING>
<P>We included in this review two RCTs (<LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK>; <LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK>), two ITS studies (<LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK>; <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK>) and three CBAs (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>; <LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK>; <LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>All seven included studies were executed in hospitals affiliated with a university or medical school. Five studies included patients admitted to paediatric medical wards (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>; <LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK>; <LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK>; <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK>; <LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK>). One study was executed on paediatric wards and on a paediatric intensive care unit (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>), and another study included paediatric wards, a paediatric intensive care unit and a neonatal intensive care unit (<LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK>). One study was performed on a neonatal intensive care unit only (<LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009</LINK>), and another study was executed in a paediatric emergency department (<LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK>).</P>
<P>Two studies originated from Canada (<LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK>; <LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK>), three from the United States of America (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>; <LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009</LINK>; <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK>), one from the United Kingdom (<LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK>) and one from China (<LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions </HEADING>
<P>Investigators studied interventions for reducing MEs. <A HREF="http://archie.cochrane.org/sections/documents/view?version=z1402051930144549611666325636909&amp;format=REVMAN#STD-Kaushal-2008">Kaushal 2008</A> and <A HREF="http://archie.cochrane.org/sections/documents/view?version=z1402051930144549611666325636909&amp;format=REVMAN#STD-Zhang-2012">Zhang 2012</A> studied the effects of including a pharmacist as part of the clinical team. Two studies examined the effects of computerised physician order entry (CPOE) (<A HREF="http://archie.cochrane.org/sections/documents/view?version=z1402051930144549611666325636909&amp;format=REVMAN#STD-King-2003">King 2003</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=z1402051930144549611666325636909&amp;format=REVMAN#STD-Walsh-2008">Walsh 2008</A>). One study described the introduction of a barcode medication administration system (BCMA) (<A HREF="http://archie.cochrane.org/sections/documents/view?version=z1402051930144549611666325636909&amp;format=REVMAN#STD-Morriss-2009">Morriss 2009</A>). <A HREF="http://archie.cochrane.org/sections/documents/view?version=z1402051930144549611666325636909&amp;format=REVMAN#STD-Lepee-2012">Lepee 2012</A> investigated the introduction of a professionally oriented check and control checklist, and <A HREF="http://archie.cochrane.org/sections/documents/view?version=z1402051930144549611666325636909&amp;format=REVMAN#STD-Kozer-2005">Kozer 2005</A> examined the use of a preprinted order sheet. None of the included studies reported subgroup analyses, neither planned nor post hoc. According to the EPOC taxonomy of interventions (<LINK REF="REF-EPOC-2002" TYPE="REFERENCE">EPOC 2002</LINK>), the included studies describe professional and organisational interventions. We categorise the check and control checklist and the preprinted order sheet as professional interventions. The clinical pharmacist, CPOE and BCMA are categorised as organisational interventions.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Description of included studies</HEADING>
<P>Clinical pharmacists or unit-based pharmacists were described in a CBA study (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>) and in an RCT (<LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK>).</P>
<P>The CBA by <LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK> was conducted on six units: two general medical units, two surgical units, a paediatric intensive care unit (PICU) and a cardiac intensive care unit (ICU). One of the medical units and one of the surgical units were randomly selected as intervention units, and the others served as controls. The PICU was randomly selected as the intervention unit; the cardiac ICU served as its control. All patients admitted during the study period were included in the study. Demographic characteristics are described in detail. On the intervention units, a pharmacist was added to the team, who provided physicians with timely information and advice, assisted nurses with preparation and provided information on administration and monitoring. In addition, the pharmacist monitored the order transcription process, medication preparation and the storage and distribution system. Serious MEs were chosen as the primary outcome. Data on serious MEs were collected upon review of all clinical data (medication orders, medication administration records and patient charts) and incident reports during six to eight weeks pre-intervention and during a 12-week post-intervention period. A research nurse collected the data. Two physicians rated adverse events on preventability (five categories), severity (four categories) and causality (algorithm of Naranjo). Medication errors were defined as errors in drug ordering, transcribing, dispensing, administering or monitoring. Serious MEs were defined as preventable injuries that resulted from the use of drugs, or non-intercepted near misses. Non-intercepted near misses were defined as MEs with significant potential for injuring patients; they did not cause harm, although they reached the participants.</P>
<P>
<LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK> investigated the effects on medication safety of including a clinical pharmacist in an RCT. During a four-month period, paediatric patients with nervous system or respiratory or digestive system diseases were randomly allocated to two groups. In both groups, most patients (70% and 69%) were younger than five years of age. In the intervention group, a clinical pharmacist made rounds together with doctors in charge and provided interventions, which included an assessment of participants' medication, diagnosis and drug treatment. The clinical pharmacist also advised physicians and nurses, monitored MEs and instructed participants. For participants in the control group, the existing medical model was continued, meaning that pharmacists were excluded from the medication process on the ward. Interventions provided by clinical pharmacists, adverse drug reactions (side effects), length of stay and costs of drugs and hospitalisation were chosen as primary outcome measures. For this review, only length of stay and costs were outcomes of interest. This study provided limited information on the data collection process. Length of stay was defined as the number of days from admission to discharge, and costs were defined as total charges for Western and Chinese traditional medicines.</P>
<P>
<LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK> evaluated the effects of CPOE on rate of MEs, using an ITS study design. Computerised physician order entry was implemented on the PICU, the NICU and surgical and paediatric medical wards; a paediatric weight-based dosage calculator and medication dosages checks were provided; wrong-dosage alerts, drug-drug interaction alerts and allergy alerts were generated. The primary outcome was the rate of non-intercepted serious MEs. Data on these serious MEs were collected upon review of inpatient records and incident reports over seven months before and nine months after implementation of the CPOE. A random sample of 40 participants per month was selected from all admissions. The median age of participants in the study was four years. Paediatricians made judgements about the preventability (five categories) and severity of MEs (four categories). Between the before and after measurements, six months was used for CPOE system implementation and instruction of professionals. Medication errors were defined as errors in drug ordering, transcribing, dispensing, administering or monitoring. Non-intercepted serious MEs were defined as MEs that caused harm or had substantial potential to cause harm and were not caught by hospital staff before reaching the patient. Preventable ADEs were defined as harm resulting from MEs.</P>
<P>
<LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK> reported the effects of CPOE on the number of MEs in a CBA. The intervention group consisted of all patients admitted to two medical paediatric wards on which the CPOE was implemented. The control group consisted of all patients admitted to one medical paediatric and two surgical paediatric wards that continued to use handwritten orders. The average age of study participants was 6.3 years. The CPOE system interfaced with the laboratory system but not with the pharmacy computer and had no clinical decision support. Primary outcomes were MEs and ADEs. Medication errors were defined as any events involving medication prescription, dispensing, administration or monitoring, irrespective of outcome. Adverse drug events were defined as MEs resulting in harm to the participant, and potential ADEs were defined as MEs with the potential for participant injury when no actual harm occurred. Potential ADEs were reported as a secondary outcome. Two physicians accessed the ME database and retrospectively reviewed all incident reports from three years before and three years after implementation of the CPOE. They classified the incidents into ADEs, potential ADEs and others. Data were not collected during the nine-month implementation period.</P>
<P>The CBA by <LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009</LINK> investigated the effects of a BCMA on MEs in an NICU. The BCMA supported the process of drug administration by verifying the drug, dose, route, time and frequency and participant identification after scanning the barcode on the participant's wristband and the unit-dose medication. During the first 19 weeks of the study, none of the beds were equipped with a BCMA system. During a second period of 12 weeks, half of randomly chosen beds on two similar units were equipped (two intervention groups), with the other half acting as controls (two control groups). In the last period of the study, lasting 19 weeks, all beds were equipped with the BCMA system. All patients admitted during the study periods were participants. The gestational age of participants was 34.5 (standard deviation (SD) 4.8) weeks. Primary outcomes were targeted preventable ADEs. Effects on MEs and potential ADEs were also reported. Medication errors were defined as errors in drug ordering, transcribing, dispensing, administering or monitoring. A preventable ADE was defined as harm to a participant resulting from an ME. A potential ADE was defined as an ME that could have harmed a participant but did not because it was intercepted, or because the participant did not experience harm. Targeted preventable ADEs were defined as MEs that were expected to be prevented by the BCMA system. Data were collected from medical records and incident reports by two paediatric nurse practitioners. A team that consisted of a neonatologist, two pharmacists and a paediatric clinical pharmacist made final judgements about the preventability and severity of MEs using the classification of the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). Data were not collected during a four-week implementation period.</P>
<P>
<LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK> assessed the effects of a check and control checklist on prescriptions for patients admitted on two paediatric wards, using an ITS study design. This checklist was used in the presence of the patient, during ward rounds. A member of the team reviewed the prescription chart using the check and control checklist and gave immediate feedback on any shortfalls to the other members of the team. Corrections and short teaching comments were made before the end of the round. The study does not report on participant characteristics. The primary outcome was the rate of technical prescribing errors. In addition, data on clinical prescribing errors were collected (secondary outcomes). A technical prescribing error was defined as unclear or missing information on the prescription. A clinical prescribing error was defined as an unintentional significant reduction in the probability that a treatment would be timely and effective, or an increase in risk of harm, when compared with more generally accepted practice, as a result of a prescribing decision or a prescription writing process. To identify technical errors, a student pharmacist screened all inpatient drug charts during two months before and two months after implementation of the checklist. The ward pharmacist identified clinical errors. No data were collected during a one-week implementation period. The quality of documentation in the medical notes was assessed concurrently and acted as a control measurement.</P>
<P>The objective of the RCT conducted by <LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK> was to assess the effects of a structured, pre-printed medication order sheet on prescriptions for paediatric patients visiting an emergency department. The study does not report on participant characteristics. During a one-month period, days were randomly allocated to the intervention group or to the control group. During intervention days, a structured, pre-printed medication order sheet was used for all visiting patients. On control days, the regular blank order sheet was used. Endpoints included the numbers of medication prescribing errors and potentially harmful MEs. Medication errors were defined as a drug regimen different from that recommended (dose difference &#8805; 20%, deviation &#8805; 2 hours from the recommended interval between doses and wrong unit or route of administration). Potentially harmful MEs were defined as MEs that could have caused significant or severe harm to participants. To identify these errors, two medical students reviewed all participant charts. After data collection, two paediatric emergency physicians reviewed the database and decided on the severity of the error, using three categories.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Excluded studies</HEADING>
<P>See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<P>We excluded 21 studies that did not meet the inclusion criteria. Ten studies were executed in non-clinical test situations (<LINK REF="STD-Balaguer-Santamaria-2001" TYPE="STUDY">Balaguer Santamaria 2001</LINK>; <LINK REF="STD-Burgess-2009" TYPE="STUDY">Burgess 2009</LINK>; <LINK REF="STD-Frush-2004" TYPE="STUDY">Frush 2004</LINK>; <LINK REF="STD-Frush-2006" TYPE="STUDY">Frush 2006</LINK>; <LINK REF="STD-Hixson-2009" TYPE="STUDY">Hixson 2009</LINK>; <LINK REF="STD-Hohenhaus-2008" TYPE="STUDY">Hohenhaus 2008</LINK>; <LINK REF="STD-Vaidya-2006" TYPE="STUDY">Vaidya 2006</LINK>; <LINK REF="STD-Yamamoto-2010" TYPE="STUDY">Yamamoto 2010</LINK>; <LINK REF="STD-Yin-2008" TYPE="STUDY">Yin 2008</LINK>; <LINK REF="STD-Yin-2011" TYPE="STUDY">Yin 2011</LINK>). We excluded three studies because they investigated MEs in home situations (<LINK REF="STD-Frush-2004" TYPE="STUDY">Frush 2004</LINK>; <LINK REF="STD-Yin-2008" TYPE="STUDY">Yin 2008</LINK>; <LINK REF="STD-Yin-2011" TYPE="STUDY">Yin 2011</LINK>). One study did not specifically aim to prevent MEs (<LINK REF="STD-Cunningham-2008" TYPE="STUDY">Cunningham 2008</LINK>). We excluded six studies because they turned out to be CBAs without the required number of intervention or control groups (<LINK REF="STD-Burmester-2008" TYPE="STUDY">Burmester 2008</LINK>; <LINK REF="STD-Dehghan_x002d_Nayeri-2013" TYPE="STUDY">Dehghan-Nayeri 2013</LINK>; <LINK REF="STD-Gazarian-2012" TYPE="STUDY">Gazarian 2012</LINK>; <LINK REF="STD-Nguyen-2014" TYPE="STUDY">Nguyen 2014</LINK>; <LINK REF="STD-Niemann-2014" TYPE="STUDY">Niemann 2014</LINK>; <LINK REF="STD-Niemann_x002c_-Bertsche-2014" TYPE="STUDY">Niemann, Bertsche 2014</LINK>). We excluded three studies because no data on hospitalised children were presented (<LINK REF="STD-Ching-2014" TYPE="STUDY">Ching 2014</LINK>; <LINK REF="STD-Elsaid-2013" TYPE="STUDY">Elsaid 2013</LINK>; <LINK REF="STD-Ramsay-2014" TYPE="STUDY">Ramsay 2014</LINK>). One study was published only in abstract form (<LINK REF="STD-Senner-2010" TYPE="STUDY">Senner 2010</LINK>).</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-02-17 11:19:15 -0500" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">Quality assessment</HEADING>
<P>We report the methodological quality of the included studies in narrative format and in risk of bias summaries and graphs (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Risk of bias in included studies</HEADING>
<P>The CBA by <LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK> describes the effects of including a clinical pharmacist. Intervention and control units were randomly selected. Participants in the pre-intervention group were similar to those in the post-intervention group. The process of data collection with blinding was performed accurately and is described in detail. The study was conducted on comparable hospital units with little chance of contamination. Outcome assessment was performed by review of clinical data and incident reports. Study authors report inter-rater reliability of 0.75 for incident classification.</P>
<P>
<LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK> studied the effects of including a clinical pharmacist in an RCT. Randomisation, allocation concealment and blinded outcome assessment do not seem to impair the quality of the study. No significant differences were noted between groups at baseline, and missing data were limited and well described. Some contamination between intervention and control groups was noted, as the clinical pharmacists also provided advice for participants in the control group when asked by physicians. This might have led to underestimation of results. Interventions by clinical pharmacists, adverse drug reactions (side effects), length of stay and costs of drugs and hospitalisation were chosen as primary outcome measures. Secondary outcomes included medication compliance rate after discharge and readmission rate. For this review, only length of stay and costs are results of interest.</P>
<P>The ITS study by <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK> had strengths and limitations. Data collectors were trained paediatric nurses who were unaware of study objectives and paediatricians who were unaware of whether possible errors occurred before or after CPOE. Researchers reported missing data, but the dataset of each time point still covered more than 80%. This study was independent of other changes, meaning that no other major organisational developments during the study period could have influenced study results. The shape of the intervention effect was prespecified, and identical months were included in the pre-CPOE and post-CPOE periods to control for seasonal effects. Risk of bias regarding whether the intervention affected data collection was low, as methods used for data collection before and after the intervention were the same. Time series analysis techniques were used to correct for changes over time, other than the intervention. Also sufficient numbers of data collection points were chosen (seven before and nine after the intervention). We report two criteria that might cause high risk of bias. Inter-rater reliability for paediatricians&#8217; judgements was calculated, resulting in inter-rater reliability for judgements about classification of a possible ME of 0.7, severity of the error of 0.4 and preventability of the error of 0.8. These results might affect the reliability of the primary endpoints. Also, the number of NICU admissions had increased in the post-intervention period, and this might have inflated the effects of CPOE because the rate of MEs in the NICU was less than in other units.</P>
<P>The CBA by <LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK> had strengths and limitations. Participant characteristics were similar in the pre-intervention and post-intervention periods and between intervention and control wards. Each ward was clinically independent, so contamination is not expected. Also, the incident reporting system, which served as the main source of outcomes, was constant during the study period. In this retrospective study, intervention and control wards were not randomly chosen, and no blinding was applied. However, only the incident reporting system was used to collect outcome measures with an inter-rater reliability of 0.64, which might have resulted in less reliable results. In addition, study authors described a decline in ADEs in the pre-intervention period, probably as the result of other interventions provided to increase medication safety.</P>
<P>The CBA by <LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009</LINK> had strengths and limitations. Small differences in baseline characteristics were noted in the number of twins and in nursing capacity, but adjustments were made for these in the analyses. Blinded professionals performed outcome assessment. Outcome assessment was performed using a combination of review of medical records and voluntary incident reports, and an inter-rater reliability of 0.82 was reported for detection of MEs. However, intervention and control beds were not randomly selected. Another main threat described in this study is possible contamination: Beds with the BCMA system and beds without the BCMA installed were in the same sections of the NICU. This might have resulted in underestimation of the results.</P>
<P>
<LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK> studied the effects of a check and control checklist in an ITS study. Data collection was performed twice a week through review of all inpatient files. The study was independent of other changes; this is shown by the concurrent control variable. The dataset of each time point covered at least 80% of all participants, and the shape of the intervention effect was prespecified. Risk of bias was low regarding whether the intervention affected data collection, as methods used for data collection before and after the intervention were the same. Time series analysis techniques were used to correct for changes over time, other than the intervention. Inter-rater reliability was examined for the primary outcome (technical error), resulting in a kappa of 0.91. Evaluators were not blinded as to whether the data were pre-intervention or post-intervention, but because the endpoint was defined as measurable and objective, there was probably no influence on the results. The number of data points and the time interval chosen in the study were based on maximising the quantity of data that could be collected within available resources (additional information obtained from the study author).</P>
<P>
<LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK> studied the effects of a structured order sheet in an RCT. Randomisation and blinded outcome assessment did not seem to impair the quality of the study. Allocation concealment was not described. No significant differences between groups were noted at baseline, and missing data were limited. Possible contamination was noted between intervention and control groups, as the same professionals worked with the structured order sheet on intervention days, as well as with the regular sheet on days chosen as controls. This might have led to underestimation of the results. We also report high risk of bias concerning the reliability of the primary outcomes because only the adverse event reporting system was used. No kappa&#8217;s were reported.</P>
</SUBSECTION>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-02-17 11:22:42 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Heterogeneity and data synthesis</HEADING>
<P>Five different interventions were evaluated in the seven included studies. Two studies explored the effects of clinical pharmacists (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>; <LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK>) but showed clinical and methodological heterogeneity. For example, two different study designs were used; primary endpoints and populations were comparable only in part, and researchers used different methods to obtain primary outcome data. Two studies described the effects of CPOE (<LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK>; <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK>). Again, differences in endpoints, methods of data collection, populations and study design were noted. As a result of this heterogeneity, data synthesis was impossible.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effects of interventions as reported in included studies</HEADING>
<P>The study by <LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK> described the effects of including a unit-based clinical pharmacist with a CBA study design. During the study period, a total of 4863 admissions with 10,385 admission days were studied in ICU wards, general medical wards and general surgical wards. Serious MEs were chosen as the primary outcome. The baseline rate of serious MEs in the paediatric ICU was 29 per 1000 admission days. After the clinical pharmacist was introduced, the paediatric ICU rate dropped to six per 1000 admission days. Study authors report a statistically significant difference between the paediatric ICU (intervention unit) and the cardiac ICU (control unit) after the unit-based clinical pharmacist was introduced (P value &lt; 0.01). On the general medical ward and the general surgical wards, results were not significant. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<P>The RCT by <LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK> reported on the effects of including a clinical pharmacist. Data on 150 participants were analysed. For this review, only length of stay and costs were results of interest. On the wards where a clinical pharmacist was part of the team, length of stay decreased from 9.06 to 7.33 days (P value 0.02). This reduction was seen mainly in patients with a respiratory system disease. Costs of both drugs and hospitalisation did not change (P value 0.945 and P value 0.125). See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<P>The ITS study by <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK> described the effects of CPOE. During the study period, a total of 627 admissions with 3234 admission days and 12,672 medications were analysed. The rate of non-intercepted serious MEs was chosen as the primary outcome. The incidence of non-intercepted serious MEs was 23.1 per 1000 admission days in the pre-intervention period and 20.6 per 1000 admission days in the post-CPOE period. Time series regression analysis indicated a 7% drop in rates of non-intercepted serious MEs (P value 0.0495) after implementation of CPOE. No change was seen in slopes of regression lines before and after the intervention. The incidence of harm as a result of error (preventable ADEs) was 7.9 per 1000 admission days in the pre-intervention period and 6.5 per 1000 admission days in the post-CPOE period. Study authors reported that time series regression analyses showed no differences. The study author when contacted did not reveal additional quantitative information. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<P>The CBA study by <LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK> described the effects of CPOE. During the study period, a total of 36,103 participants and 179,183 admission days were studied. Primary outcomes were MEs and ADEs (injuries as a result of error). In the pre-CPOE period, 173 MEs (4.48 per 1000 admission days) were discovered on the intervention wards and 243 (4.80 per 1000 admission days) on the control wards. In the post-CPOE period, the incidence of MEs was 120 (3.13 per 1000 admission days) on the intervention wards and 268 (5.19 per 1000 admission days) on the control wards. The change in rate ratios of MEs after implementation of CPOE is expressed as odds ratio (OR) 1.54 (95% confidence interval (CI) 1.27 to 1.88). Also potential ADEs were reduced after CPOE implementation: OR 0.24, 95% CI 0.09 to 0.68. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<P>The study by <LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009</LINK> described the effects of BCMA using a CBA study design. During the study period, a total of 958 admissions, representing 12,248 patient-days and 92,398 medication doses, were studied. Primary outcomes were targeted preventable ADEs, and secondary outcomes were potential ADEs and MEs. Unadjusted analysis shows a reduction in targeted preventable ADEs. Potential ADEs were also decreased. In contrast, MEs were increased after implementation of BCMA. Study authors used a generalised estimating equation (GEE) to adjust for non-linearity and additional co-variates. Results of the GEE show a relative risk of targeted preventable ADEs in the intervention group of 0.53 (95% CI 0.29 to 0.98). Adjusted results for MEs are not reported. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<P>The study by <LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK> reported on the effectiveness of the check and correct checklist for prescribing errors using an ITS study design. During the study period, a total of 1887 medication orders, comprising 30,105 opportunities for technical errors and 1163 for clinical errors, were studied. Two outcomes were defined: technical prescription writing errors ("technical errors") and prescribing errors involving clinical decision making ("clinical errors"). Data were analysed using segmented regression analysis, corrected for overall documentation quality of medical records, which was chosen as a concurrent control measurement. This analysis revealed a decrease of 5% in the technical error rate (95% CI -7.09% to -2.95%) after the intervention. A decrease in the trend was also reported: -0.21 (95% CI -0.41 to -0.01). Regarding clinical medication errors, study authors reported no effect. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<P>The RCT by <LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK> reported on the effects of a structured, pre-printed medication order sheet on prescriptions for patients visiting a paediatric emergency department. During the month of the study, data from 2058 participants were obtained. A total of 411 medications were prescribed on the regular form, and 376 medications were prescribed on the new form. Two outcomes were reported: the total numbers of medication prescribing errors and medication errors that were considered significantly or severely harmful. Medication errors were identified in 68 prescriptions when the regular form was used and in 37 prescriptions on the new form. Analysis revealed a reduction in medication errors: adjusted OR 0.55 (95% CI 0.34 to 0.90). Potentially harmful MEs (significant and severe errors) were reduced from 36 when the regular form was used to 14 on the days when the new form was used. This reduction was substantial: adjusted OR 0.39 (95% CI 0.21 to 0.77). See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-02-17 11:39:43 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Summary of main results</HEADING>
<P>Currently evidence is limited on interventions that are effective in preventing medication errors (MEs) in a paediatric population in hospital. We included seven studies describing five different organisational interventions: a clinical pharmacist, computerised physician order entry (CPOE), a barcode medication administration system (BCMA), a structured prescribing form and a check and control checklist in combination with feedback. Clinical and methodological heterogeneity between studies precluded meta-analyses. Although some interventions described in this review show a decrease in MEs, results are not consistent, and none of the studies reported a significant reduction in patient harm. Based on the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach, overall quality and strengfh of the evidence are low.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Overall completeness and applicability of evidence</HEADING>
<P>We aimed to create an overview concerning the effectiveness of interventions to reduce medication errors and related harm in children. Because medication safety in paediatric care is different from that in adult care, interventions preferably include components that focus on specific paediatric safety issues, for example, clinical decision support, calculation aids and dosage control. This review describes five different interventions from seven studies, which were evaluated according to the EPOC (Effective Practice and Organisation of Care Group) criteria.</P>
<P>First, a clinical pharmacist might serve as a valuable contribution at different stages of the medication process. Both <LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK> and <LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK> described the contributions of a clinical pharmacist, for example, in advising doctors on drug selection and dosage, advising nurses on preparation and administration and providing monitoring and education. <LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK> mentioned the level of education and skills of the clinical pharmacist. Second, information technology might play an important role in medication safety. The recommended system includes CPOE and BCMA, because each system targets specific types of medication errors. In paediatric care, a CPOE is required that is sufficiently flexible to respond to rapid and specific changes that occur in children, and continuous adaptation to weight changes must be possible (<LINK REF="REF-Johnson-2013" TYPE="REFERENCE">Johnson 2013</LINK>). The CPOE described by <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK> includes specific paediatric features (e.g. weight-based dosage calculator, automatic dosage checks), but <LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK> describes a CPOE system without clinical decision support and with no interface with the pharmacy. Morriss studied a BCMA system, but it remains unclear whether this was connected with CPOE. <LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK> implemented a check and control checklist to identify technical and clinical errors in prescriptions. Included in this intervention were immediate feedback and instruction to the team during ward rounds. The instruction might have highlighted specific features of paediatric pharmaceutical care, such as weight-based dosages or routes of administration. Structured prescribing forms might improve prescribing practices in general, as shown by <LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK>. In conclusion, although all seven studies aimed to improve medication safety for children, not all interventions targeted specific paediatric safety issues.</P>
<P>All studies are coming from North America or Europe, except one that originates from China. Also, all are conducted in tertiary university medical centres, some in highly specialised paediatric wards. This might impact the generalisability of findings.</P>
<P>Other strategies are used to decrease medication errors, such as avoidance of verbal orders, verbal orders read back, medication reconciliation, double check and patient (parent) active participation in care. This review shows that only a handful of medication safety strategies are being studied with robust study designs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Quality of evidence</HEADING>
<P>Based on study design, we graded the quality of the two included randomised controlled trials (<LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK>; <LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK>) and four observational studies (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008;</LINK> <LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK>; <LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009;</LINK> <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK>) as 'low'. We degraded one observational study to 'very low', because results could not be distinguished from other system changes during the study period (<LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Potential biases in the review process</HEADING>
<P>We followed the EPOC Group guidelines for conducting the review, which included performing a very sensitive search of the databases, as well as the grey literature. However, publication bias remains a potential (but unknown) source of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Agreements and disagreements with existing knowledge</HEADING>
<P>We are aware of other reviews that have evaluated the effectiveness of interventions in preventing medication errors in paediatric care.</P>
<P>
<LINK REF="REF-Sanghera-2006" TYPE="REFERENCE">Sanghera 2006</LINK> conducted a systematic review examining whether interventions by clinical pharmacists improve medication safety in children, and <LINK REF="REF-Chedoe-2007" TYPE="REFERENCE">Chedoe 2007</LINK> reviewed the literature to identify strategies to improve medication safety in neonatal intensive care, while including the contribution of a clinical pharmacist. In both reviews, included studies were observational studies without controls (before-after studies or case series). All studies reported significant improvements and concluded that a clinical pharmacist plays an important role in detecting and preventing medication errors. The two studies on this subject included in our systematic review support in part the conclusions based on existing evidence (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>; <LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK>). As described before, Kaushal showed a significant decrease in serious MEs with a full-time clinical pharmacist in a paediatric intensive care unit (PICU), but not on paediatric medical wards. Zhang showed a decrease in length of stay, but not in costs; however these results might be underestimated by contamination between intervention and control groups.</P>
<P>The effect of CPOE has been summarised in three systematic reviews (<LINK REF="REF-Chedoe-2007" TYPE="REFERENCE">Chedoe 2007;</LINK> <LINK REF="REF-Conroy-2007" TYPE="REFERENCE">Conroy 2007</LINK>; <LINK REF="REF-Rosse-van-2009" TYPE="REFERENCE">Rosse van 2009</LINK>). Again, most of the included studies were observational studies; only the research conducted by <LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK> used a controlled before-after design. Most studies report a beneficial effect of CPOE on MEs, but mixed effects on patient harm are reported. Also new errors (e.g. typographical mistakes, poor design of screens) seemed to appear with the use of CPOE (<LINK REF="REF-Cheung-2013" TYPE="REFERENCE">Cheung 2013</LINK>; <LINK REF="REF-Koppel-2005" TYPE="REFERENCE">Koppel 2005</LINK>; <LINK REF="REF-Walsh-2006" TYPE="REFERENCE">Walsh 2006</LINK>). One study reported an increase in mortality rate after implementation of CPOE in a PICU (<LINK REF="REF-Han-2005" TYPE="REFERENCE">Han 2005</LINK>), but this finding was not confirmed (<LINK REF="REF-Del-Baccaro-2006" TYPE="REFERENCE">Del Baccaro 2006</LINK>; <LINK REF="REF-Keene-2007" TYPE="REFERENCE">Keene 2007</LINK>). Computerised clinical decision support as part of CPOE shows multiple functionalities, and the effect on patient care is inconsistent or unknown (<LINK REF="REF-Stultz-2012" TYPE="REFERENCE">Stultz 2012</LINK>). The two studies on this subject included in our systematic review support the mixed results shown in the existing evidence. <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK> described a just significant (P value 0.495) decrease in non-intercepted serious MEs but no reduction in preventable harm. <LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK> showed a significant decrease in MEs but no reduction in harmful ADEs and even an increase in potentially harmful ADEs. These results are not surprising, as the constant need for weight- and surface area-based dosing and unit conversion is the key risk for children, and this risk might only be diminished by a CPOE with specific paediatric features, which was the case in only some of the included studies.</P>
<P>
<LINK REF="REF-Rinke-2014" TYPE="REFERENCE">Rinke 2014</LINK> conducted a systematic review to study interventions to reduce paediatric MEs. Study authors aimed to be as inclusive as possible and therefore used definitions that are broader than the definitions used by the Cochrane EPOC Review Group. This resulted in the inclusion of 63 studies, which the study authors considered as 52 ITS and eight CBA studies. Studies investigated the effects on MEs of the following interventions: CPOE (n = 26), education (n = 20), preprinted order sheets (n = 9), protocol implementation (n = 8), reporting of error rates (n = 7) and pharmacist participation (n = 5). Four studies are included in our systematic review as well (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>; <LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK>; <LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009</LINK>; <LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK>). This review shows that multiple interventions revealed statistically significant results, but many studies show high risk of bias. The observations of Rinke et al are congruent with our conclusions, namely, that evidence on preventing paediatric medication errors is seriously hampered by non-uniform definitions, data collection methods and outcome measures.</P>
<P>
<LINK REF="REF-Manias-2014" TYPE="REFERENCE">Manias 2014</LINK> published a systematic review to study interventions provided to reduce MEs in PICUs. In total, 34 studies were included. Apart from one study (<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>), all were before-after studies without a comparative, concurrent study group. Six types of interventions were studied: CPOE (n = 8), intravenous systems (n = 5), education (n = 11), protocols and guidelines (n = 2), pharmacist involvement (n = 3) and decision support (n = 5). Although the study authors report statistically significant results from meta-analyses for CPOE, intravenous systems and education, they conclude that the evidence remains limited because of variation in definitions and data collection and because of the low quality of the studies. Again, this conclusion is congruent with our observations.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Heterogeneity</HEADING>
<P>Despite efforts toward standardisation (<LINK REF="REF-Lisby-2012" TYPE="REFERENCE">Lisby 2012</LINK>; <LINK REF="REF-Miller-2007" TYPE="REFERENCE">Miller 2007</LINK>; <LINK REF="REF-Yu-2005" TYPE="REFERENCE">Yu 2005</LINK>), we found differences in the definitions of an ME and harm (numerator data) and in study populations (denominator data), creating heterogeneity in the results presented in these studies. For example, numerator data are presented as MEs, serious MEs, technical MEs, harmful MEs or potentially harmful MEs, preventable ADEs or potential ADEs. Denominator data are presented as participants, 1000 admission days, 1000 prescriptions or 1000 gifts. Not all studies categorised MEs by severity of outcome for participants, or different scales were used. This variety in definitions and classifications made accurate comparison of results impossible.</P>
</SUBSECTION>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-02-17 11:32:07 -0500" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2015-02-17 11:30:33 -0500" MODIFIED_BY="[Empty name]">
<P>Organisations implementing interventions to improve medication safety for hospitalised children must be aware that the evidence endorsing these interventions is limited both in volume and in methodological quality. Although some interventions described in this review show a decrease in MEs, the results are not conclusive, and benefits for patients in terms of less harm remain unclear. The relevance of these results should be weighted in the organisational context.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-02-17 11:32:07 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Evidence</HEADING>
<P>Appropriately powered and methodologically sound studies are needed before evidence-based recommendations can be made. Researchers should use the most robust design possible to minimise bias and maximise generalisability. The standard RCT methodology may not be well suited to answering questions concerning medication safety in the light of social and organisational contexts and their changes over time. Cluster-randomised trials, factorial designs or non-randomised designs like interrupted time series must be considered (<LINK REF="REF-Eccles-2003" TYPE="REFERENCE">Eccles 2003</LINK>; <LINK REF="REF-Fan-2010" TYPE="REFERENCE">Fan 2010</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Population </HEADING>
<P>Medication errors are hazardous for all patients, but children are believed to be at exceptionally high risk of harm from such errors. Neonates, infants and surgical paediatric patients are believed to be at higher risk of harm than other children. In addition, medications are very diverse and have a wide range of risk profiles, and MEs do not always cause patient harm. Those with a heightened risk of causing patient harm are known as high-alert medications; their misuse has serious consequences for patients. Therefore it is strongly recommended that research on medication safety should include high-risk populations and high-alert medications. As existing evidence originates from highly specialised pediatric wards in tertiary university medical centres, research from smaller hospitals with fewer resources is welcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intervention and comparison</HEADING>
<P>To improve medication safety in paediatric care, interventions must include components that focus on specific paediatric safety issues, for example, clinical decision support, calculation aids, alerts in cases of underdosage or overdosage, educational interventions and close monitoring. Apart from technical innovations like CPOE and BCMA, non-technical calculation aids and alerts must be subjects of investigation to support professionals in countries where high-tech applications are not feasible. Attention must be focused on comparable participant groups or study sites.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcome</HEADING>
<P>In evaluating safety, patient harm caused by MEs or potentially harmful MEs is more relevant than MEs alone, because errors do not necessarily result in patient harm. Future studies should include (potentially) harmful MEs as main outcome measures. Efforts must be made to ensure uniform definitions of MEs and harm.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Time stamp</HEADING>
<P>Given the vulnerability of paediatric patients in hospital, medication safety should be high on every research agenda.</P>
</SUBSECTION>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2015-02-23 08:22:30 -0500" MODIFIED_BY="[Empty name]">
<P>The authors would like to thank Alain Mayhew and Michelle Fiander for ongoing support provided during the development of this systematic review. We also express our gratitude to the people who critically appraised the final manuscript: Robin Ferner, Orlaith Burke, Francois Cachat, Pierre Durieux, Julia Worswick and Bernard Burnand.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-02-17 07:58:32 -0500" MODIFIED_BY="[Empty name]">
<P>None.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-02-17 07:58:29 -0500" MODIFIED_BY="[Empty name]">
<P>The review authors made substantial contributions to the design of the review (JM, HV, BA, BF, MG, AN, ST, AS), acquisition of data (JM, HV, AS), analysis of data (JM, HV, AS) or drafting of the review (JM, HV, BA, BF, MG, AN, ST, AS). All review authors approved the final version to be submitted (JM, HV, BA, BF, MG, AN, ST, AS).</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-02-17 11:32:45 -0500" MODIFIED_BY="[Empty name]">
<P>In the protocol, we defined two primary outcomes: MEs and patient harm as a result of MEs. During the review, we found that in several included studies, harm was expressed as potentially harmful MEs. We considered this information valuable for this review and report potentially harmful MEs as well.</P>
<P>The review authors' sequence and position have changed.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-02-18 09:11:47 -0500" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2015-02-17 10:42:33 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2015-02-17 10:10:20 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Kaushal-2008" MODIFIED="2015-02-17 10:08:36 -0500" MODIFIED_BY="[Empty name]" NAME="Kaushal 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-02-17 10:08:36 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaushal R, Bates DW, Abramson EL, Soukup JR, Goldmann DA</AU>
<TI>Unit-based clinical pharmacists' prevention of serious medication errors in pediatric inpatients</TI>
<SO>American Journal of Health System Pharmacy</SO>
<YR>2008</YR>
<VL>65</VL>
<PG>1254-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-King-2003" MODIFIED="2015-02-17 10:09:24 -0500" MODIFIED_BY="[Empty name]" NAME="King 2003" YEAR="2003">
<REFERENCE MODIFIED="2015-02-17 10:09:24 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>King WJ, Paice N, Rangrej J, Forestell GJ, Swartz R</AU>
<TI>The effect of computerized physician order entry on medication errors and adverse drug events in pediatric inpatients</TI>
<SO>Pediatrics</SO>
<YR>2003</YR>
<VL>112</VL>
<PG>506-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kozer-2005" MODIFIED="2015-02-17 10:09:37 -0500" MODIFIED_BY="[Empty name]" NAME="Kozer 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-02-17 10:09:37 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kozer E, Scolnik D, Macpherson A, Rauchwerger D, Koren G</AU>
<TI>Using a preprinted order sheet to reduce prescription errors in a pediatric emergency department: a randomized controlled trial</TI>
<SO>Pediatrics</SO>
<YR>2005</YR>
<VL>116</VL>
<PG>1299-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lepee-2012" MODIFIED="2015-02-17 10:09:54 -0500" MODIFIED_BY="[Empty name]" NAME="Lepee 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-02-17 10:09:54 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lepee C, Klaber RE, Benn J, Fletcher PJ, Cortoos P-J, Jacklin A, et al</AU>
<TI>The use of consultant-led ward round checklist tot improve paediatric prescribing: an interrupted time serie study</TI>
<SO>European Journal of Pediatrics</SO>
<YR>2012</YR>
<VL>171</VL>
<PG>1239-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morriss-2009" MODIFIED="2015-02-17 10:10:08 -0500" MODIFIED_BY="[Empty name]" NAME="Morriss 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-02-17 10:10:08 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morriss FH, Abramowitz PW, Nelson SP, Milavetz G, Michael SL, Gordon SN, et al</AU>
<TI>Effectiveness of a barcode medication administration system in reducing preventable adverse drug events in a neonatal intensive care unit: a prospective cohort study</TI>
<SO>Journal of Pediatrics</SO>
<YR>2009</YR>
<VL>154</VL>
<PG>363-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walsh-2008" MODIFIED="2015-02-17 10:10:20 -0500" MODIFIED_BY="[Empty name]" NAME="Walsh 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-02-17 10:10:20 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walsh KE, Landrigan CP, Adams WG, Vinci RJ, Chessare JB, Cooper MR, et al</AU>
<TI>Effect of computer order entry on prevention of serious medication errors in hospitalised children</TI>
<SO>Pediatrics</SO>
<YR>2008</YR>
<VL>121</VL>
<PG>e421-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2012" MODIFIED="2013-05-05 11:20:59 -0400" MODIFIED_BY="Jolanda Maaskant" NAME="Zhang 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-05-05 11:20:59 -0400" MODIFIED_BY="Jolanda Maaskant" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang C, Zhang L, Huang L, Luo R, Wen J</AU>
<TI>Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial</TI>
<SO>PLoS ONE</SO>
<YR>2001</YR>
<VL>7</VL>
<PG>e30856</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-02-17 10:42:33 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Balaguer-Santamaria-2001" MODIFIED="2015-02-17 10:10:36 -0500" MODIFIED_BY="[Empty name]" NAME="Balaguer Santamaria 2001" YEAR="2001">
<REFERENCE MODIFIED="2015-02-17 10:10:36 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balaguer Santamaria JA, Fernandex Ballart JD, Escribano SJ</AU>
<TI>Usefulness of a software package to reduce medication errors in neonatal care</TI>
<SO>Anales Espanoles de Pediatria</SO>
<YR>2001</YR>
<VL>55</VL>
<PG>541-5</PG>
<IDENTIFIERS MODIFIED="2013-05-05 05:44:19 -0400" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burgess-2009" MODIFIED="2013-05-05 05:48:44 -0400" MODIFIED_BY="Jolanda Maaskant" NAME="Burgess 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-05-05 05:48:44 -0400" MODIFIED_BY="Jolanda Maaskant" PRIMARY="NO" TYPE="OTHER">
<AU>Burgess CC</AU>
<TI>Comparison of the effectiveness of traditional nursing medication administration with the Color Coding Kids system in a sample of undergraduate nursing students</TI>
<SO>Dissertation University of North Carolina</SO>
<YR>2009</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burmester-2008" MODIFIED="2015-02-17 10:10:57 -0500" MODIFIED_BY="[Empty name]" NAME="Burmester 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-02-17 10:10:57 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burmester MK, Dionne R, Thiagarajan RR, Laussen PG</AU>
<TI>Interventions to reduce medication prescribing errors in a paediatric cardiac intensive care unit</TI>
<SO>Intensive Care Medicine</SO>
<YR>2008</YR>
<VL>34</VL>
<PG>1083-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ching-2014" MODIFIED="2015-02-17 10:11:59 -0500" MODIFIED_BY="[Empty name]" NAME="Ching 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-02-17 10:11:59 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ching JM, Williams BL, Idemoto LM, Blackmore CC</AU>
<TI>Using lean "automation with a human touch" to improve medication safety: a step closer to the "perfect dose"</TI>
<SO>Joint Commission Journal on Quality and Patient Safety</SO>
<YR>2014</YR>
<VL>40</VL>
<PG>341-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cunningham-2008" MODIFIED="2015-02-17 10:12:14 -0500" MODIFIED_BY="[Empty name]" NAME="Cunningham 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-02-17 10:12:14 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cunningham S, Logan C, Lockerbie L, Dunn MJG, McMurray A, Prescott R</AU>
<TI>Effect of an integrated care pathway on acute asthma/wheeze in children attending hospital: cluster randomized trial</TI>
<SO>The Journal of Pediatrics</SO>
<YR>2008</YR>
<VL>152</VL>
<PG>315-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dehghan_x002d_Nayeri-2013" MODIFIED="2015-02-17 10:12:40 -0500" MODIFIED_BY="[Empty name]" NAME="Dehghan-Nayeri 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-02-17 10:12:40 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dehghan-Nayeri N, Bayat F, Salehi T, Faghihzadeh S</AU>
<TI>The effectiveness of risk management program on pediatric nurses' medication error</TI>
<SO>Iranian Journal on Nursing and Midwifery Research</SO>
<YR>2013</YR>
<VL>18</VL>
<PG>371-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elsaid-2013" MODIFIED="2015-02-17 10:42:33 -0500" MODIFIED_BY="[Empty name]" NAME="Elsaid 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-02-17 10:42:33 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elsaid K, Truong T, Monckeberg M, McCarthy H, Butera J, Collins C</AU>
<TI>Impact of electronic chemotherapy order forms on prescribing errors at an urban medical center: results from an interrupted time-series analysis</TI>
<SO>International Journal on Quality of Health Care</SO>
<YR>2013</YR>
<VL>25</VL>
<PG>656-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frush-2004" MODIFIED="2015-02-17 10:13:57 -0500" MODIFIED_BY="[Empty name]" NAME="Frush 2004" YEAR="2004">
<REFERENCE MODIFIED="2015-02-17 10:13:57 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frush KS, Luo XM, Hutchinson P, Higgins JN</AU>
<TI>Evaluation of a method to reduce over-the-counter medication dosing error</TI>
<SO>Archives of Pediatric &amp; Adolescent Medicine</SO>
<YR>2004</YR>
<VL>158</VL>
<PG>620-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frush-2006" MODIFIED="2013-05-05 06:14:40 -0400" MODIFIED_BY="Jolanda Maaskant" NAME="Frush 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-05-05 06:14:40 -0400" MODIFIED_BY="Jolanda Maaskant" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frush K, Hohenhaus S, Luo X, Gerardi M, Wiebe RA</AU>
<TI>Evaluation of a web-based education program on reducing medication error: a multicenter, randomized controlled trial</TI>
<SO>Pediatric Emergency Care</SO>
<YR>2006</YR>
<VL>22</VL>
<PG>62-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gazarian-2012" MODIFIED="2015-02-17 10:14:30 -0500" MODIFIED_BY="[Empty name]" NAME="Gazarian 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-02-17 10:14:30 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gazarian M, Graudins LV</AU>
<TI>Long-term reduction in adverse drug events: an evidence-based improvement model</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>129</VL>
<PG>e1334-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hixson-2009" MODIFIED="2015-02-17 10:14:49 -0500" MODIFIED_BY="[Empty name]" NAME="Hixson 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-02-17 10:14:49 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hixson R, Gandhi M, Holton F</AU>
<TI>A randomised trial to evaluate prescribing accuracy when using the Paediatric Analgesia Wheel</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>2009</YR>
<VL>94</VL>
<PG>268-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hohenhaus-2008" MODIFIED="2015-02-17 10:15:07 -0500" MODIFIED_BY="[Empty name]" NAME="Hohenhaus 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-02-17 10:15:07 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hohenhaus SM, Cadwell SM, Stone-Griffith S, Sears-Russell N, Baxter T, Hicks W, et al</AU>
<TI>Assessment of emergency nursing practice during critical pediatric medication administration in a simulated resuscitation using the "Color Coding Kids Hospital System"</TI>
<SO>Advanced Nursing Emergency Journal</SO>
<YR>2008</YR>
<VL>30</VL>
<PG>233-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nguyen-2014" MODIFIED="2015-02-17 10:15:42 -0500" MODIFIED_BY="[Empty name]" NAME="Nguyen 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-02-17 10:15:42 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nguyen HT, Pham HT, Vo DK, Nguyen TD, van den Heuvel ER, Haaijer-Ruskamp FM, et al</AU>
<TI>The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study</TI>
<SO>BMJ Quality and Safety</SO>
<YR>2014</YR>
<VL>23</VL>
<PG>319-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niemann_x002c_-Bertsche-2014" MODIFIED="2015-02-17 10:16:50 -0500" MODIFIED_BY="[Empty name]" NAME="Niemann, Bertsche 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-02-17 10:16:50 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Niemann D, Bertsche A, Meyrath D, Oelsner S, Ewen AL, Pickardt B, et al</AU>
<TI>Drug handling in a paediatric intensive care unit: can errors be prevented by a three-step intervention</TI>
<SO>Klinische Padiatrie</SO>
<YR>2014</YR>
<VL>226</VL>
<PG>62-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niemann-2014" MODIFIED="2015-02-17 10:20:18 -0500" MODIFIED_BY="[Empty name]" NAME="Niemann 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-02-17 10:20:18 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Niemann D, Bertsche A, Meyrath D, Koepf ED, Traiser C, Seebald K, et al</AU>
<TI>A prospective three-step intervention study to prevent medication errors in drug handling in paediatric care</TI>
<SO>Journal of Clinical Nursing</SO>
<YR>2014</YR>
<VL>June</VL>
<PG>doi:10.1111/jocn.12592 (epub ahead of printing)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramsay-2014" MODIFIED="2015-02-17 10:20:52 -0500" MODIFIED_BY="[Empty name]" NAME="Ramsay 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-02-17 10:20:52 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramsay AI, Turner S, Cavell G, Oborne CA, Thomas RE, Cookson G, et al</AU>
<TI>Governing patient safety: lessons learned from a mixed methods evaluation of implementing a ward-level medication safety scorecard in two English NHS hospitals</TI>
<SO>BMJ Quality and Safety</SO>
<YR>2014</YR>
<VL>23</VL>
<PG>136-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Senner-2010" MODIFIED="2015-02-17 10:21:12 -0500" MODIFIED_BY="[Empty name]" NAME="Senner 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-02-17 10:21:12 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Senner A, Byrne L, Fischmann A, Daly G, Wright F, Cohn R, et al</AU>
<TI>A simple intervention targeting patient safety at the bedside</TI>
<SO>Journal of Oncology Pharmacy Practice Conference</SO>
<YR>2010</YR>
<VL>16(2 suppl)</VL>
<PG>6-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vaidya-2006" MODIFIED="2015-02-17 10:22:16 -0500" MODIFIED_BY="[Empty name]" NAME="Vaidya 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-02-17 10:22:16 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Vaidya V, Sowan AK, Mills ME, Soeken K, Gaffoor M, Hilmas E</AU>
<TI>Evaluating the safety and efficiency of a CPOE system for continuous medication infusions in a pediatric ICU</TI>
<SO>AMIA Symposium Proceedings, page 1128</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yamamoto-2010" MODIFIED="2015-02-17 10:22:33 -0500" MODIFIED_BY="[Empty name]" NAME="Yamamoto 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-02-17 10:22:33 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yamamoto L, Kanemori J</AU>
<TI>Comparing errors in ED computer-assisted vs conventional pediatric drug dosing and administration</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>2010</YR>
<VL>28</VL>
<PG>588-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yin-2008" MODIFIED="2015-02-17 10:22:46 -0500" MODIFIED_BY="[Empty name]" NAME="Yin 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-02-17 10:22:46 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yin HS, Dreyer BP, van Schaick SL, Foltin GL, Dinglas C, Mendelsohn AL</AU>
<TI>Rndomized controlled trial of a pictogram-based intervention to reduce liquid medication dosing errors and improve adherence among caregivers and young children</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>2008</YR>
<VL>162</VL>
<PG>814-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yin-2011" MODIFIED="2015-02-17 10:23:01 -0500" MODIFIED_BY="[Empty name]" NAME="Yin 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-02-17 10:23:01 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yin HS, Medelsohn AL, Fierman A, van Schaick SL, Bazan IS, Dreyer BP</AU>
<TI>Use of a pictographic diagram to decrease parent dosing errors with infant acetaminophen: a health literacy perspective</TI>
<SO>Academic Pediatrics</SO>
<YR>2011</YR>
<VL>11</VL>
<PG>50-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-05-30 04:59:33 -0400" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2013-05-05 12:37:16 -0400" MODIFIED_BY="Jolanda Maaskant">
<STUDY DATA_SOURCE="PUB" ID="STD-Kaushal" MODIFIED="2013-05-05 12:37:16 -0400" MODIFIED_BY="Jolanda Maaskant" NAME="Kaushal" YEAR="2000">
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-02-18 09:11:47 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-02-18 09:11:47 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Aspden-2007" MODIFIED="2015-02-17 10:23:42 -0500" MODIFIED_BY="[Empty name]" NAME="Aspden 2007" TYPE="BOOK">
<AU>Aspden P, Wolcott JA, Bootman L, Cronenwelt LR</AU>
<SO>Prevention Medication Errors: Quality Chasm Series</SO>
<YR>2007</YR>
<PB>The National Academic Press</PB>
<CY>Washington DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chedoe-2007" MODIFIED="2015-02-17 10:23:58 -0500" MODIFIED_BY="[Empty name]" NAME="Chedoe 2007" TYPE="JOURNAL_ARTICLE">
<AU>Chedoe I, Molendijk HA, Dittrich ST, Jansman FG, Harting JW, Brouwers JR, et al</AU>
<TI>Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety</TI>
<SO>Drug Safety</SO>
<YR>2007</YR>
<VL>30</VL>
<PG>503-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cheung-2013" MODIFIED="2015-01-29 10:39:28 -0500" MODIFIED_BY="[Empty name]" NAME="Cheung 2013" TYPE="JOURNAL_ARTICLE">
<AU>Cheung KC, Veen van der W, Bouvy ML, Wensing M, Bemt van den PM, Smet de PA</AU>
<TI>Classification of medication incidents associated with information technology</TI>
<SO>Journal of the American Medical Informatics Association</SO>
<YR>2014</YR>
<VL>21</VL>
<NO>E1</NO>
<PG>e63-e70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Conroy-2007" MODIFIED="2015-02-17 10:24:17 -0500" MODIFIED_BY="[Empty name]" NAME="Conroy 2007" TYPE="JOURNAL_ARTICLE">
<AU>Conroy S, Sweis D, Planner C, Yeung V, Collier J, Haines L, Wong IC</AU>
<TI>Interventions to reduce dosing errors in children: a systematic review of the literature</TI>
<SO>Drug Safety</SO>
<YR>2007</YR>
<VL>30</VL>
<PG>1111-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cousins-2002" MODIFIED="2015-02-17 10:24:38 -0500" MODIFIED_BY="[Empty name]" NAME="Cousins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Cousins D, Clarkson A, Conroy S, Choonara I</AU>
<TI>Medication errors in children - an eight year review using press reports</TI>
<SO>Paediatric and Perinatal Drug Therapy</SO>
<YR>2002</YR>
<VL>5</VL>
<PG>52-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davidhizar-2002" MODIFIED="2013-01-14 05:20:40 -0500" MODIFIED_BY="[Empty name]" NAME="Davidhizar 2002" TYPE="JOURNAL_ARTICLE">
<AU>Davidhizar R, Lonser G</AU>
<TI>Medication errors: what case managers can do</TI>
<SO>Hospital Case Management</SO>
<YR>2002</YR>
<VL>10</VL>
<PG>77-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Del-Baccaro-2006" MODIFIED="2015-02-17 10:25:02 -0500" MODIFIED_BY="[Empty name]" NAME="Del Baccaro 2006" TYPE="JOURNAL_ARTICLE">
<AU>Del Baccaro MA, Jeffries HE, Eisenberg MA, Harry ED</AU>
<TI>Computerized provider order entry implementation: no association with increased mortality rates in an intensive care unit</TI>
<SO>Pediatrics</SO>
<YR>2006</YR>
<VL>118</VL>
<PG>290-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eccles-2003" MODIFIED="2015-02-17 10:25:18 -0500" MODIFIED_BY="[Empty name]" NAME="Eccles 2003" TYPE="JOURNAL_ARTICLE">
<AU>Eccles M, Grimshaw J, Campbell M, Ramsay C</AU>
<TI>Research designs for studies evaluating the effectiveness of change and improvement strategies</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2003</YR>
<VL>12</VL>
<PG>47-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EPOC-2002" MODIFIED="2015-02-18 09:10:43 -0500" MODIFIED_BY="[Empty name]" NAME="EPOC 2002" TYPE="OTHER">
<TI>The Data Collection Checklist</TI>
<SO>Cochrane Effective Practice and Organisation of Care Review Group</SO>
<YR>2002. www.epoc.uottawa.ca/checklist2002.doc (accessed 12 November 2014)</YR>
<IDENTIFIERS MODIFIED="2012-11-04 08:33:37 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-EPOC-2014" MODIFIED="2015-02-18 09:11:21 -0500" MODIFIED_BY="[Empty name]" NAME="EPOC 2014" TYPE="OTHER">
<AU>Effective Practice and Organisation of Care (EPOC)</AU>
<TI>Suggested risk of bias criteria for EPOC reviews</TI>
<SO>EPOC Resources for Review Authors.</SO>
<VL>Oslo: Norwegian Knowledge Centre for the Health Services; 2014. http://epoc.cochrane.org/epoc-specific-resources-review-authors (accessed 12 November 2014)</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fan-2010" MODIFIED="2015-02-17 10:43:25 -0500" MODIFIED_BY="[Empty name]" NAME="Fan 2010" TYPE="JOURNAL_ARTICLE">
<AU>Fan E, Laupacis A, Pronovost PJ, Guyatt GH, Needham DM</AU>
<TI>How to use an article about quality improvement</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2010</YR>
<VL>304</VL>
<PG>2279-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Franklin-2005" MODIFIED="2015-02-17 10:28:18 -0500" MODIFIED_BY="[Empty name]" NAME="Franklin 2005" TYPE="JOURNAL_ARTICLE">
<AU>Franklin B, Vincent C, Schachter M, Barber N</AU>
<TI>The incidence of prescribing errors in hospital inpatients: an overview of the research methods</TI>
<SO>Drug Safety</SO>
<YR>2005</YR>
<VL>28</VL>
<PG>891-900</PG>
<IDENTIFIERS MODIFIED="2012-04-14 12:50:15 -0400" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Garfield-2013" MODIFIED="2015-02-17 10:28:31 -0500" MODIFIED_BY="[Empty name]" NAME="Garfield 2013" TYPE="JOURNAL_ARTICLE">
<AU>Garfield S, Reynolds M, Dermont L, Franklin BD</AU>
<TI>Measuring the severity of prescribing errors: a systematic review</TI>
<SO>Drug Safety</SO>
<YR>2013</YR>
<VL>36</VL>
<PG>1151-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ghaleb-2006" MODIFIED="2015-02-17 10:28:44 -0500" MODIFIED_BY="[Empty name]" NAME="Ghaleb 2006" TYPE="JOURNAL_ARTICLE">
<AU>Ghaleb MA, Barber N, Franklin BD, Yeung VW, Khaki ZF, Wong IC</AU>
<TI>Systematic review of medication errors in pediatric patients</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>2006</YR>
<VL>40</VL>
<PG>1766-76</PG>
<IDENTIFIERS MODIFIED="2012-03-09 04:39:50 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2008" MODIFIED="2015-02-17 10:28:59 -0500" MODIFIED_BY="[Empty name]" NAME="Guyatt 2008" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al</AU>
<TI>GRADE: an emerging consensus on rating quality of evidence and strength of recommendations</TI>
<SO>BMJ (Clinical research ed)</SO>
<YR>2008</YR>
<VL>336</VL>
<NO>7650</NO>
<PG>924-6</PG>
<IDENTIFIERS MODIFIED="2012-03-09 04:40:05 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Han-2005" MODIFIED="2015-02-17 10:29:15 -0500" MODIFIED_BY="[Empty name]" NAME="Han 2005" TYPE="JOURNAL_ARTICLE">
<AU>Han YY, Carcillo JA, Venkataraman ST, Clark RS, Watson RS, Nguyen TC, et al</AU>
<TI>Unexpected increased mortality rate after implementation of a commercially sold computerized physician order entry system</TI>
<SO>Pediatrics</SO>
<YR>2005</YR>
<VL>116</VL>
<PG>1506-12 (erratum in Pediatrics 2006;117:594)</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-Cochrane-Handbook-2011" MODIFIED="2015-02-17 10:29:37 -0500" MODIFIED_BY="[Empty name]" NAME="Higgins Cochrane Handbook 2011" TYPE="BOOK">
<AU>Higgins J, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>Version 5.1.0 [updated March 2011]</YR>
<PB>Wiley-Blackwell</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hug-2012" MODIFIED="2015-02-17 10:29:56 -0500" MODIFIED_BY="[Empty name]" NAME="Hug 2012" TYPE="JOURNAL_ARTICLE">
<AU>Hug BL, Keohane C, Seger DL, Yoon C, Bates DW</AU>
<TI>The costs of adverse drug events in community hospitals</TI>
<SO>Joint Commission Journal on Quality and Patient Safety/Joint Commission Resources</SO>
<YR>2012</YR>
<VL>38</VL>
<PG>120-6</PG>
<IDENTIFIERS MODIFIED="2012-04-14 12:52:36 -0400" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2013" MODIFIED="2015-02-17 10:30:15 -0500" MODIFIED_BY="[Empty name]" NAME="Johnson 2013" TYPE="JOURNAL_ARTICLE">
<AU>Johnson KB, Lehmann CU; Council on Clinical Information Technology</AU>
<TI>Electronic prescribing in paediatrics: towards safer and more effective medication management</TI>
<SO>Pediatrics</SO>
<YR>2013</YR>
<VL>131</VL>
<PG>1350-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kale-2012" MODIFIED="2015-02-17 10:30:29 -0500" MODIFIED_BY="[Empty name]" NAME="Kale 2012" TYPE="JOURNAL_ARTICLE">
<AU>Kale A, Keohane CA, Maviglia S, Gandhi TK, Poon EG</AU>
<TI>Adverse drug events caused by serious medication administration errors</TI>
<SO>BMJ Quality and Safety</SO>
<YR>2012</YR>
<VL>21</VL>
<PG>933-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kaushal-2001" MODIFIED="2015-02-17 10:44:14 -0500" MODIFIED_BY="[Empty name]" NAME="Kaushal 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, et al</AU>
<TI>Medication errors and adverse drug events in pediatric inpatients</TI>
<SO>Journal of the Aerican Medical Association</SO>
<YR>2001</YR>
<VL>285</VL>
<PG>2114-20</PG>
<IDENTIFIERS MODIFIED="2012-03-09 04:40:29 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Keene-2007" MODIFIED="2015-02-17 10:31:09 -0500" MODIFIED_BY="[Empty name]" NAME="Keene 2007" TYPE="JOURNAL_ARTICLE">
<AU>Keene A, Ashton L, Shure D, Napoleone D, Katyal C, Bellin E</AU>
<TI>Mortality before and after initiation of a computerized physician order entry system in a critically ill pediatric population</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2007</YR>
<VL>8</VL>
<PG>268-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Koppel-2005" MODIFIED="2015-02-17 10:44:39 -0500" MODIFIED_BY="[Empty name]" NAME="Koppel 2005" TYPE="JOURNAL_ARTICLE">
<AU>Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, et al</AU>
<TI>Role of computerized physician order entry systems in facilitating medication errors</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2005</YR>
<VL>293</VL>
<PG>1197-203</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lisby-2010" MODIFIED="2015-02-17 10:32:11 -0500" MODIFIED_BY="[Empty name]" NAME="Lisby 2010" TYPE="JOURNAL_ARTICLE">
<AU>Lisby M, Nielsen LP, Brock B, Mainz J</AU>
<TI>How are medication errors defined? A systematic literature review of definitions and characteristics</TI>
<SO>International Journal for Quality in Health Care (ISQua)</SO>
<YR>2010</YR>
<VL>22</VL>
<PG>507-18</PG>
<IDENTIFIERS MODIFIED="2012-03-09 04:40:40 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Lisby-2012" MODIFIED="2013-01-14 05:40:16 -0500" MODIFIED_BY="Jolanda Maaskant" NAME="Lisby 2012" TYPE="JOURNAL_ARTICLE">
<AU>Lisby M, Nielsen LP, Brock B, Mainz J</AU>
<TI>How should medication errors be defined? Development and test of a definition</TI>
<SO>Scandinavian Journal of Public Health</SO>
<YR>2012</YR>
<VL>40</VL>
<PG>203-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Manias-2014" MODIFIED="2015-02-17 10:32:50 -0500" MODIFIED_BY="[Empty name]" NAME="Manias 2014" TYPE="JOURNAL_ARTICLE">
<AU>Manias E, Kinney S, Cranswick N, Williams A, Borrott N</AU>
<TI>Interventions to reduce medication errors in pediatric intensive care</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>2014</YR>
<VL>48</VL>
<PG>1313-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meyer_x002d_Massetti-2011" MODIFIED="2015-02-17 10:33:22 -0500" MODIFIED_BY="[Empty name]" NAME="Meyer-Massetti 2011" TYPE="JOURNAL_ARTICLE">
<AU>Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, et al</AU>
<TI>Systematic review of medication safety assessment methods</TI>
<SO>American Journal of Health System Pharmacy</SO>
<YR>2011</YR>
<VL>68</VL>
<PG>227-40</PG>
<IDENTIFIERS MODIFIED="2012-03-09 04:40:54 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Miller-2007" MODIFIED="2015-02-17 10:44:58 -0500" MODIFIED_BY="[Empty name]" NAME="Miller 2007" TYPE="JOURNAL_ARTICLE">
<AU>Miller MR, Robinson KA, Lubomski LH, Rinke ML, Pronovost PJ</AU>
<TI>Medication errors in paediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2007</YR>
<VL>16</VL>
<PG>116-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morimoto-2004" MODIFIED="2015-02-17 10:45:09 -0500" MODIFIED_BY="[Empty name]" NAME="Morimoto 2004" TYPE="JOURNAL_ARTICLE">
<AU>Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW</AU>
<TI>Adverse drug events and medication errors: detection and classification methods</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2004</YR>
<VL>13</VL>
<PG>306-14</PG>
<IDENTIFIERS MODIFIED="2012-03-09 04:41:08 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-NCC-MERP" MODIFIED="2015-02-17 10:34:03 -0500" MODIFIED_BY="[Empty name]" NAME="NCC MERP" TYPE="OTHER">
<AU>National Coordinating Council for Medication Error Reporting and Prevention</AU>
<TI>About medication errors: what is a medication error?</TI>
<SO>http://www.nccmerp.org/about-medication-errors</SO>
<YR>(accessed 8 March 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olsen-2007" MODIFIED="2015-02-17 10:45:28 -0500" MODIFIED_BY="[Empty name]" NAME="Olsen 2007" TYPE="JOURNAL_ARTICLE">
<AU>Olsen S, Neale G, Schwab K, Psaila B, Patel T, Chapman EJ, et al</AU>
<TI>Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2007</YR>
<VL>16</VL>
<PG>40-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oren-2003" MODIFIED="2013-01-15 22:09:27 -0500" MODIFIED_BY="[Empty name]" NAME="Oren 2003" TYPE="JOURNAL_ARTICLE">
<AU>Oren E, Shaffer ER, Guglielmo BJ</AU>
<TI>Impact of emerging technologies on medication errors and adverse drug events</TI>
<SO>Americal Journal of Health System Pharmacology</SO>
<YR>2003</YR>
<VL>60</VL>
<PG>1447-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ramsay-2003" MODIFIED="2015-02-17 10:35:45 -0500" MODIFIED_BY="[Empty name]" NAME="Ramsay 2003" TYPE="JOURNAL_ARTICLE">
<AU>Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE</AU>
<TI>Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2003</YR>
<VL>19</VL>
<PG>613-23</PG>
<IDENTIFIERS MODIFIED="2012-03-09 04:41:24 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Rinke-2014" MODIFIED="2015-02-17 10:36:13 -0500" MODIFIED_BY="[Empty name]" NAME="Rinke 2014" TYPE="JOURNAL_ARTICLE">
<AU>Rinke ML, Bundy DG, Valesquez CA, Rao S, Zerhouni Y, Lobner K, et al</AU>
<TI>Interventions to reduce pediatric medication errors: a systematic review</TI>
<SO>Pediatrics</SO>
<YR>2014</YR>
<VL>134</VL>
<PG>338-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosse-van-2009" MODIFIED="2015-02-17 10:36:26 -0500" MODIFIED_BY="[Empty name]" NAME="Rosse van 2009" TYPE="JOURNAL_ARTICLE">
<AU>Rosse van F, Maat B, Rademaker CM, Vlught van AJ, Egberts AC, Bollen CW</AU>
<TI>The effect of computerized physician order entry on medication prescription errors and clinical outcome in pediatric and intensive care: a systematic review</TI>
<SO>Pediatrics</SO>
<YR>2009</YR>
<VL>123</VL>
<PG>1184-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Samp-2014" MODIFIED="2015-02-17 10:36:39 -0500" MODIFIED_BY="[Empty name]" NAME="Samp 2014" TYPE="JOURNAL_ARTICLE">
<AU>Samp JC, Touchette DR, Marinac JS, Kuo GM; American College of Clinical Pharmacy Practice-Based Research Network Collaborative</AU>
<TI>Economic evaluation of the impact of medication errors reported by US clinical pharmacists</TI>
<SO>Pharmacotherapy</SO>
<YR>2014</YR>
<VL>34</VL>
<PG>350-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sanghera-2006" MODIFIED="2015-02-17 10:36:52 -0500" MODIFIED_BY="[Empty name]" NAME="Sanghera 2006" TYPE="JOURNAL_ARTICLE">
<AU>Sanghera N, Chan P, Khaki ZF, Planner C, Lee KK, Cranswick NE, et al</AU>
<TI>Interventions of hospital pharmacists in improving drug therapy in children</TI>
<SO>Drug Safety</SO>
<YR>2006</YR>
<VL>29</VL>
<PG>1031-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Santell-2003" MODIFIED="2015-02-17 10:37:08 -0500" MODIFIED_BY="[Empty name]" NAME="Santell 2003" TYPE="JOURNAL_ARTICLE">
<AU>Santell JP</AU>
<TI>Medication errors: experience of the United States Pharmacopeia (USP) MEDMARX reporting system</TI>
<SO>Journal of Medical Pharmacology</SO>
<YR>2003</YR>
<VL>43</VL>
<PG>760-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schunemann-2011" MODIFIED="2015-02-17 10:37:24 -0500" MODIFIED_BY="[Empty name]" NAME="Schunemann 2011" TYPE="JOURNAL_ARTICLE">
<AU>Schunemann H, Hill S, Guyatt G, Akl EA, Ahmed F</AU>
<TI>The GRADE approach and Bradford Hill's criteria for causation</TI>
<SO>Journal of Epidemiology and Community Health</SO>
<YR>2011</YR>
<VL>65</VL>
<PG>392-5</PG>
<IDENTIFIERS MODIFIED="2012-03-09 04:41:35 -0500" MODIFIED_BY="Jolanda Maaskant"/>
</REFERENCE>
<REFERENCE ID="REF-Stucky-2003" MODIFIED="2015-02-17 10:37:36 -0500" MODIFIED_BY="[Empty name]" NAME="Stucky 2003" TYPE="JOURNAL_ARTICLE">
<AU>Stucky ER</AU>
<TI>Prevention of medication errors in the pediatric inpatient setting</TI>
<SO>Pediatrics</SO>
<YR>2003</YR>
<VL>112</VL>
<PG>431-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stultz-2012" MODIFIED="2015-02-17 10:37:51 -0500" MODIFIED_BY="[Empty name]" NAME="Stultz 2012" TYPE="JOURNAL_ARTICLE">
<AU>Stultz JS, Nahata MC</AU>
<TI>Computerized clinical decision support for medication prescribing and utilization in pediatrics</TI>
<SO>Journal of the American Medical Informatics Association</SO>
<YR>2012</YR>
<VL>19</VL>
<PG>942-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tam-2005" MODIFIED="2015-02-17 10:38:26 -0500" MODIFIED_BY="[Empty name]" NAME="Tam 2005" TYPE="JOURNAL_ARTICLE">
<AU>Tam VC</AU>
<TI>Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>2005</YR>
<VL>173</VL>
<PG>510-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vries-de-2008" MODIFIED="2015-02-17 10:38:42 -0500" MODIFIED_BY="[Empty name]" NAME="Vries de 2008" TYPE="JOURNAL_ARTICLE">
<AU>Vries de EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA</AU>
<TI>The incidence and nature of in-hospital adverse events: a systematic review</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2008</YR>
<VL>16</VL>
<PG>216-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walsh-2006" MODIFIED="2015-02-17 10:39:30 -0500" MODIFIED_BY="[Empty name]" NAME="Walsh 2006" TYPE="JOURNAL_ARTICLE">
<AU>Walsh KE, Adams WG, Bauchner H, Vinci RJ, Chessare JB, Cooper MR, et al</AU>
<TI>Medication errors related to computerized order entry for children</TI>
<SO>Pediatrics</SO>
<YR>2006</YR>
<VL>118</VL>
<PG>1872-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weingart--2000" MODIFIED="2015-02-17 10:39:55 -0500" MODIFIED_BY="[Empty name]" NAME="Weingart  2000" TYPE="JOURNAL_ARTICLE">
<AU>Weingart SN, Wilson R, Gibberd RW, Harrison B</AU>
<TI>Epidemiology of medical error - education and debate</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>320</VL>
<PG>774-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2009" MODIFIED="2015-02-18 09:11:47 -0500" MODIFIED_BY="[Empty name]" NAME="WHO 2009" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Conceptial Framework for the International Classification for Patient Safety</TI>
<SO>Final Technical Report</SO>
<YR>2009 [Version 1.1]. http://www.who.int/patientsafety/implementation/taxonomy/en/ (accessed 12 November 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yu-2005" MODIFIED="2015-02-17 10:41:56 -0500" MODIFIED_BY="[Empty name]" NAME="Yu 2005" TYPE="JOURNAL_ARTICLE">
<AU>Yu KH, Nation RL, Dooley MJ</AU>
<TI>Multiplicity of medication safety terms, definitions and functional meanings: when is enough enough?</TI>
<SO>Quality and Safety in Health Care</SO>
<YR>2005</YR>
<VL>14</VL>
<PG>358-63</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-02-17 15:46:08 -0500" MODIFIED_BY="Julia Worswick">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-02-17 15:46:08 -0500" MODIFIED_BY="Julia Worswick" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-02-17 08:01:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaushal-2008">
<CHAR_METHODS MODIFIED="2013-05-05 11:39:05 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Controlled before-after study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-17 08:00:45 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Setting</I>
</P>
<P>Medical, surgical and ICU, as part of a paediatric teaching hospital, USA</P>
<P>
<I>Patients</I>
</P>
<P>Patients admitted to participating wards. Total number of participants in the study was 4863, of whom less than 5% were adults. Demographic characteristics are described in detail</P>
<P>
<I>Professionals</I>
</P>
<P>Not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-17 08:01:00 -0500" MODIFIED_BY="[Empty name]">
<P>Clinical pharmacist (full time in the PICU and part time on the medical and surgical wards) compared with no clinical pharmacist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-17 08:01:12 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Primary outcomes</I>
</P>
<P>Serious MEs, defined as preventable ADEs (harm to patients as a result of MEs) and non-intercepted near misses (MEs with significant potential for injuring patients)</P>
<P>
<I>Secondary outcomes</I>
</P>
<P>-</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-17 08:01:42 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Period</I>
</P>
<P>Pre-intervention 6 to 8 weeks each ward between March and August 2000 (1576 participants) and post-intervention 3 months each ward between June and November 2000 (3287 patients)</P>
<P>
<I>Other</I>
</P>
<P>Sample size calculation not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-02-17 08:09:00 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-King-2003">
<CHAR_METHODS MODIFIED="2013-05-05 11:39:12 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Controlled before-after study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-17 08:07:35 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Setting</I>
</P>
<P>Medical and surgical paediatric wards, as part of a tertiary care paediatric teaching hospital, Canada</P>
<P>
<I>Patients</I>
</P>
<P>Total number of participants was 36,103. Average age of participants was 6.3 years</P>
<P>
<I>Professionals</I>
</P>
<P>Intervention wards: a team consisting of paediatric generalists and subspecialists with assistance from paediatric residents, interns and medical students</P>
<P>Control wards: not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-17 08:07:41 -0500" MODIFIED_BY="[Empty name]">
<P>CPOE compared with handwritten orders</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-17 08:08:24 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Primary outcomes</I>
</P>
<P>MEs, defined as any events involving medication prescription, dispensing, administration or monitoring, irrespective of outcome</P>
<P>ADEs, defined as medication errors resulting in injury to the patient</P>
<P>
<I>Secondary outcomes</I>
</P>
<P>Potential ADEs, defined as medication errors with the potential for patient injury when no actual harm occurred</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-17 08:09:00 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Period</I>
</P>
<P>3 years before (from April 1993 to March 1996; 18,618 participants) and 3 years after (from January 1997 to December 1999; 17,485 participants) implementation of CPOE</P>
<P>
<I>Other</I>
</P>
<P>Sample size calculation not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-02-17 08:47:32 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kozer-2005">
<CHAR_METHODS MODIFIED="2015-02-17 08:11:09 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-17 08:45:35 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Setting</I>
</P>
<P>Paediatric emergency department, part of a tertiary care paediatric facility, Canada</P>
<P>
<I>Patients</I>
</P>
<P>All children on participating days (non-urgent, semi-urgent, urgent and emergent/resuscitation). The study does not report on participant characteristics. In total, 2058 participants with 787 orders were included: intervention group 376 orders; control group 411 orders</P>
<P>
<I>Professionals</I>
</P>
<P>Medical doctors, staff and trainees</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-17 08:45:49 -0500" MODIFIED_BY="[Empty name]">
<P>Structured, pre-printed medication order sheet compared with regular blank order sheets (regular form)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-17 08:47:23 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Primary outcomes</I>
</P>
<P>Medication prescribing errors, defined as drug regimen different from recommended (dose difference &#8805; 20%, deviation &#8805; 2 hours from the recommended interval between doses and wrong unit or route of administration). Absence of date and unclear signature were not considered errors</P>
<P>
<I>Secondary outcomes</I>
</P>
<P>Severity of medication prescribing errors</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-17 08:47:32 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Period</I>
</P>
<P>July 2001 (1 month)</P>
<P>
<I>Other</I>
</P>
<P>Sample size calculation not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-02-17 08:52:17 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lepee-2012">
<CHAR_METHODS MODIFIED="2013-05-05 11:45:24 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Interrupted time series</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-17 08:51:03 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Setting</I>
</P>
<P>2 paediatric wards, together comprising 24 beds, part of an academic health sciences centre, United Kingdom</P>
<P>
<I>Patients</I>
</P>
<P>The study does not report on participant characteristics</P>
<P>
<I>Professionals</I>
</P>
<P>Nurses, medical consultants, doctors in training (from 4 months' to over 10 years&#8217; experience in paediatrics)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-17 08:51:16 -0500" MODIFIED_BY="[Empty name]">
<P>Check and correct checklist compared with no such checklist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-17 08:51:49 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Primary outcomes</I>
</P>
<P>Technical (prescribing) errors, defined as unclear or missing information on the prescription</P>
<P>
<I>Secondary outcomes</I>
</P>
<P>Clinical (prescribing) errors, defined as unintentional significant reductions in the probability of treatment being timely and effective, or an increase in the risk of harm when compared with generally accepted practice</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-17 08:52:17 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Period</I>
</P>
<P>Pre-intervention from 15 March until 15 May 2011 (2 months, 18 data points) and post-intervention from 23 May until 23 July 2011 (2 months, 18 data points)</P>
<P>
<I>Other</I>
</P>
<P>Quality of documentation in participants' medical notes as a concurrent control measurement</P>
<P>Sample size calculation not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-02-17 08:55:20 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morriss-2009">
<CHAR_METHODS MODIFIED="2013-05-26 09:26:54 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Controlled before-after study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-17 08:54:03 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Setting</I>
</P>
<P>NICU, part of a university children's hospital, USA</P>
<P>
<I>Patients</I>
</P>
<P>All 958 patients admitted during the study periods were participants. The gestational age of participants was 34.5 (SD 4.8) weeks</P>
<P>
<I>Professionals</I>
</P>
<P>Not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-17 08:54:27 -0500" MODIFIED_BY="[Empty name]">
<P>Barcode medication administration system (BCMA, intervention group, 475 participants, 46,308 doses administered) compared with no BCMA (control group, 483 participants, 46,090 doses administered)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-17 08:55:07 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Primary outcomes</I>
</P>
<P>Targeted preventable adverse drug events, defined as ADEs that are expected to be prevented by a BCMA system</P>
<P>
<I>Secondary outcomes</I>
</P>
<P>MEs, defined as errors in ordering, transcribing, dispensing, administering or monitoring a medication</P>
<P>Potential MEs, defined as MEs that could have harmed the participant but did not</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-17 08:55:20 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Period</I>
</P>
<P>A total of 50 weeks</P>
<P>
<I>Other</I>
</P>
<P>Researchers calculated that a study during which 92,000 medications were administered could detect a 45% or greater decrease in the primary outcome</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-02-17 11:38:13 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Walsh-2008">
<CHAR_METHODS MODIFIED="2013-05-05 11:41:31 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Interrupted time series</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-17 08:57:31 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Setting</I>
</P>
<P>PICU, NICU and surgical and medical paediatric wards, part of an urban medical centre, United States of America</P>
<P>
<I>Patients</I>
</P>
<P>A random sample of 627 admissions. Median age of participants was 4 years; participants had different racial/ethnic backgrounds and diagnoses, and median length of stay was 3 days</P>
<P>
<I>Professionals</I>
</P>
<P>Paediatric nurses and paediatricians</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-17 11:38:13 -0500" MODIFIED_BY="[Empty name]">
<P>Computerised physician order entry system (CPOE) compared with handwritten orders</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-17 08:58:01 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Primary outcomes</I>
</P>
<P>Non-intercepted serious MEs, defined as MEs that caused harm or had substantial potential to cause harm and were not caught by hospital staff</P>
<P>
<I>Secondary outcomes</I>
</P>
<P>Preventable adverse drug events, defined as MEs that resulted in patient harm</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-17 08:58:30 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Period</I>
</P>
<P>Pre-intervention from September 2001 until March 2002 (7 months, 7 data collection points, 275 participants) and post-intervention from September 2002 until May 2003 (9 months, 9 data collection points, 352 participants)</P>
<P>
<I>Other</I>
</P>
<P>Sample size calculation not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-02-17 09:05:10 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2012">
<CHAR_METHODS MODIFIED="2015-02-17 09:01:18 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-17 09:04:04 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Setting</I>
</P>
<P>Paediatric wards, part of a university hospital, China</P>
<P>
<I>Patients</I>
</P>
<P>Children from birth to 18 years old, with nervous system, respiratory system or digestive system diseases. In total, 150 participants were included, 76 in the intervention group and 74 in the control group. In both groups, most participants (70% and 69%) were younger than 5 years of age</P>
<P>
<I>Professionals</I>
</P>
<P>Not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-17 09:04:16 -0500" MODIFIED_BY="[Empty name]">
<P>Clinical pharmacist compared with the traditional medical model</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-17 09:04:41 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Primary outcomes</I>
</P>
<P>Interventions by clinical pharmacists, adverse drug reactions (side effects), length of stay and costs of drugs and hospitalisation</P>
<P>
<I>Secondary outcomes</I>
</P>
<P>Medication compliance rate after discharge and readmission rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-17 09:05:10 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>Period</I>
</P>
<P>From December 1, 2010, until March 31, 2011 (4 months)</P>
<P>
<I>Other</I>
</P>
<P>No definitions of outcomes reported</P>
<P>Researchers calculated a sample size of 160 participants, with 80 in each group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ADE: adverse drug event.</P>
<P>BCMA: barcode medication administration.</P>
<P>CBA: controlled before-after study.</P>
<P>CPOE: computerised physician order entry.</P>
<P>ED: emergency department.</P>
<P>ICU: intensive care unit.</P>
<P>ME: medication error.</P>
<P>NICU: newborn intensive care unit.</P>
<P>PICU: paediatric intensive care unit.</P>
<P>SD: standard deviation.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-02-17 09:08:43 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:06:22 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Balaguer-Santamaria-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:06:22 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:06:29 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burgess-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:06:29 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:06:34 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burmester-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:06:34 -0500" MODIFIED_BY="[Empty name]">
<P>Before-after design without control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:06:40 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ching-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:06:40 -0500" MODIFIED_BY="[Empty name]">
<P>No data on hospitalised children</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:06:43 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cunningham-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:06:43 -0500" MODIFIED_BY="[Empty name]">
<P>Medication safety is not the aim of the intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:06:47 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dehghan_x002d_Nayeri-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:06:47 -0500" MODIFIED_BY="[Empty name]">
<P>Before-after design without control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:06:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Elsaid-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:06:57 -0500" MODIFIED_BY="[Empty name]">
<P>No data on hospitalised children</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:07:30 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frush-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:07:30 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation, no hospital setting</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:07:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frush-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:07:42 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:07:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gazarian-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:07:44 -0500" MODIFIED_BY="[Empty name]">
<P>Before-after design without control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:07:49 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hixson-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:07:49 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:07:54 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hohenhaus-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:07:54 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:03 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nguyen-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:03 -0500" MODIFIED_BY="[Empty name]">
<P>Controlled before-after design with 1 intervention and 1 control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:06 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Niemann-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:06 -0500" MODIFIED_BY="[Empty name]">
<P>Before-after design without control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:09 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Niemann_x002c_-Bertsche-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:09 -0500" MODIFIED_BY="[Empty name]">
<P>Before-after design without control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:20 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramsay-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:20 -0500" MODIFIED_BY="[Empty name]">
<P>No data on hospitalised children</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:23 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Senner-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:23 -0500" MODIFIED_BY="[Empty name]">
<P>Before-after design without control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vaidya-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:27 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:32 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yamamoto-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:32 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:37 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yin-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:37 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation, no hospital setting</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-17 09:08:43 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yin-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-17 09:08:43 -0500" MODIFIED_BY="[Empty name]">
<P>Non-clinical, but test situation, no hospital setting</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-05-30 04:59:33 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-02-17 11:38:45 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-02-17 11:38:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaushal">
<CHAR_STUDY_NAME MODIFIED="2014-02-01 13:13:07 -0500" MODIFIED_BY="Jolanda Maaskant">
<P>Serious medication errors in paediatrics: evaluation of prevention strategies</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-05-05 12:38:30 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Prospective cohort study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-05 12:38:52 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Children admitted to Children's Hospital and Brigham and Women's Hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-17 11:38:45 -0500" MODIFIED_BY="[Empty name]">
<P>The purpose of this study is to determine how effective ward-based clinical pharmacists and computerised physician order entry systems are in reducing serious medication errors (MEs) in paediatric inpatients</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-05 12:40:14 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Serious medication errors</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-05-05 12:39:15 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>February 2000</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-05-05 12:40:03 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>rkaushal@partners.org</P>
<P>
<A HREF="http://clinicaltrials.gov/show/NCT00153205">http://clinicaltrials.gov/show/NCT00153205</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-05-05 12:40:04 -0400" MODIFIED_BY="Jolanda Maaskant">
<P>Estimate of reporting date: unknown</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-02-17 15:44:21 -0500" MODIFIED_BY="Julia Worswick">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-02-17 09:05:18 -0500" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:01:54 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>"One of the medical units and one of the surgical units were randomly selected as experimental groups, and the others served as controls. The paediatric ICU was randomly selected as an experimental group; the cardiac ICU served as its control"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:09:03 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>CBA, retrospective design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:47:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>"Eighteen days were selected randomly during July 2001 by a computer-generated random number (block randomization)..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:12 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:55:27 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>"We could not design a blinded, randomized controlled trial of the new medication administration procedure"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-29 14:47:10 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:05:18 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>"Randomization was completed by SPSS 16.0-generated algorithm&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-02-17 09:05:26 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:01:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>No bias reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:09:06 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>CBA, retrospective design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:47:54 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:13 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:55:31 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>"We could not design a blinded, randomized controlled trial of the new medication administration procedure"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-29 14:47:24 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:05:26 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>"Treating assignments, kept in sealed opaque envelopes with only number labeled, were opened after patient gave their informed consents. One of the two clinical pharmacists distributed envelopes and recorded patients in each group enrollment and patient assignment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2015-02-17 15:44:21 -0500" MODIFIED_BY="Julia Worswick" NO="9">
<NAME>Baseline characteristics, comparable control sites</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:02:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>"Pre-intervention patients were generally similar to post-intervention patients in all study units, with most variation occurring in age distribution"</P>
<P>"The SMEs/1000 patient days (primary outcome) pre-intervention for the intervention wards and control wards were not different, as shown in table 2"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:10:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>Participants: Characteristics of participants (age and gender) are similar in the pre-intervention and post-intervention periods, as well as between intervention and control wards</P>
<P>Outcome: "The MERs before the introduction of CPOE for the intervention and control wards were indistinguishable (p=0.5, ratio 0.93, CI 0.76 to 1.13)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:49:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>"There were no significant differences in the patients' acuity (based on triage category on arrival of the ED) or the time at which the order was given with the regular form compared to the new form" </P>
<P>"However, in a multiple logistic regression analysis, the level of training of the prescribing physician did not contribute to the increased risk for error"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:52:25 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:55:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>"There were small but significant differences only in the proportion of subjects who were twins and in the available nursing/hours/day"</P>
<P>"....and we adjusted the analyses for subject and environmental differences that might be confounders"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:58:42 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>"The number of NICU admissions increased after CPOE implementation, although not statistically significantly. The rate of NICU admissions was smaller than in other units, so this increase would have biased the study toward inflating the effect of CPOE"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:05:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>"There were no significant differences between the two groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2015-02-17 15:44:21 -0500" MODIFIED_BY="Julia Worswick" NO="10">
<NAME/>
<DESCRIPTION/>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-05-05 11:49:27 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-05-05 12:12:43 -0400" MODIFIED_BY="Jolanda Maaskant" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2015-02-17 09:05:40 -0500" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-02-17 08:02:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>"Two physicians independently reviewed each suspected ADE and near miss and classified them as ADEs, near misses, or MEs. The reviewers were blinded to the time period (i.e. before or after intervention) and the unit location of events in order to minimize potential bias"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-02-17 08:10:09 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>Confirmed by the first study author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-02-17 08:49:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>"Two paediatric emergency physicians, blinded to the form used, reviewed the database and independently decided whether there was an error"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-02-17 08:52:28 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>"A limitation is that the evaluators were not blinded as to whether the data were pre- or post-intervention"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-02-17 08:56:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>"....a panel including a neonatologist, 2 pharmacists, and a paediatric clinical pharmacist who were blinded to subject and date identifiers, reviewed out of sequence of all occurrences that the auditors had tentatively designated as either potential ADEs or preventable ADEs"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-02-17 08:58:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>"All components of the inpatient record, ....., were reviewed for possible MEs and possible adverse drug events by trained paediatric nurses who were unaware of the study objectives. Nurses then presented a description of possible MEs to 2 paediatricians who were unaware of whether the possible errors occurred before or after CPOE"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-02-17 09:05:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>"Patients and clinical pharmacists were aware of the interventions while the trial research assistants and statisticians responsible for the outcome recording and data analysis, respectively, were blinded to treatment assignment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2015-02-17 15:44:21 -0500" MODIFIED_BY="Julia Worswick" NO="11">
<NAME>Protection against contamination</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:02:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>Allocation was by hospital unit, and it is unlikely that the control group received the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:10:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>"Each ward is clinically independent with respect to nursing staff"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:49:53 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>"Before the study commenced, ED staff were oriented to the new forms during research and staff meetings"</P>
<P>"Trainees alo attended a short tutorial on the appropriate ordering of drugs before the study commenced"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:56:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>"The NICU is configured as 2 similar sections; the BCMA system was installed in each room of 1 section for the portion of the study when only some of the beds were BCMA system-equipped"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:05:51 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>"First, clinical pharmacists did not participate in treatment of patients in the control group, but in fact, clinical pharmacists also provided suggestions for patients in the control group when the physicians consulted them, which led to contamination and interference of results of the two groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-02-17 09:05:59 -0500" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-02-17 08:02:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>"Medication errors, near misses and ADEs were identified through detailed review of all medication orders and patient charts by a nurse data collector randomly assigned to each study unit on a daily basis"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-02-17 08:10:20 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>"Medication errors are reported in a standardized fashion by the adverse event reporting system on all inpatient floors. This is a passive reporting system that was constant throughout the duration of the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-02-17 08:50:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>"In 8 (1%) cases, there was not sufficient information to determine if an error had occurred. These orders were excluded from analysis"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-02-17 08:52:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>&#8220;All patients' drug charts were screened twice weekly during the full study period" </P>
<P>&#8220;All inpatient drug charts were screened to identify the primary outcome (technical errors)...&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-02-17 08:56:22 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-02-17 08:59:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>"Nine charts before CPOE and 20 charts after CPOE were incomplete (0.3% and 5.7% after, p=.2). An additional 5 charts before CPOE and 8 charts after CPOE were excluded because many parts were missing at the time of the review, making adequate review impossible"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-02-17 09:05:59 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>"In the experimental group, after two patients gave up treatment and another two were transferred to another department, only 76 patients received clinical pharmacists' intervention. In the control group, after four patients gave up treatment and another two were transferred to another department, only 74 patients received usual care"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-02-17 09:06:04 -0500" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:02:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>"We hypothesized that unit-based clinical pharmacists might be able to reduce rates of serious medication errors in paediatric inpatients in both ICU and general care unit settings." Results on this outcome measure are described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:10:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>"We assessed the impact of a commercially available CPOE system on medication errors and ADEs in paediatric inpatients at a tertiary care paediatric hospital" <BR/>Results of these outcome measures are described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:50:16 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>"The objective of this study was to assess the impact of a structured order sheet on the incidence of medication errors in a paediatric ED" </P>
<P>Results on these outcome measures are described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:52:51 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>"The primary outcome was the rate of technical errors" </P>
<P>Results on these outcome measures are described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:56:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>Results on targeted preventable ADEs (primary outcome) and MEs (secondary outcome) are reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:59:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>"The primary study outcome was the rate of non-intercepted serious medication errors per 1000 patient-days"</P>
<P>"Time-series regression analysis indicated a statistically significant 7% drop in the level of rates of non-intercepted serious medication errors (p=0.0495) after implementation of CPOE"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:06:04 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>Primary and secondary outcomes are clearly defined and reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-13" LEVEL="STUDY" MODIFIED="2015-02-17 08:59:27 -0500" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Secular changes</NAME>
<DESCRIPTION>
<P>Intervention is independently of other changes over time.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:40:46 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:40:59 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-King-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 10:01:17 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:52:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>"The impact of the intervention was measured using an ITS design, with a concurrent control measurement"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:24 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:59:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>"The hospital did not implement any other major systemic change at the time of implementation of CPOE"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 08:00:17 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-14" LEVEL="STUDY" MODIFIED="2015-02-17 08:59:36 -0500" MODIFIED_BY="[Empty name]" NO="14">
<NAME>Shape of intervention effect</NAME>
<DESCRIPTION>
<P>The shape of the intervention effect is specified.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:40:47 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:00 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-King-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 10:01:19 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:53:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>"Our main hypothesis was that the prevalence of the technical errors would be reduced by the implementation of Check and Correct, when compared with any inherent improvement due to increasing prescriber experience"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:26 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:59:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>"At the time of the study design, we considered it possible that the CPOE system might have more of an effect the longer it was in use or might have a good impact initially with less impact over time"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 08:00:18 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-15" LEVEL="STUDY" MODIFIED="2015-02-17 15:44:21 -0500" MODIFIED_BY="Julia Worswick" NO="15">
<NAME>Intervention unlikely to affect data collection.</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:40:48 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:01 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-King-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 10:01:21 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:53:05 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:27 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:00:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>Data collection was the same in the pre-intervention and post-intervention periods</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 08:00:19 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-16" LEVEL="STUDY" MODIFIED="2015-02-17 15:44:21 -0500" MODIFIED_BY="Julia Worswick" NO="16">
<NAME>Time series analysis techniques</NAME>
<DESCRIPTION>
<P>The right time series analysis techniques are used.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:40:49 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:03 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-King-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 10:01:24 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:53:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>&#8220;Error rates for each half-weekly data point were then plotted over time to visually examine temporal trends and formally analyzed using segmented regression analysis whilst adjusting for possible trends in the control data. We checked auto-correlation using the Durban-Watson test and by calculating the (partial) autocorrelation function"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:28 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:00:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>"We used linear, interrupted time-series analysis to estimate sudden changes in levels or trends in the time series of the study outcome" </P>
<P>"We controlled for auto-correlation by assuming the first-order autoregressive process (correlation between 2 consecutive observations), and used residual analysis to test the adequacy of the resulting models"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 08:00:21 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-17" LEVEL="STUDY" MODIFIED="2015-02-17 09:00:34 -0500" MODIFIED_BY="[Empty name]" NO="17">
<NAME>Data collection points and time interval</NAME>
<DESCRIPTION>
<P>Rationale for data collection points and time interval is given.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:40:50 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:04 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-King-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 10:01:26 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:53:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>Explained by the corresponding author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-20 03:41:29 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:00:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>"Identical months were included in the pre-CPOE and post-CPOE sampling frame to control for seasonal effects on errors rates with two additional months in the post-CPOE period"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 08:00:22 -0400" MODIFIED_BY="Jolanda Maaskant" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="STUDY" MODIFIED="2015-02-17 15:44:21 -0500" MODIFIED_BY="Julia Worswick" NO="12">
<NAME>Reliable primary outcome measure(s)</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:03:37 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>Outcome assessment by review of all clinical data and reports of errors</P>
<P>"Measures of inter-rater reliability (before discussion and consensus) were calculated using Kappa statistics, with moderate-to-excellent levels of agreement (0.75 for incident classification)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:10:47 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>Outcome assessment by adverse event reporting system</P>
<P>"Twenty random incident reports were independently rated by each of the 2 reviewers with good agreement (K = 0.64: CI 0.45 - 0.82)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:50:29 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>
<I>Outcome assessment</I>
</P>
<P>Incident reporting system</P>
<P>"A consensus between reviewers of whether an error had occurred was reached in all but 7 cases. These 7 cases were reviewed by a third paediatrician and the median rank was used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:53:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>Outcome assessment by review of all inpatient drug charts</P>
<P>"Inter-observer agreement was examined for the primary outcome (technical error), resulting in a Kappa of 0.91, indicating high consistent agreement&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:56:46 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>Outcome assessment by review of the medical records (using triggers) and voluntary incident reports</P>
<P>"The inter-observer agreement K calculation was 0.82 for detection of MEs by the 2 auditors"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:01:04 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>Outcome assessment by review of inpatient records and voluntary incident reports</P>
<P>"Inter-rater reliability scores for paediatrician judgments during the review were calculated using K scores. Inter-rater reliability for judgments about the classification of the possible error was 0.7 (95% CI 0.68-0.84), about the severity of the error was 0.4 (95% CI 0.26-0.57) and about the preventability of the error was 0.8 (95% CI 0.67-0.82)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:06:10 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>Criteria not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-02-17 09:06:13 -0500" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:03:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaushal-2008">
<DESCRIPTION>
<P>No bias reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:10:55 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-King-2003">
<DESCRIPTION>
<P>"... our institution saw a decline in potential ADEs and ADEs in both the intervention (from 11-7) and control wards (from 19-5), perhaps the result of other system changes to reduce medical error, such as ward-based pharmacists"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:50:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kozer-2005">
<DESCRIPTION>
<P>No bias reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:53:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lepee-2012">
<DESCRIPTION>
<P>No bias reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 08:56:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morriss-2009">
<DESCRIPTION>
<P>No bias reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:01:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-2008">
<DESCRIPTION>
<P>No bias reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 09:06:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhang-2012">
<DESCRIPTION>
<P>No bias reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-02-17 09:20:52 -0500" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-02-17 09:20:52 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-08-05 13:16:58 -0400" MODIFIED_BY="[Empty name]">Summary of findings</TITLE>
<TABLE COLS="8" ROWS="45">
<TR>
<TH VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH COLSPAN="2" VALIGN="TOP">
<P>Comparison</P>
</TH>
<TH VALIGN="TOP">
<P>Effect size (95% CI) or P value</P>
</TH>
<TH VALIGN="TOP">
<P>Sample<BR/>(studies)</P>
</TH>
<TH VALIGN="TOP">
<P>GRADE</P>
</TH>
<TH VALIGN="TOP">
<P>Comments</P>
</TH>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Clinical pharmacist vs no clinical pharmacist</B>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>
<B>Pre-intervention</B>
</P>
</TD>
<TD>
<P>
<B>Post-intervention</B>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Serious MEs</P>
<P>(ICU)</P>
</TD>
<TD>
<P>Intervention</P>
<P>wards: 29<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Intervention</P>
<P>wards: 6<SUP>a</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P>P value &lt; 0.01</P>
</TD>
<TD ROWSPAN="2">
<P>2967<SUP>b</SUP> (1 study)</P>
</TD>
<TD ROWSPAN="6">
<P>Low</P>
</TD>
<TD ROWSPAN="6">
<P>
<LINK REF="STD-Kaushal-2008" TYPE="STUDY">Kaushal 2008</LINK>; CBA</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Control wards:</P>
<P>20<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Control wards:</P>
<P>30<SUP>a</SUP>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Serious MEs</P>
<P>(medical ward)</P>
</TD>
<TD>
<P>Intervention wards: 8<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Intervention</P>
<P>wards: 9<SUP>a</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P>P value 0.78</P>
</TD>
<TD ROWSPAN="2">
<P>3746<SUP>b</SUP> (1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Control wards:</P>
<P>7<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Control wards:</P>
<P>8<SUP>a</SUP>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Serious MEs</P>
<P>(surgical ward)</P>
</TD>
<TD>
<P>Intervention</P>
<P>wards: 7<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Intervention</P>
<P>wards: 9<SUP>a</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P>P value 0.89</P>
</TD>
<TD ROWSPAN="2">
<P>3672<SUP>b</SUP> (1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Control wards:</P>
<P>8<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Control wards:</P>
<P>10<SUP>a</SUP>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>
<B>Control</B>
</P>
</TD>
<TD>
<P>I<B>nterventio</B>n</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Length of stay in days</P>
<P>(mean and SD)</P>
</TD>
<TD>
<P>9.06 (SD ± 5.47)</P>
</TD>
<TD>
<P>7.33 (SD ± 3.52)</P>
</TD>
<TD>
<P>-1.73 (-3.31 to -0.25)</P>
<P>P value 0.02</P>
</TD>
<TD>
<P>150<SUP>c</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD ROWSPAN="3">
<P>Low</P>
</TD>
<TD ROWSPAN="3">
<P>
<LINK REF="STD-Zhang-2012" TYPE="STUDY">Zhang 2012</LINK>; RCT</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Costs of drugs<SUP>d</SUP>
</P>
<P>($: number of participants)</P>
</TD>
<TD>
<P>&lt; 120: 35</P>
<P>120-360: 26</P>
<P>360-600: 4</P>
<P>&gt; 600: 9</P>
</TD>
<TD>
<P>&lt; 120: 36</P>
<P>120-360: 24</P>
<P>360-600: 10</P>
<P>&gt; 600: 6</P>
</TD>
<TD>
<P>P value 0.945</P>
</TD>
<TD>
<P>150<SUP>c</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Costs of hospitalisation</P>
<P>($: number of participants)</P>
</TD>
<TD>
<P>&lt; 240: 15</P>
<P>240-480: 25</P>
<P>480-720: 10</P>
<P>&gt; 720: 24</P>
</TD>
<TD>
<P>&lt; 240: 18</P>
<P>240-480: 33</P>
<P>480-720: 10</P>
<P>&gt; 720: 15</P>
</TD>
<TD>
<P>P value 0.125</P>
</TD>
<TD>
<P>150<SUP>c</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<SUP>a</SUP>Per 1000 admission days.</P>
<P>
<SUP>b</SUP>Total number of admission days on intervention and control wards in the pre-intervention and post-intervention periods.</P>
<P>
<SUP>c</SUP>Total number of included participants.</P>
<P>
<SUP>d</SUP>American dollars, 1 February 2011: currency exchange rate 1000 Chinese yuan = 120 American dollars.</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>CPOE vs no CPOE</B>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>
<B>Pre-intervention</B>
</P>
</TD>
<TD>
<P>
<B>Post-intervention</B>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Non-intercepted serious MEs</P>
</TD>
<TD>
<P>23.1<SUP>a</SUP>
</P>
<P/>
</TD>
<TD>
<P>20.6<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Change in level:</P>
<P>-7%; P value 0.0495</P>
<P/>
<P>Change in slope:</P>
<P>not significant</P>
</TD>
<TD>
<P>3234<SUP>b</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD ROWSPAN="2">
<P>Low</P>
</TD>
<TD ROWSPAN="2">
<P>
<LINK REF="STD-Walsh-2008" TYPE="STUDY">Walsh 2008</LINK>; ITS</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Preventable ADEs (harm)</P>
</TD>
<TD>
<P>7.9<SUP>a</SUP>
</P>
</TD>
<TD>
<P>6.5<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Change in level:</P>
<P>not significant</P>
<P/>
<P>Change in slope:</P>
<P>not significant</P>
</TD>
<TD>
<P>3234<SUP>b</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>MEs</P>
</TD>
<TD>
<P>Intervention wards:</P>
<P>173; 4.48<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Intervention wards:</P>
<P>120; 3.13<SUP>a</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P>Ratio of rate ratios:</P>
<P>1.54 (1.27 to 1.88);</P>
<P>P value &lt; 0.001</P>
</TD>
<TD ROWSPAN="2">
<P>179,183<SUP>b</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD ROWSPAN="6">
<P>Very low</P>
</TD>
<TD ROWSPAN="6">
<P>
<LINK REF="STD-King-2003" TYPE="STUDY">King 2003</LINK>; CBA</P>
<P/>
<P>Significant <I>increase</I> in potentially harmful ADEs</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Control wards:</P>
<P>243; 4.80<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Control wards:</P>
<P>268; 5.19<SUP>a</SUP>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Harmful ADEs</P>
</TD>
<TD>
<P>Intervention wards:</P>
<P>6</P>
</TD>
<TD>
<P>Intervention wards:</P>
<P>1</P>
</TD>
<TD ROWSPAN="2">
<P>Ratio of rate ratios:</P>
<P>1.30 (0.47 to 3.52);</P>
<P>P value 0.6</P>
</TD>
<TD ROWSPAN="2">
<P>179,183<SUP>b</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Control wards:</P>
<P>9</P>
</TD>
<TD>
<P>Control wards:</P>
<P>2</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Potentially harmful ADEs</P>
</TD>
<TD>
<P>Intervention wards:</P>
<P>5</P>
</TD>
<TD>
<P>Intervention wards:</P>
<P>6</P>
</TD>
<TD ROWSPAN="2">
<P>Ratio of rate ratios:</P>
<P>0.24 (0.09 to 0.68);</P>
<P>P value &lt; 0.001</P>
</TD>
<TD ROWSPAN="2">
<P>179,183<SUP>b</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Control wards:</P>
<P>10</P>
</TD>
<TD>
<P>Control wards:</P>
<P>3</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<SUP>a</SUP>Per 1000 admission days.</P>
<P>
<SUP>b</SUP>Admission days on intervention and control wards in the pre-intervention and post-intervention periods.</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>BCMA vs no BCMA</B>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>
<B>Pre-intervention</B>
</P>
</TD>
<TD>
<P>
<B>Post-intervention</B>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Targeted preventable ADEs</P>
</TD>
<TD>
<P>Intervention beds:</P>
<P>0.86<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Intervention beds:</P>
<P>0.43<SUP>a</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P>Unadjusted analysis:</P>
<P>P value 0.008</P>
<P>Adjusted RR:</P>
<P>0.53 (0.29 to 0.98); P value 0.044</P>
</TD>
<TD ROWSPAN="2">
<P>12,248<SUP>b</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD ROWSPAN="6">
<P>Low</P>
</TD>
<TD ROWSPAN="6">
<P>
<LINK REF="STD-Morriss-2009" TYPE="STUDY">Morriss 2009</LINK>; CBA</P>
<P/>
<P>Significant <I>increase</I> in MEs</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Control beds:</P>
<P>not reported</P>
</TD>
<TD>
<P>Control beds:</P>
<P>not reported</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Potential ADEs</P>
</TD>
<TD>
<P>Intervention beds:</P>
<P>15.1<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Intervention beds:</P>
<P>4.4<SUP>a</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P>Unadjusted analysis:</P>
<P>P value &lt; 0.001</P>
</TD>
<TD ROWSPAN="2">
<P>12,248<SUP>b</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Control beds:</P>
<P>not reported</P>
</TD>
<TD>
<P>Control beds:</P>
<P>not reported</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>MEs</P>
</TD>
<TD>
<P>Intervention beds:</P>
<P>69.5<SUP>a</SUP>
</P>
</TD>
<TD>
<P>Intervention beds: 79.7<SUP>a</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P>Unadjusted analysis:</P>
<P>P value &lt; 0.001</P>
</TD>
<TD ROWSPAN="2">
<P>12,248<SUP>b</SUP>
</P>
<P>(1 study</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Control beds:</P>
<P>not reported</P>
</TD>
<TD>
<P>Control beds:</P>
<P>not reported</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<SUP>a</SUP>Per 1000 medication doses.</P>
<P>
<SUP>b</SUP>Subject-days on intervention and control wards in the pre-intervention and post-intervention periods.</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Check and correct checklist vs no check and correct checklist</B>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>
<B>Pre-intervention</B>
</P>
</TD>
<TD>
<P>
<B>Post-intervention</B>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Technical</P>
<P>prescribing MEs</P>
</TD>
<TD>
<P>107.70<SUP>a</SUP>
</P>
<P/>
</TD>
<TD>
<P>73.08<SUP>a</SUP>
</P>
<P/>
</TD>
<TD>
<P>Change in level:</P>
<P>-5.02 (-7.09 to -2.95); P value &lt; 0.0001</P>
<P/>
<P>Change in slope:</P>
<P>-0.21 (-0.41 to &#8211; 0.01); P value 0.039</P>
</TD>
<TD>
<P>30,105<SUP>b</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD ROWSPAN="2">
<P>Low</P>
</TD>
<TD ROWSPAN="2">
<P>
<LINK REF="STD-Lepee-2012" TYPE="STUDY">Lepee 2012</LINK>; ITS</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Clinical</P>
<P>prescribing MEs</P>
</TD>
<TD>
<P>47.18<SUP>c</SUP>
</P>
<P/>
</TD>
<TD>
<P>55.33<SUP>c</SUP>
</P>
</TD>
<TD>
<P>Change in level:</P>
<P>not significant</P>
<P/>
<P>Change in slope:</P>
<P>not significant</P>
</TD>
<TD>
<P>1163<SUP>d</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<SUP>a</SUP>Per 1000 opportunities for error.</P>
<P>
<SUP>b</SUP>Opportunities for error on the intervention wards in the pre-intervention and post-intervention periods.</P>
<P>
<SUP>c</SUP>Per 1000 medication orders.</P>
<P>
<SUP>d</SUP>Number of medication orders in the pre-intervention and post-intervention periods.</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Preprinted medication order sheet vs no preprinted medication order sheet</B>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>
<B>Control</B>
</P>
</TD>
<TD>
<P>
<B>Intervention</B>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>MEs</P>
</TD>
<TD>
<P>68</P>
</TD>
<TD>
<P>37</P>
</TD>
<TD>
<P>Adjusted OR 0.55</P>
<P>(0.34 to 0.90)</P>
</TD>
<TD>
<P>376<SUP>a</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD ROWSPAN="2">
<P>Low</P>
</TD>
<TD ROWSPAN="2">
<P>
<LINK REF="STD-Kozer-2005" TYPE="STUDY">Kozer 2005</LINK>; RCT</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Potentially harmful MEs</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>Adjusted OR 0.39</P>
<P>(0.21 to 0.77)</P>
</TD>
<TD>
<P>411<SUP>a</SUP>
</P>
<P>(1 study)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<SUP>a</SUP>Prescriptions.</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2012-03-09 03:33:28 -0500" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-05-20 11:36:49 -0400" MODIFIED_BY="Jolanda Maaskant"/>
<FIGURES MODIFIED="2015-02-17 09:22:08 -0500" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Dia1.jpg" FILE_TYPE="JPG" ID="FIG-01" MODIFIED="2015-02-17 09:21:33 -0500" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study selection process.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph-RCT and CBA.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-02-17 09:21:52 -0500" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Risk of bias graph: RCT and CBA designs.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjQAAAEyCAMAAADa5LqxAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary- RCT and CBA.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2015-02-17 09:21:59 -0500" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Risk of bias summary: RCT and CBA designs.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAXQAAAHBCAIAAAD2BtfCAAAaM0lEQVR42u3dv24kxxHHcQICBAUX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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph ITS.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2015-02-17 09:21:37 -0500" MODIFIED_BY="[Empty name]" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Risk of bias graph: ITS design.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjQAAAFkCAMAAAAAM1FbAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary ITS.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2015-02-17 09:22:08 -0500" MODIFIED_BY="[Empty name]" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Risk of bias summary: ITS design.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAaUAAAFnCAIAAACJkMFGAAAVvUlEQVR42u3dv44cWRXH8ZGQEMEE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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2013-01-22 14:22:23 -0500" MODIFIED_BY="Jolanda Maaskant"/>
<APPENDICES MODIFIED="2015-02-23 12:03:07 -0500" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2015-02-17 09:24:11 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-11-04 08:38:50 -0500" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-17 09:24:11 -0500" MODIFIED_BY="[Empty name]">
<P>Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations and Ovid MEDLINE(R) &lt;1946 to Present&gt;, Ovid MEDLINE(R) Daily Update &lt;October 29, 2013&gt;<BR/>
<BR/>1 (preventable adverse drug or medication related adverse event?).ti. [Screen all] (37)<BR/>2 Medication errors/ or Inappropriate Prescribing/ (10960)<BR/>3 (medication safety or medication incident? or medication error?).ti,ab. (3989)<BR/>4 ((pharmacist? or prescrib$ or prescription? or dispens$ or dosing) adj2 (error? or mistake? or miscalculat$)).ti,ab. (1404)<BR/>5 (medication? adj2 misadventure?).ti,ab. (40)<BR/>6 ((inappropriate adj3 (prescription? or medication?)) or ((appropriat$ or inappropriat$ or optimal) adj2 prescrib$)).ti,ab. (2743)<BR/>7 effective prescribing practice?.ti,ab. (6)<BR/>8 medication reconciliation/ [...done to avoid medication errors.] (264)<BR/>9 (quality improv$ and (prescrib$ or prescript$ or dosing)).ti. (32)<BR/>10 ((weight-based or surface-based or weight independent) adj2 (prescrib$ or dose or dosing or dosage?)).ti,ab. and (safety or error?).ti,hw. (59)<BR/>11 ((drug? or medication? or medicine? or dose or dosage? or dosing) adj2 wrong$).ti,ab. (402)<BR/>12 (medication? adj2 (reconciliation? or audit? or quality improvement)).ti. (269)<BR/>13 (accident$ adj2 overdose?).ti,ab. (450)<BR/>14 (near miss or near misses).ti,ab. (1266)<BR/>15 ((excess$ or inadequat$) adj2 (dosage? or dose? or dosing)).ti,ab. (2207)<BR/>16 ("medication related" adj2 (problem? or issue? or hospitali?ation? or mortal$ or morbid$ or illness$ or condition?)).ti,ab. (299)<BR/>17 Medical Order Entry Systems/ and (prescript$ or prescrib$).ti,hw. (374)<BR/>18 Decision Support Systems, Clinical/ and (prescrib*.ti,hw. or medication?.ti. or *drug therapy/) (327)<BR/>19 "Drug Therapy, Computer-Assisted"/ and (safety or error?).ti. (125)<BR/>20 Electronic prescribing/ and (safety or error? or improv$).ti. (115)<BR/>21 (prevent$ and (error? or (adverse adj2 event?))).ti. and (dosing or drug? or medication? or prescript$ or prescrib$).ti,hw. (505)<BR/>22 ((drug? or medication? or prescrib$) adj3 error?).ti. and ((prevent$ or reduce? or reducing).ti. or pc.fs.) (1090)<BR/>23 "Pharmaceutical Preparations"/ae and (prevent$.ti. or (prevention or preventing).hw.) (187)<BR/>24 (Pharmaceutical preparations/ or Drug Therapy/ or exp Drug Administration Routes/ or exp Drug administration schedule/ or exp drug delivery systems/ or drug dosage calculations/ or exp drug prescriptions/ or exp drug therapy, Combination/ or Drug Therapy, Computer-assisted/) and (error? or mistake or mistakes or prevent$ adverse).ti. (1418)<BR/>25 (Medication Systems, Hospital/ or Pharmacy Service, Hospital/) and ((error? or mistake or mistakes or prevent$ adverse).ti. or ((prevent$ or reduce? or reducing) adj2 (error? or adverse event? or adverse drug event? or medication related problem?)).ab.) (921)<BR/>26 (exp therapeutic uses/ or exp anti-infective agents/ or exp anti-bacterial agents/) and (((prevent$ or reduce? or reducing) and (error? or (adverse$ adj3 event?))) or (inappropriat$ adj2 "use")).ti. (358)<BR/>27 Medical errors/pc and (medication? or drug?).ti,ab. (415)<BR/>28 (exp therapeutic uses/ or exp anti-infective agents/ or exp anti-bacterial agents/) and Medical Errors/ (403)<BR/>29 (Pharmaceutical preparations/ or Drug Therapy/ or exp Drug Administration Routes/ or exp Drug administration schedule/ or exp drug delivery systems/ or drug dosage calculations/ or exp drug prescriptions/ or exp drug therapy, Combination/ or Drug Therapy, Computer-assisted/) and Medical Errors/ (369)<BR/>30 (prevent$ adverse drug or (causes adj2 (prescri$ error? or medication? error?)) or medication related adverse).ti,ab. (396)<BR/>31 Medication errors/pc or Inappropriate Prescribing/pc (4775)<BR/>32 or/2-31 [Med Errors] (21118)<BR/>33 exp Hospitals/ (200382)<BR/>34 perioperative care/ or intraoperative care/ or postoperative care/ or perioperative period/ or intraoperative period/ or postoperative period/ or preoperative period/ or Pain, Postoperative/ (140684)<BR/>35 exp Hospitalization/ (159154)<BR/>36 exp Personnel, Hospital/ (77788)<BR/>37 hospital$.ti. or ("in hospital?" or hospitali$).ab. (379338)<BR/>38 or/33-37 [Hosptials, Hospitalization General] (753824)<BR/>39 Intensive Care Units, Pediatric/ or Intensive Care, Neonatal/ or Intensive Care Units, Neonatal/ or Hospitals, Pediatric/ (25940)<BR/>40 Pediatric Nursing/ or Neonatal Nursing/ or Neonatology/ or Perinatology/ (18628)<BR/>41 ((p?ediatric? or children? or neonatal or infant?) adj3 (hospital? or ICU or intensive care or care unit or department?)).ti,ab. (53874)<BR/>42 or/39-41 [Pediatric Hospitals] (80991)<BR/>43 exp child/ or adolescent/ (2429627)<BR/>44 (child or children or child? or newborn? or p?ediatric? or infant? or neonate? or teenager? or teens or adolescent? or baby or babies).ti,ab. (1397185)<BR/>45 Pediatrics/ or Adolescent Medicine/ (40945)<BR/>46 Neonatology/ or Perinatology/ (3531)<BR/>47 or/43-46 [Child/Pediatrics] (3004657)<BR/>48 exp Adults/ (5618048)<BR/>49 exp Residential Facilities/ (43206)<BR/>50 (elderly or nursing home?).ti,ab. or geriatric?.ti,ab,hw. or adult?.ti. (456222)<BR/>51 or/48-50 [Adults, Elderly, Nursing Homes non-hospital facilities] (5759432)<BR/>52 (cocaine or cannabis or marijuana or drug abuse or street drug?).ti,ab,hw. [Terms to exclude] (70327)<BR/>53 32 and 38 and 47 [Med Errors &amp; Hospitals &amp; Child/Pediatrics] (761)<BR/>54 (32 and 42) not 53 [Med Errors &amp; Pediatric Units/Hospitals] (338)<BR/>55 (32 and 38) not 51 not (or/53-54) [Med Errors &amp; Hospitals not Adults] (2471)<BR/>56 (or/53-55) not 52 [Results before Filters--illicit drug terms excluded] (3566)<BR/>57 (randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti. (897270)<BR/>58 exp animals/ not humans.sh. (4055578)<BR/>59 57 not 58 [Cochrane RCT Filter 6.4.d Sens/Precision Maximizing--placebo removed] (833187)<BR/>60 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or doctor? or educational or family doctor? or family physician? or family practitioner? or financial or GP or general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. (166583)<BR/>61 (pre-intervention? or preintervention? or "pre intervention?" or post-intervention? or postintervention? or "post intervention?").ti,ab. [added 2.4] (10314)<BR/>62 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw. (721910)<BR/>63 demonstration project?.ti,ab. (1989)<BR/>64 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab. (65937)<BR/>65 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. (610)<BR/>66 trial.ti. or ((study adj3 aim?) or "our study").ab. (635247)<BR/>67 (before adj10 (after or during)).ti,ab. (363594)<BR/>68 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. [ML] (104652)<BR/>69 ("time series" adj2 interrupt$).ti,ab,hw. [ML] (1192)<BR/>70 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab. (9441)<BR/>71 pilot.ti. (40033)<BR/>72 Pilot projects/ [ML] (84176)<BR/>73 (clinical trial or controlled clinical trial or multicenter study).pt. [ML] (650503)<BR/>74 (multicentre or multicenter or multi-centre or multi-center).ti. (29891)<BR/>75 random$.ti,ab. or controlled.ti. (781262)<BR/>76 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not (controlled clinical trial or randomized controlled trial).pt. [ML] (413431)<BR/>77 "comment on".cm. or review.ti,pt. or randomized controlled trial.pt. [ML] (2964738)<BR/>78 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti. (1370441)<BR/>79 exp animals/ not humans.sh. [ML] (4055578)<BR/>80 (or/60-76) not (or/77-79) [EPOC Methods Filter 2.4 Medline] (2156894)</P>
<P>
<B>Results from search conducted 29 October 2013</B>
</P>
<P>
<BR/>81 56 and 59 [RCT Results] (182)<BR/>82 (56 and 80) not 81 [EPOC Filter Results] (2131)<BR/>83 ((1 and (or/42,47)) or (1 not 51)) not (or/81-82) [KW Results] (11)<BR/>84 "2013".ep,ed,yr. (789818)<BR/>85 ("201211$" or "201212$").ed,ep. [Nov-Dec 2012] (259202)<BR/>86 (or/81-83) and (or/84-85) [Update results Nov 2012 to Oct 29, 2013] (144)</P>
<P>
<B>Results from search conducted October 2012</B>
</P>
<P>81 56 and 59 [RCT Results] (145)<BR/>82 (56 and 80) not 81 [EPOC Filter Results] (1837)<BR/>83 ((1 and (or/42,47)) or (1 not 51)) not (or/81-82) [KW Results] (13)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-02-17 09:25:16 -0500" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2015-01-29 10:04:28 -0500" MODIFIED_BY="Julia Worswick">EMBASE strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-17 09:25:16 -0500" MODIFIED_BY="[Empty name]">
<P>
<B>EMBASE Classic + EMBASE &lt;1947 to 29 October 2013&gt;</B>
<BR/>1 (preventable adverse drug or medication related adverse event?).ti. (50)<BR/>2 effective prescribing practice?.ti,ab. (8)<BR/>3 medication related adverse.ti. (10)<BR/>4 or/1-3 [KW] (59)<BR/>5 medication error/ (12229)<BR/>6 inappropriate prescribing/ (897)<BR/>7 (medication safety or medication incident? or medication error?).ti,ab. (5767)<BR/>8 "inappropriate use".ti. and (drug?.hw,ti. or medication?.ti.) (147)<BR/>9 ((pharmacist? or prescrib$ or prescription? or dispens$ or dosing) adj2 (error? or mistake? or miscalculat$)).ti,ab. (2096)<BR/>10 (medication? adj2 misadventure?).ti,ab. (65)<BR/>11 ((inappropriate adj3 (prescription? or medication?)) or ((appropriat$ or inappropriat$ or optimal) adj2 prescrib$)).ti,ab. (3904)<BR/>12 medication therapy management/ [includes med reconciliation] (1975)<BR/>13 (quality improv$ and (prescrib$ or prescript$ or dosing)).ti. (36)<BR/>14 ((weight-based or surface-based or weight independent) adj2 (prescrib$ or dose or dosing or dosage?)).ti,ab. and (safety or error?).ti,hw. (187)<BR/>15 ((drug? or medication? or medicine? or dose or dosage? or dosing) adj2 wrong$).ti,ab. (675)<BR/>16 (medication? adj2 (reconciliation? or audit? or quality improvement)).ti. (428)<BR/>17 (accident$ adj2 overdose?).ti,ab. (545)<BR/>18 (near miss or near misses).ti,ab. (1721)<BR/>19 ((excess$ or inadequat$) adj2 (dosage? or dose? or dosing)).ti,ab. (3594)<BR/>20 ("medication related" adj2 (problem? or issue? or hospitali?ation? or mortal$ or morbid$ or illness$ or condition?)).ti,ab. (419)<BR/>21 ("drug use"/ or prescription/) and medical error/ [EM] (544)<BR/>22 hospital pharmacy/ and (medical error/ or error?.ti. or preventable.ti. or preventing.ti.) [EM] (403)<BR/>23 Decision Support System/ and "drug use"/ [EM] (79)<BR/>24 decision support system/ and (prescrib$.ti,hw. or medication?.ti.) (429)<BR/>25 computer assisted drug therapy/ and (safety or error?).ti. [EM] (66)<BR/>26 Electronic prescribing/ and (safety or error? or improv$).ti. [EM] (168)<BR/>27 (prevent$ and (error? or (adverse adj2 event?))).ti. and (dosing or drug? or medication? or prescript$ or prescrib$).ti,hw. (750)<BR/>28 ((drug? or medication? or prescrib$) adj3 error?).ti. and ((prevent$ or reduce? or reducing).ti. or pc.fs.) (1087)<BR/>29 drug/ and (error? or mistake or mistakes or prevent$ adverse).ti. (270)<BR/>30 drug/ and inappropriat$.ti. (48)<BR/>31 drug/ae and prevent$.ti. (106)<BR/>32 decision support system/ and drug/ (55)<BR/>33 drug/ and medical error/ (54)<BR/>34 exp drug/ and medical error/ (184)<BR/>35 medication? related adverse.ab. (104)<BR/>36 (prescrib$ or drug therapy or medication management).ti. and patient safety.ti,hw. (344)<BR/>37 or/5-36 [Med Errors] (28760)<BR/>38 *medication therapy management/ or (quality improv$ and (prescrib$ or prescript$ or dosing)).ti. (1021)<BR/>39 ((weight-based or surface-based or weight independent) adj2 (prescrib$ or dose or dosing or dosage?)).ti,ab. and (safety or error?).ti,hw. (187)<BR/>40 ((drug? or medication? or medicine? or dose or dosage? or dosing) adj2 wrong$).ti,ab. (675)<BR/>41 ((excess$ or inadequat$) adj2 (dosage? or dose? or dosing)).ti,ab. and (prevent$.ti. or prevent?ble.ab.) (83)<BR/>42 ("medication related" adj2 (problem? or issue? or hospitali?ation? or mortal$ or morbid$ or illness$ or condition?)).ti,ab. (419)<BR/>43 ((*"drug use"/ or *prescription/) and *medical error/) or (*hospital pharmacy/ and (*medical error/ or error?.ti. or preventable.ti. or preventing.ti.)) or (*Decision Support System/ and *"drug use"/) or (*decision support system/ and (prescrib$.ti,hw. or medication?.ti.)) or (*computer assisted drug therapy/ and (safety or error?).ti.) or (*Electronic prescribing/ and (safety or error? or improv$).ti.) or ((prevent$ and (error? or (adverse adj2 event?))).ti. and (dosing or drug? or medication? or prescript$ or prescrib$).ti,hw.) or (((drug? or medication? or prescrib$) adj3 error?).ti. and ((prevent$ or reduce? or reducing).ti. or pc.fs.)) or (exp *drug/ and (error? or mistake or mistakes or prevent$ adverse).ti.) or (*drug/ and inappropriat$.ti.) or (*drug/ae and prevent$.ti.) (2145)<BR/>44 (*decision support system/ and exp *drug/) or (exp *drug/ and *medical error/) or medication? related adverse.ab. or ((prescrib$ or drug therapy or medication management).ti. and patient safety.ti,hw.) (480)<BR/>45 medication error/ and (patient safety/ or accident prevention/) (1450)<BR/>46 ((medication safety or medication error?) adj4 (improv$ or reduce? or reducing or implement$ or prevent$)).ab. (1319)<BR/>47 (medication? adj2 misadventure?).ti,ab. (65)<BR/>48 (accident$ adj2 overdose?).ti,ab. (545)<BR/>49 (medication? adj2 (reconciliation? or audit? or quality improvement)).ti. (428)<BR/>50 (near miss or near misses).ti,ab. and ((prevent$ or reduc$ or improv$).ti. or pc.fs.) (334)<BR/>51 *medication error/ (6397)<BR/>52 (medication safety or medication incident? or medication error?).ti,ab. and ((improv$ or reduc$ or implement$ or prevent$).ti. or pc.fs.) (1951)<BR/>53 or/38-52 [Med Errors focussed] (12390)<BR/>54 hospital/ or community hospital/ or general hospital/ or geriatric hospital/ or hospital building/ or "hospital subdivisions and components"/ or magnet hospital/ or mental hospital/ or non profit hospital/ or private hospital/ or public hospital/ or exp teaching hospital/ (429959)<BR/>55 hospital$.ti. or hospitali$.ab. (455496)<BR/>56 hospital patient/ (72915)<BR/>57 inpatient?.ti,ab. (88179)<BR/>58 or/54-57 [Hospital] (829280)<BR/>59 adult/ or exp aged/ or middle aged/ or geriatrics/ (5637241)<BR/>60 (adult? or elder$ or geriatric$).ti. (400955)<BR/>61 or/59-60 [Adult] (5748674)<BR/>62 hospitalized adolescent/ (371)<BR/>63 pediatric hospital/ (12115)<BR/>64 or/62-63 [Pediatric hospital] (12484)<BR/>65 pediatrics/ or child psychiatry/ or child urology/ or exp neonatology/ (83610)<BR/>66 *adolescent/ or juvenile/ (53036)<BR/>67 exp child/ or embryo/ or fetus/ or exp newborn/ (2634785)<BR/>68 (child$ or infant? or baby or neonat$ or preschool$ or pre-school$ or fetus or fetal or newborn?).ti. (1145250)<BR/>69 or/65-68 [Child/pediatrics] (2905568)<BR/>70 37 and 58 and 69 [Med Errors &amp; Hosp &amp; Child] (574)<BR/>71 (37 and 64) not 69 [Med Errors &amp; Pediatric Hospitals] (60)<BR/>72 (37 and 58) not 61 not (or/70-71) [Med Errors &amp; Hospitals not Adult] (3642)<BR/>73 controlled clinical trial/ or controlled study/ or randomized controlled trial/ [EM] (4248126)<BR/>74 (book or conference paper or editorial or letter or review).pt. not randomized controlled trial/ [Per BMJ Clinical Evidence filter] (4037268)<BR/>75 (random sampl$ or random digit$ or random effect$ or random survey or random regression).ti,ab. not randomized controlled trial/ [Per BMJ Clinical Evidence filter] (54329)<BR/>76 (animal$ not human$).sh,hw. (3916035)<BR/>77 73 not (or/74-76) [Trial filter per BMJ CLinical Evidence] (2804210)<BR/>78 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or doctor? or educational or family doctor? or family physician? or family practitioner? or financial or GP or general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. (201883)<BR/>79 (pre-intervention? or preintervention? or "pre intervention?" or post-intervention? or postintervention? or "post intervention?").ti,ab. [added 2.4] (12654)<BR/>80 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw. (1626348)<BR/>81 demonstration project?.ti,ab. (2362)<BR/>82 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab. (93606)<BR/>83 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. (809)<BR/>84 trial.ti. or ((study adj3 aim?) or "our study").ab. (840342)<BR/>85 (before adj10 (after or during)).ti,ab. (474598)<BR/>86 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab. (11772)<BR/>87 pilot.ti. (49865)<BR/>88 (multicentre or multicenter or multi-centre or multi-center).ti. (39260)<BR/>89 random$.ti,ab. or controlled.ti. (934044)<BR/>90 review.ti. (313223)<BR/>91 (animal$ not human$).sh,hw. (3916035)<BR/>92 *experimental design/ or *pilot study/ or quasi experimental study/ (7012)<BR/>93 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab. (128839)<BR/>94 ("time series" adj2 interrupt$).ti,ab. (1127)<BR/>95 (or/78-89,92-94) not (or/90-91) [EPOC Methods Filter 2.4 EMBASE] (3328457)<BR/>96 (or/70-72) and 79 [RCT] (69)<BR/>97 (53 and 58 and 95) not 61 not (or/70-71,96) [Med Errors Focussed &amp; Hospitals (not Adult) &amp; EPOC Filter] (1362)<BR/>98 4 not (or/96-97) [KW] (48)<BR/>99 (201244$ or 201245$ or 201246$ or 201247$ or 201248$ or 201249$ or 20125$ or 2013$).em. (1534962)<BR/>100 (or/96-98) and 99 [Update results October 30-2013] (226)</P>
<P>
<B>EMBASE Classic + EMBASE &lt;1947 to 1 November 2012&gt;</B>
<BR/>1 (preventable adverse drug or medication related adverse event?).ti. (43)<BR/>2 effective prescribing practice?.ti,ab. (8)<BR/>3 medication related adverse.ti. (7)<BR/>4 or/1-3 [KW] (52)<BR/>5 medication error/ (11044)<BR/>6 inappropriate prescribing/ (522)<BR/>7 (medication safety or medication incident? or medication error?).ti,ab. (5045)<BR/>8 "inappropriate use".ti. and (drug?.hw,ti. or medication?.ti.) (131)<BR/>9 ((pharmacist? or prescrib$ or prescription? or dispens$ or dosing) adj2 (error? or mistake? or miscalculat$)).ti,ab. (1835)<BR/>10 (medication? adj2 misadventure?).ti,ab. (57)<BR/>11 ((inappropriate adj3 (prescription? or medication?)) or ((appropriat$ or inappropriat$ or optimal) adj2 prescrib$)).ti,ab. (3387)<BR/>12 medication therapy management/ [includes med reconciliation] (1178)<BR/>13 (quality improv$ and (prescrib$ or prescript$ or dosing)).ti. (28)<BR/>14 ((weight-based or surface-based or weight independent) adj2 (prescrib$ or dose or dosing or dosage?)).ti,ab. and (safety or error?).ti,hw. (157)<BR/>15 ((drug? or medication? or medicine? or dose or dosage? or dosing) adj2 wrong$).ti,ab. (596)<BR/>16 (medication? adj2 (reconciliation? or audit? or quality improvement)).ti. (341)<BR/>17 (accident$ adj2 overdose?).ti,ab. (485)<BR/>18 (near miss or near misses).ti,ab. (1480)<BR/>19 ((excess$ or inadequat$) adj2 (dosage? or dose? or dosing)).ti,ab. (3403)<BR/>20 ("medication related" adj2 (problem? or issue? or hospitali?ation? or mortal$ or morbid$ or illness$ or condition?)).ti,ab. (351)<BR/>21 ("drug use"/ or prescription/) and medical error/ [EM] (484)<BR/>22 hospital pharmacy/ and (medical error/ or error?.ti. or preventable.ti. or preventing.ti.) [EM] (380)<BR/>23 Decision Support System/ and "drug use"/ [EM] (73)<BR/>24 decision support system/ and (prescrib$.ti,hw. or medication?.ti.) (366)<BR/>25 computer assisted drug therapy/ and (safety or error?).ti. [EM] (61)<BR/>26 Electronic prescribing/ and (safety or error? or improv$).ti. [EM] (113)<BR/>27 (prevent$ and (error? or (adverse adj2 event?))).ti. and (dosing or drug? or medication? or prescript$ or prescrib$).ti,hw. (701)<BR/>28 ((drug? or medication? or prescrib$) adj3 error?).ti. and ((prevent$ or reduce? or reducing).ti. or pc.fs.) (1002)<BR/>29 drug/ and (error? or mistake or mistakes or prevent$ adverse).ti. (264)<BR/>30 drug/ and inappropriat$.ti. (41)<BR/>31 drug/ae and prevent$.ti. (99)<BR/>32 decision support system/ and drug/ (49)<BR/>33 drug/ and medical error/ (46)<BR/>34 exp drug/ and medical error/ (158)<BR/>35 medication? related adverse.ab. (89)<BR/>36 (prescrib$ or drug therapy or medication management).ti. and patient safety.ti,hw. (286)<BR/>37 or/5-36 [Med Errors] (25204)<BR/>38 *medication therapy management/ or (quality improv$ and (prescrib$ or prescript$ or dosing)).ti. (652)<BR/>39 ((weight-based or surface-based or weight independent) adj2 (prescrib$ or dose or dosing or dosage?)).ti,ab. and (safety or error?).ti,hw. (157)<BR/>40 ((drug? or medication? or medicine? or dose or dosage? or dosing) adj2 wrong$).ti,ab. (596)<BR/>41 ((excess$ or inadequat$) adj2 (dosage? or dose? or dosing)).ti,ab. and (prevent$.ti. or prevent?ble.ab.) (80)<BR/>42 ("medication related" adj2 (problem? or issue? or hospitali?ation? or mortal$ or morbid$ or illness$ or condition?)).ti,ab. (351)<BR/>43 ((*"drug use"/ or *prescription/) and *medical error/) or (*hospital pharmacy/ and (*medical error/ or error?.ti. or preventable.ti. or preventing.ti.)) or (*Decision Support System/ and *"drug use"/) or (*decision support system/ and (prescrib$.ti,hw. or medication?.ti.)) or (*computer assisted drug therapy/ and (safety or error?).ti.) or (*Electronic prescribing/ and (safety or error? or improv$).ti.) or ((prevent$ and (error? or (adverse adj2 event?))).ti. and (dosing or drug? or medication? or prescript$ or prescrib$).ti,hw.) or (((drug? or medication? or prescrib$) adj3 error?).ti. and ((prevent$ or reduce? or reducing).ti. or pc.fs.)) or (exp *drug/ and (error? or mistake or mistakes or prevent$ adverse).ti.) or (*drug/ and inappropriat$.ti.) or (*drug/ae and prevent$.ti.) (1965)<BR/>44 (*decision support system/ and exp *drug/) or (exp *drug/ and *medical error/) or medication? related adverse.ab. or ((prescrib$ or drug therapy or medication management).ti. and patient safety.ti,hw.) (401)<BR/>45 medication error/ and (patient safety/ or accident prevention/) (1199)<BR/>46 ((medication safety or medication error?) adj4 (improv$ or reduce? or reducing or implement$ or prevent$)).ab. (1147)<BR/>47 (medication? adj2 misadventure?).ti,ab. (57)<BR/>48 (accident$ adj2 overdose?).ti,ab. (485)<BR/>49 (medication? adj2 (reconciliation? or audit? or quality improvement)).ti. (341)<BR/>50 (near miss or near misses).ti,ab. and ((prevent$ or reduc$ or improv$).ti. or pc.fs.) (280)<BR/>51 *medication error/ (5854)<BR/>52 (medication safety or medication incident? or medication error?).ti,ab. and ((improv$ or reduc$ or implement$ or prevent$).ti. or pc.fs.) (1743)<BR/>53 or/38-52 [Med Errors focussed] (10856)<BR/>54 hospital/ or community hospital/ or general hospital/ or geriatric hospital/ or hospital building/ or "hospital subdivisions and components"/ or magnet hospital/ or mental hospital/ or non profit hospital/ or private hospital/ or public hospital/ or exp teaching hospital/ (380626)<BR/>55 hospital$.ti. or hospitali$.ab. (419860)<BR/>56 hospital patient/ (61124)<BR/>57 inpatient?.ti,ab. (78306)<BR/>58 or/54-57 [Hospital] (747481)<BR/>59 adult/ or exp aged/ or middle aged/ or geriatrics/ (5279904)<BR/>60 (adult? or elder$ or geriatric$).ti. (370800)<BR/>61 or/59-60 [Adult] (5385621)<BR/>62 hospitalized adolescent/ (342)<BR/>63 pediatric hospital/ (10365)<BR/>64 or/62-63 [Pediatric hospital] (10705)<BR/>65 pediatrics/ or child psychiatry/ or child urology/ or exp neonatology/ (78627)<BR/>66 *adolescent/ or juvenile/ (47978)<BR/>67 exp child/ or embryo/ or fetus/ or exp newborn/ (2510845)<BR/>68 (child$ or infant? or baby or neonat$ or preschool$ or pre-school$ or fetus or fetal or newborn?).ti. (1088180)<BR/>69 or/65-68 [Child/pediatrics] (2766254)<BR/>70 37 and 58 and 69 [Med Errors &amp; Hosp &amp; Child] (485)<BR/>71 (37 and 64) not 69 [Med Errors &amp; Pediatric Hospitals] (55)<BR/>72 (37 and 58) not 61 not (or/70-71) [Med Errors &amp; Hospitals not Adult] (3102)<BR/>73 controlled clinical trial/ or controlled study/ or randomized controlled trial/ [EM] (3975625)<BR/>74 (book or conference paper or editorial or letter or review).pt. not randomized controlled trial/ [Per BMJ Clinical Evidence filter] (3833563)<BR/>75 (random sampl$ or random digit$ or random effect$ or random survey or random regression).ti,ab. not randomized controlled trial/ [Per BMJ Clinical Evidence filter] (47298)<BR/>76 (animal$ not human$).sh,hw. (3769775)<BR/>77 73 not (or/74-76) [Trial filter per BMJ CLinical Evidence] (2608907)<BR/>78 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or doctor? or educational or family doctor? or family physician? or family practitioner? or financial or GP or general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. (175395)<BR/>79 (pre-intervention? or preintervention? or "pre intervention?" or post-intervention? or postintervention? or "post intervention?").ti,ab. [added 2.4] (10256)<BR/>80 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw. (1445318)<BR/>81 demonstration project?.ti,ab. (2221)<BR/>82 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab. (80422)<BR/>83 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. (682)<BR/>84 trial.ti. or ((study adj3 aim?) or "our study").ab. (725507)<BR/>85 (before adj10 (after or during)).ti,ab. (439104)<BR/>86 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab. (9904)<BR/>87 pilot.ti. (44135)<BR/>88 (multicentre or multicenter or multi-centre or multi-center).ti. (34482)<BR/>89 random$.ti,ab. or controlled.ti. (840955)<BR/>90 review.ti. (286121)<BR/>91 (animal$ not human$).sh,hw. (3769775)<BR/>92 *experimental design/ or *pilot study/ or quasi experimental study/ (5335)<BR/>93 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab. (119894)<BR/>94 ("time series" adj2 interrupt$).ti,ab. (911)<BR/>95 (or/78-89,92-94) not (or/90-91) [EPOC Methods Filter 2.4 EMBASE] (2981054)<BR/>96 (or/70-72) and 79 [RCT] (51)<BR/>97 (53 and 58 and 95) not 61 not (or/70-71,96) [Med Errors Focussed &amp; Hospitals (not Adult) &amp; EPOC Filter] (1167)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2015-02-17 09:25:38 -0500" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2015-01-29 10:04:56 -0500" MODIFIED_BY="Julia Worswick">Cochrane Library strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-17 09:25:38 -0500" MODIFIED_BY="[Empty name]">
<P>EBM Reviews - Cochrane Central Register of Controlled Trials &lt;September 2013&gt;, EBM Reviews - Health Technology Assessment &lt;3rd Quarter 2013&gt;, EBM Reviews - NHS Economic Evaluation Database &lt;3rd Quarter 2013&gt;<BR/>--<BR/>1 (preventable adverse drug or medication related adverse event?).ti. [Screen all] (1)<BR/>2 Medication errors/ or Inappropriate Prescribing/ (172)<BR/>3 (medication safety or medication incident? or medication error?).ti,ab. (109)<BR/>4 ((pharmacist? or prescrib$ or prescription? or dispens$ or dosing) adj2 (error? or mistake? or miscalculat$)).ti,ab. (89)<BR/>5 (medication? adj2 misadventure?).ti,ab. (5)<BR/>6 ((inappropriate adj3 (prescription? or medication?)) or ((appropriat$ or inappropriat$ or optimal) adj2 prescrib$)).ti,ab. (165)<BR/>7 effective prescribing practice?.ti,ab. (0)<BR/>8 medication reconciliation/ [...done to avoid medication errors.] (10)<BR/>9 (quality improv$ and (prescrib$ or prescript$ or dosing)).ti. (4)<BR/>10 ((weight-based or surface-based or weight independent) adj2 (prescrib$ or dose or dosing or dosage?)).ti,ab. and (safety or error?).ti,hw. (14)<BR/>11 ((drug? or medication? or medicine? or dose or dosage? or dosing) adj2 wrong$).ti,ab. (11)<BR/>12 (medication? adj2 (reconciliation? or audit? or quality improvement)).ti. (8)<BR/>13 (accident$ adj2 overdose?).ti,ab. (8)<BR/>14 (near miss or near misses).ti,ab. (12)<BR/>15 ((excess$ or inadequat$) adj2 (dosage? or dose? or dosing)).ti,ab. (187)<BR/>16 ("medication related" adj2 (problem? or issue? or hospitali?ation? or mortal$ or morbid$ or illness$ or condition?)).ti,ab. (25)<BR/>17 Medical Order Entry Systems/ and (prescript$ or prescrib$).ti,hw. (14)<BR/>18 Decision Support Systems, Clinical/ and (prescrib*.ti,hw. or medication?.ti. or *drug therapy/) (27)<BR/>19 "Drug Therapy, Computer-Assisted"/ and (safety or error?).ti. (7)<BR/>20 Electronic prescribing/ and (safety or error? or improv$).ti. (2)<BR/>21 (prevent$ and (error? or (adverse adj2 event?))).ti. and (dosing or drug? or medication? or prescript$ or prescrib$).ti,hw. (14)<BR/>22 ((drug? or medication? or prescrib$) adj3 error?).ti. and ((prevent$ or reduce? or reducing).ti. or pc.fs.) (26)<BR/>23 "Pharmaceutical Preparations"/ae and (prevent$.ti. or (prevention or preventing).hw.) (0)<BR/>24 (Pharmaceutical preparations/ or Drug Therapy/ or exp Drug Administration Routes/ or exp Drug administration schedule/ or exp drug delivery systems/ or drug dosage calculations/ or exp drug prescriptions/ or exp drug therapy, Combination/ or Drug Therapy, Computer-assisted/) and (error? or mistake or mistakes or prevent$ adverse).ti. (26)<BR/>25 (Medication Systems, Hospital/ or Pharmacy Service, Hospital/) and ((error? or mistake or mistakes or prevent$ adverse).ti. or ((prevent$ or reduce? or reducing) adj2 (error? or adverse event? or adverse drug event? or medication related problem?)).ab.) (19)<BR/>26 (exp therapeutic uses/ or exp anti-infective agents/ or exp anti-bacterial agents/) and (((prevent$ or reduce? or reducing) and (error? or (adverse$ adj3 event?))) or (inappropriat$ adj2 "use")).ti. (33)<BR/>27 Medical errors/pc and (medication? or drug?).ti,ab. (0)<BR/>28 (exp therapeutic uses/ or exp anti-infective agents/ or exp anti-bacterial agents/) and Medical Errors/ (7)<BR/>29 (Pharmaceutical preparations/ or Drug Therapy/ or exp Drug Administration Routes/ or exp Drug administration schedule/ or exp drug delivery systems/ or drug dosage calculations/ or exp drug prescriptions/ or exp drug therapy, Combination/ or Drug Therapy, Computer-assisted/) and Medical Errors/ (8)<BR/>30 (prevent$ adverse drug or (causes adj2 (prescri$ error? or medication? error?)) or medication related adverse).ti,ab. (31)<BR/>31 Medication errors/pc or Inappropriate Prescribing/pc (25)<BR/>32 or/2-31 [Med Errors] (764)<BR/>33 exp Hospitals/ (2504)<BR/>34 perioperative care/ or intraoperative care/ or postoperative care/ or perioperative period/ or intraoperative period/ or postoperative period/ or preoperative period/ or Pain, Postoperative/ (15863)<BR/>35 exp Hospitalization/ (10135)<BR/>36 exp Personnel, Hospital/ (684)<BR/>37 hospital$.ti. or ("in hospital?" or hospitali$).ab. (43791)<BR/>38 or/33-37 [Hosptials, Hospitalization General] (61491)<BR/>39 Intensive Care Units, Pediatric/ or Intensive Care, Neonatal/ or Intensive Care Units, Neonatal/ or Hospitals, Pediatric/ (885)<BR/>40 Pediatric Nursing/ or Neonatal Nursing/ or Neonatology/ or Perinatology/ (241)<BR/>41 ((p?ediatric? or children? or neonatal or infant?) adj3 (hospital? or ICU or intensive care or care unit or department?)).ti,ab. (3005)<BR/>42 or/39-41 [Pediatric Hospitals] (3576)<BR/>43 exp child/ or adolescent/ (91053)<BR/>44 (child or children or child? or newborn? or p?ediatric? or infant? or neonate? or teenager? or teens or adolescent? or baby or babies).ti,ab. (65038)<BR/>45 Pediatrics/ or Adolescent Medicine/ (414)<BR/>46 Neonatology/ or Perinatology/ (28)<BR/>47 or/43-46 [Child/Pediatrics] (126443)<BR/>48 exp Adults/ (319983)<BR/>49 exp Residential Facilities/ (1122)<BR/>50 (elderly or nursing home?).ti,ab. or geriatric?.ti,ab,hw. or adult?.ti. (26282)<BR/>51 or/48-50 [Adults, Elderly, Nursing Homes non-hospital facilities] (329749)<BR/>52 (cocaine or cannabis or marijuana or drug abuse or street drug?).ti,ab,hw. [Terms to exclude] (3529)<BR/>53 32 and 38 and 47 [Med Errors &amp; Hospitals &amp; Child/Pediatrics] (34)<BR/>54 (32 and 42) not 53 [Med Errors &amp; Pediatric Units/Hospitals] (2)<BR/>55 (32 and 38) not 51 not (or/53-54) [Med Errors &amp; Hospitals not Adults] (65)<BR/>56 (or/53-55) not 52 [Results before Filters--illicit drug terms excluded] (100)<BR/>57 from 56 keep 1-92 [CRCT export no date limits October 2013] (92)</P>
<P>
<B>Cochrane Library via Wiley (2012 strategy)</B>
</P>
<P>Search conducted: 8/11/2012 16:05:15.736<BR/>
<BR/>#1(preventable adverse drug or medication related adverse event?):ti<BR/>#2MeSH descriptor: [Medication Errors] this term only<BR/>#3MeSH descriptor: [Inappropriate Prescribing] this term only<BR/>#4(medication safety or medication incident? or medication error?):ti,ab<BR/>#5((pharmacist? or prescrib* or prescription? or dispens* or dosing) near/2 (error? or mistake? or miscalculat*)):ti,ab<BR/>#6(medication? near/2 misadventure?):ti,ab<BR/>#7((inappropriate near/3 (prescription? or medication?)) or ((appropriat* or inappropriat* or optimal) near/2 prescrib*)):ti,ab<BR/>#8effective prescribing practice?:ti,ab<BR/>#9MeSH descriptor: [Medication Reconciliation] this term only<BR/>#10(quality improv* and (prescrib* or prescript* or dosing)):ti<BR/>#11((weight-based or surface-based or weight independent) near/2 (prescrib* or dose or dosing or dosage?)):ti,ab and (safety or error?):ti,kw<BR/>#12((drug? or medication? or medicine? or dose or dosage? or dosing) near/2 wrong*):ti,ab<BR/>#13(medication? near/2 (reconciliation? or audit? or "quality improvement")):ti<BR/>#14(accident* near/2 overdose?):ti,ab<BR/>#15("near miss" or "near misses"):ti,ab<BR/>#16((excess* or inadequat*) near/2 (dosage? or dose? or dosing)):ti,ab<BR/>#17("medication related" near/2 (problem? or issue? or hospitali?ation? or mortal* or morbid* or illness* or condition?)):ti,ab<BR/>#18MeSH descriptor: [Medical Order Entry Systems] this term only<BR/>#19(prescript* or prescrib*):ti,kw<BR/>#20#18 and #19<BR/>#21MeSH descriptor: [Decision Support Systems, Clinical] this term only<BR/>#22prescrib*:ti,kw or medication?:ti<BR/>#23MeSH descriptor: [Drug Therapy] this term only<BR/>#24#21 and (#22 or #23)<BR/>#25MeSH descriptor: [Drug Therapy, Computer-Assisted] this term only<BR/>#26(safety or error?):ti or error?:ab<BR/>#27#25 and #26<BR/>#28MeSH descriptor: [Electronic Prescribing] this term only<BR/>#29(safety or improv*):ti,kw or error?:ti,ab,kw<BR/>#30#28 and #29<BR/>#31(prevent* and (error? or (adverse near/2 event?))):ti and (dosing or drug? or medication? or prescript* or prescrib*):ti,kw or (prevent* near/3 (error? or (adverse drug event?) or (adverse medication event?))):ab,kw<BR/>#32((drug? or medication? or prescrib*) near/3 error?):ti and (prevent* or reduce? or reducing):ti,kw or (((drug? or medication? or prescrib*) near/3 error?) near/4 (prevent* or reduce? or reducing or reduction)):ab,kw<BR/>#33MeSH descriptor: [Pharmaceutical Preparations] this term only and with qualifiers: [Adverse effects - AE]<BR/>#34(prevent*:ti or ("prevention" or "preventing"):kw)<BR/>#35#33 and #34<BR/>#36MeSH descriptor: [Pharmaceutical Preparations] this term only<BR/>#37MeSH descriptor: [Drug Administration Routes] explode all trees<BR/>#38MeSH descriptor: [Drug Administration Schedule] explode all trees<BR/>#39MeSH descriptor: [Drug Delivery Systems] explode all trees<BR/>#40MeSH descriptor: [Drug Dosage Calculations] this term only<BR/>#41MeSH descriptor: [Drug Prescriptions] explode all trees<BR/>#42MeSH descriptor: [Drug Therapy, Combination] explode all trees<BR/>#43(error? or mistake or mistakes or prevent* adverse):ti or error?:ab<BR/>#44(#23 or #25 or #36 or #37 or #38 or #39 or #40 or #41 or #42) and #43<BR/>#45MeSH descriptor: [Medication Systems, Hospital] this term only<BR/>#46MeSH descriptor: [Pharmacy Service, Hospital] this term only<BR/>#47((error? or mistake or mistakes or prevent* adverse):ti or ((prevent* or reduce? or reducing) near/2 (error? or adverse event? or adverse drug event? or medication related problem?)):ab) or ERROR?:ab<BR/>#48(#45 or #46) and #47<BR/>#49MeSH descriptor: [Therapeutic Uses] explode all trees<BR/>#50MeSH descriptor: [Anti-Infective Agents] explode all trees<BR/>#51MeSH descriptor: [Anti-Bacterial Agents] explode all trees<BR/>#52(((prevent* or reduce? or reducing or PRESCRIB*) and (error? or (adverse* near/3 event?))) or (inappropriat* near/2 "use")):ti or ERROR?:ab<BR/>#53(#49 or #50 or #51) and #52<BR/>#54MeSH descriptor: [Medical Errors] explode all trees<BR/>#55(medication? or drug?):ti,ab,kw<BR/>#56#54 and #55<BR/>#57MeSH descriptor: [Medical Errors] this term only<BR/>#58(#49 or #50 or #51) and #57<BR/>#59(#23 or #25 or #36 or #37 or #38 or #39 or #40 or #41 or #42) and #57<BR/>#60(prevent* adverse drug or (causes near/2 (prescri* error? or medication? error?)) or medication related adverse):ti,ab<BR/>#61MeSH descriptor: [Medication Errors] explode all trees and with qualifiers: [Prevention &amp; control - PC]<BR/>#62MeSH descriptor: [Inappropriate Prescribing] this term only and with qualifiers: [Prevention &amp; control - PC]<BR/>#63#2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #20 or #24 or #27 or #30 or #31 or #32 or #35 or #44 or #48 or #53 or #56 or #58 or #59 or #60 or #61 or #62<BR/>#64MeSH descriptor: [Hospitals] explode all trees<BR/>#65MeSH descriptor: [Perioperative Care] this term only<BR/>#66MeSH descriptor: [Intraoperative Care] this term only<BR/>#67MeSH descriptor: [Postoperative Care] this term only<BR/>#68MeSH descriptor: [Perioperative Period] this term only<BR/>#69MeSH descriptor: [Intraoperative Period] this term only<BR/>#70MeSH descriptor: [Postoperative Period] this term only<BR/>#71MeSH descriptor: [Preoperative Period] this term only<BR/>#72MeSH descriptor: [Pain, Postoperative] this term only<BR/>#73MeSH descriptor: [Hospitalization] explode all trees<BR/>#74MeSH descriptor: [Personnel, Hospital] explode all trees<BR/>#75hospital*:ti or ("in hospital?" or hospitali*):ab<BR/>#76#64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73 or #74 or #75<BR/>#77MeSH descriptor: [Intensive Care Units, Pediatric] this term only<BR/>#78MeSH descriptor: [Intensive Care, Neonatal] this term only<BR/>#79MeSH descriptor: [Intensive Care Units, Neonatal] this term only<BR/>#80MeSH descriptor: [Hospitals, Pediatric] this term only<BR/>#81MeSH descriptor: [Pediatric Nursing] this term only<BR/>#82MeSH descriptor: [Neonatal Nursing] this term only<BR/>#83MeSH descriptor: [Neonatology] this term only<BR/>#84MeSH descriptor: [Perinatology] this term only<BR/>#85((p?ediatric? or children? or neonatal or infant?) near/3 (hospital? or ICU or intensive care or care unit or department?)):ti,ab<BR/>#86#77 or #78 or #79 or #80 or #81 or #82 or #83 or #84 or #85<BR/>#87MeSH descriptor: [Child] explode all trees<BR/>#88MeSH descriptor: [Adolescent] this term only<BR/>#89(child or children or child? or newborn? or p?ediatric? or infant? or neonate? or teenager? or teens or adolescent? or baby or babies):ti,ab<BR/>#90MeSH descriptor: [Pediatrics] this term only<BR/>#91MeSH descriptor: [Adolescent Medicine] this term only<BR/>#92#83 or #84 or #87 or #88 or #89 or #90 or #91<BR/>#93MeSH descriptor: [Adult] explode all trees<BR/>#94MeSH descriptor: [Residential Facilities] explode all trees<BR/>#95(elderly or nursing home?):ti,ab or geriatric?:ti,ab,kw or adult?:ti<BR/>#96#93 or #94 or #95<BR/>#97(cocaine or cannabis or marijauna or drug abuse or street drug?):ti,ab,kw<BR/>#98#63 and #76 and #92<BR/>#99(#63 and #86) not #98<BR/>#100(#63 and #76) not #96<BR/>#101(#98 or #99 or #100)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2015-02-23 12:03:07 -0500" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2014-12-02 13:44:10 -0500" MODIFIED_BY="Julia Worswick">CINAHL strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-23 12:03:07 -0500" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="93">
<TR>
<TD>
<P/>
</TD>
<TD VALIGN="BOTTOM">
<P>
<B>#</B>
</P>
</TD>
<TD VALIGN="BOTTOM">
<P>
<B>Query</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>
<B>Results</B>
</P>
</TD>
<TD VALIGN="BOTTOM">
<P/>
</TD>
<TD VALIGN="BOTTOM">
<P>S88 or s89 or S90 and Published Date: 20121001-20131031 [October 2013 update]</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>37</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S90</P>
</TD>
<TD VALIGN="BOTTOM">
<P>((S1 and (S39 or S44)) or (S1 not S48)) NOT (S88 or S89 ) [November 6, 2012]</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>17</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S89</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(S53 and S87) NOT S88 [November 6, 2012]</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>297</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S88</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S53 and S62 [November 6, 2012]</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>72</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S87</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S63 or S64 or S65 or S66 or S67 or S68 or S69 or S70 or S71 or S72 or S73 or S74 or S75 or S76 or S77 or S78 or S79 or S80 or S81 or S82 or S83 or S84 or S85 or S86</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>378026</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S86</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((time points n3 over) or (time points n3 multiple) or (time points n3 three) or (time points n3 four) or (time points n3 five) or (time points n3 six) or (time points n3 seven) or (time points n3 eight) or (time points n3 nine) or (time points n3 ten) or (time points n3 eleven) or (time points n3 twelve) or (time points n3 month*) or (time points n3 hour*) or (time points n3 day*) or (time points n3 "more than") ) or AB ((time points n3 over) or (time points n3 multiple) or (time points n3 three) or (time points n3 four) or (time points n3 five) or (time points n3 six) or (time points n3 seven) or (time points n3 eight) or (time points n3 nine) or (time points n3 ten) or (time points n3 eleven) or (time points n3 twelve) or (time points n3 month*) or (time points n3 hour*) or (time points n3 day*) or (time points n3 "more than"))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>1346</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S85</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((control w3 area) or (control w3 cohort*) or (control w3 compar*) or (control w3 condition) or (control w3 group*) or (control w3 intervention*) or (control w3 participant*) or (control w3 study)) or AB ((control w3 area) or (control w3 cohort*) or (control w3 compar*) or (control w3 condition) or (control w3 group*) or (control w3 intervention*) or (control w3 participant*) or (control w3 study))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>41092</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S84</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (multicentre or multicenter or multi-centre or multi-center) or AB random*</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>88053</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S83</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI random* OR controlled</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>29899</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S82</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (trial or (study n3 aim) or "our study") or AB ((study n3 aim) or "our study")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>73171</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S81</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (pre-workshop or preworkshop or post-workshop or postworkshop or (before n3 workshop) or (after n3 workshop)) or AB (pre-workshop or preworkshop or post-workshop or postworkshop or (before n3 workshop) or (after n3 workshop))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>281</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S80</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (demonstration project OR demonstration projects OR preimplement* or pre-implement* or post-implement* or postimplement*) or AB (demonstration project OR demonstration projects OR preimplement* or pre-implement* or post-implement* or postimplement*)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>1189</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S79</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(intervention n6 clinician*) or (intervention n6 community) or (intervention n6 complex) or (intervention n6 design*) or (intervention n6 doctor*) or (intervention n6 educational) or (intervention n6 family doctor*) or (intervention n6 family physician*) or (intervention n6 family practitioner*) or (intervention n6 financial) or (intervention n6 GP) or (intervention n6 general practice*) Or (intervention n6 hospital*) or (intervention n6 impact*) Or (intervention n6 improv*) or (intervention n6 individualize*) Or (intervention n6 individualise*) or (intervention n6 individualizing) or (intervention n6 individualising) or (intervention n6 interdisciplin*) or (intervention n6 multicomponent) or (intervention n6 multi-component) or (intervention n6 multidisciplin*) or (intervention n6 multi-disciplin*) or (intervention n6 multifacet*) or (intervention n6 multi-facet*) or (intervention n6 multimodal*) or (intervention n6 multi-modal*) or (intervention n6 personalize*) or(intervention n6 personalise*) or (intervention n6 personalizing) or (intervention n6 personalising) or (intervention n6 pharmaci*) or (intervention n6 pharmacist*) or (intervention n6 pharmacy) or (intervention n6 physician*) or (intervention n6 practitioner*) Or (intervention n6 prescrib*) or (intervention n6 prescription*) or (intervention n6 primary care) or (intervention n6 professional*) or (intervention* n6 provider*) or (intervention* n6 regulatory) or (intervention n6 regulatory) or (intervention n6 tailor*) or (intervention n6 target*) or (intervention n6 team*) or (intervention n6 usual care)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>36531</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S78</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (collaborativ* or collaboration* or tailored or personalised or personalized) or AB (collaborativ* or collaboration* or tailored or personalised or personalized)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>33670</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S77</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI pilot</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>10254</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S76</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Pilot Studies")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>26470</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S75</P>
</TD>
<TD VALIGN="BOTTOM">
<P>AB "before-and-after"</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>15258</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S74</P>
</TD>
<TD VALIGN="BOTTOM">
<P>AB time series</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>1564</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S73</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI time series</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>218</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S72</P>
</TD>
<TD VALIGN="BOTTOM">
<P>AB (before* n10 during or before n10 after) or AU (before* n10 during or before n10 after)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>28931</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S71</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((time point*) or (period* n4 interrupted) or (period* n4 multiple) or (period* n4 time) or (period* n4 various) or (period* n4 varying) or (period* n4 week*) or (period* n4 month*) or (period* n4 year*)) or AB ((time point*) or (period* n4 interrupted) or (period* n4 multiple) or (period* n4 time) or (period* n4 various) or (period* n4 varying) or (period* n4 week*) or (period* n4 month*) or (period* n4 year*))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>44078</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S70</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((quasi-experiment* or quasiexperiment* or quasi-random* or quasirandom* or quasi control* or quasicontrol* or quasi* W3 method* or quasi* W3 study or quasi* W3 studies or quasi* W3 trial or quasi* W3 design* or experimental W3 method* or experimental W3 study or experimental W3 studies or experimental W3 trial or experimental W3 design*)) or AB ((quasi-experiment* or quasiexperiment* or quasi-random* or quasirandom* or quasi control* or quasicontrol* or quasi* W3 method* or quasi* W3 study or quasi* W3 studies or quasi* W3 trial or quasi* W3 design* or experimental W3 method* or experimental W3 study or experimental W3 studies or experimental W3 trial or experimental W3 design*))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>10858</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S69</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI pre w7 post or AB pre w7 post</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>7993</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S68</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH "Multiple Time Series" or MH "Time Series"</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>1198</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S67</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((comparative N2 study) or (comparative N2 studies) or evaluation study or evaluation studies) or AB ((comparative N2 study) or (comparative N2 studies) or evaluation study or evaluation studies)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>9367</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S66</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH Experimental Studies or Community Trials or Community Trials or Pretest-Posttest Design + or Quasi-Experimental Studies + Pilot Studies or Policy Studies + Multicenter Studies</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>30633</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S65</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (pre-test* or pretest* or posttest* or post-test*) or AB (pre-test* or pretest* or posttest* or "post test*) OR TI (preimplement*" or pre-implement*) or AB (pre-implement* or preimplement*)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>6192</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S64</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (intervention* or multiintervention* or multi-intervention* or postintervention* or post-intervention* or preintervention* or pre-intervention*) or AB (intervention* or multiintervention* or multi-intervention* or postintervention* or post-intervention* or preintervention* or pre-intervention*)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>131264</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S63</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Quasi-Experimental Studies")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>5226</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S62</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>136507</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S61</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI controlled AND TI (trial or trials or study or experiment* or intervention)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>15711</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S60</P>
</TD>
<TD VALIGN="BOTTOM">
<P>AB ((multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*)) or AB ((multi-cent* n2 design*) or (multi-cent* n2 study) or (multi-cent* n2 studies) or (multi-cent* n2 trial*))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>5820</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S59</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI multicentre or multicenter or multi-centre or multi-center</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>3835</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S58</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment*) OR AB (cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment*)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>1437</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S57</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (control group or control groups OR control* experiment* or control* design or controlled study) OR AB (control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>44417</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S56</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI random* or AB random*</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>97077</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S55</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (&#8220;clinical study&#8221; or &#8220;clinical studies&#8221;) or AB (&#8220;clinical study&#8221; or &#8220;clinical studies&#8221;)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>6259</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S54</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MM "Clinical Trials+")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>7510</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S53</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(S50 or S51 or S52) NOT S49</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>1605</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S52</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(S29 and S35) NOT S48 NOT (S50 or S51)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>1136</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S51</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(S29 and S39) NOT S50</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>184</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S50</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S29 and S35 and S44</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>285</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S49</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (cocaine or cannabis or marijauna or drug abuse or street drug#) OR AB (cocaine or cannabis or marijauna or drug abuse or street drug#) OR MW (cocaine or cannabis or marijauna or drug abuse or street drug#)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>11583</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S48</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S45 or S46 or S47</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>659369</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S47</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(TI (elderly or nursing home#) OR AB (elderly or nursing home#)) OR (TI (geriatric#) OR AB (geriatric#) OR MW (geriatric#)) OR TI adult#</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>101606</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S46</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Residential Facilities+")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>17635</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S45</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Adult+")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>631032</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S44</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S40 or S41 or S42 or S43</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>414718</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S43</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH neonatology OR MH perinatology</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>423</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S42</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH pediatrics OR MH adolescent medicine</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>5788</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S41</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (child or children or child# or newborn# or p#ediatric# or infant# or neonate# or teenager# or teens or adolescent# or baby or babies) OR AB (child or children or child# or newborn# or p#ediatric# or infant# or neonate# or teenager# or teens or adolescent# or baby or babies)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>224131</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S40</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Child+") OR (MH "Adolescence")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>366722</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S39</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S36 or S37 or S38</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>25827</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S38</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((p#ediactric# or children# or neonatal or infant) N3 (hospital# or ICU or intensive care or care unit or department#)) OR AB ((p#ediactric# or children# or neonatal or infant) N3 (hospital# or ICU or intensive care or care unit or department#))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>6914</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S37</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH pediatric nursing OR MH neonatal nursing OR MH neotalogy OR MH perinatology</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>10767</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S36</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Intensive Care Units, Pediatric") OR (MH "Intensive Care Units, Neonatal") OR (MH "Intensive Care, Neonatal") OR (MH "Hospitals, Pediatric")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>12821</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S35</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S30 or S31 or S32 or S33 or S34</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>170323</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S34</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI hospital* OR AB (("in hospital#" or hospitali*))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>77174</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S33</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Personnel, Health Facility+")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>18851</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S32</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Hospitalization+")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>31178</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S31</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Perioperative Care") OR (MH "Intraoperative Care") OR (MH "Postoperative Care") OR (MH "Intraoperative Period") OR (MH "Postoperative Period") OR (MH "Preoperative Period") OR (MH "Postoperative Pain")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>22902</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S30</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Hospitals+")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>54736</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S29</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>11019</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S28</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Medication Errors/PC")</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>3771</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S27</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (prevent# adverse drug OR (causes N2 (prescri# error? or medication? error?)) OR medication related adverse) or AB (prevent# adverse drug OR (causes N2 (prescri# error? or medication? error?)) OR medication related adverse)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>116</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S26</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Drug therapy" or MH "Drug administration routes+" or MH "drug administration schedule+" or MH "drug delivery systems+" or MH "drug prescriptions+" or MH "drug therapy, Combination+" or MH "drug therapy, computer-assisted+") AND MH "Treatment Errors"</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>58</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S25</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Antiinfective Agents+") AND MH Treatment Errors</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>24</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S24</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Treatment Errors/PC") AND (TI (medication# or drug#) OR AB (medication# or drug#))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>66</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S23</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Antiinfective Agents+") AND (TI ((prevent* or reduce# or reducing) and (error# or (adverse* N3 event#))) or (inappropriat* N2 "use"))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>132</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S22</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(MH "Drug Therapy" OR MH "Drug Administration Routes+" OR MH "Drug administration schedule+" OR MH "drug delivery systems+" OR MH "drug prescriptions+" OR MH "drug therapy, Combination+" AND MH "Drug Therapy, Computer-assisted+") AND (TI error# or mistake or mistakes or prevent* adverse)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>454</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S21</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((drug# or medication# or prescrib*) N3 error#) AND TI (prevent* or reduce# or reducing)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>451</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S20</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (prevent* and (error# or (adverse N2 event#))) AND (TI (dosing or drug# or medication# or prescript* or prescrib*) or MW (dosing or drug# or medication# or prescript* or prescrib*))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>422</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S19</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH "Drug Therapy, Computer Assisted" AND TI (safety or error#)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>37</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S18</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH Drug Therapy, Computer-Assisted AND TI (safety or error#)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>0</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S17</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH Decision Support Systems, Clinical AND (((TI (prescrib*) or MW (prescrib*)) or TI medication# or MH drug therapy))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>113</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S16</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ("medication related" N2 (problem# or issue# or hospitali#ation# or mortal* or morbid* or illness* or condition#)) OR AB ("medication related" N2 (problem# or issue# or hospitali#ation# or mortal* or morbid* or illness* or condition#))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>89</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S15</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((excess* or inadequat*) N2 (dosage# or dose# or dosing)) OR AB ((excess* or inadequat*) N2 (dosage# or dose# or dosing))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>170</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S14</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (near miss or near misses) OR AB (near miss or near misses)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>416</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S13</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI accident* N2 overdose# OR AB accident* N2 overdose#</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>82</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S12</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI medication# N2 (reconciliation# or audit# or quality improvement)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>185</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S11</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((drug# or medication# or medicine# or dose or dosage# or dosing) N2 wrong*) OR AB ((drug# or medication# or medicine# or dose or dosage# or dosing) N2 wrong*)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>177</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S10</P>
</TD>
<TD VALIGN="BOTTOM">
<P>(TI ((weight-based or surface-based or weight independent) N2 (prescrib* or dose or dosing or dosage#)) OR AB ((weight-based or surface-based or weight independent) N2 (prescrib* or dose or dosing or dosage#))) AND (TI ( safety or error#) OR MW (safety or error#))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>25</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S9</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI quality improv* and (prescrib* or prescript* or dosing)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>26</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S8</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH medication reconciliation</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>294</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S7</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI effective prescribing practice# OR AB effective prescribing practice#</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>13</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S6</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((inappropriate N3 (prescription# or medication#)) or ((appropriat* or inappropriat* or optimal) N2 prescrib*)) OR AB ((inappropriate N3 (prescription# or medication#)) or ((appropriat* or inappropriat* or optimal) N2 prescrib*))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>865</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S5</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI medication# N2 misadventure# OR AB medication# N2 misadventure#</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>11</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S4</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI ((pharmacist# or prescrib* or prescription# or dispens* or dosing) N2 (error# or mistake# or miscalculat*)) OR AB ((pharmacist# or prescrib* or prescription# or dispens* or dosing) N2 (error# or mistake# or miscalculat*))</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>470</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S3</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI (medication safety or medication incident# or medication error#) OR AB (medication safety or medication incident# or medication error#)</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>3617</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S2</P>
</TD>
<TD VALIGN="BOTTOM">
<P>MH Medication errors</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>7741</P>
</TD>
<TD VALIGN="BOTTOM">
<P>S1</P>
</TD>
<TD VALIGN="BOTTOM">
<P>TI preventable adverse drug or medication related adverse event#</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM">
<P>23</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2015-02-17 09:39:31 -0500" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2014-12-02 13:44:23 -0500" MODIFIED_BY="Julia Worswick">PsycInfo strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-17 09:39:31 -0500" MODIFIED_BY="[Empty name]">
<P>PsycINFO &lt;1806 to October Week 5 2012&gt; &amp; PsycINFO &lt;1806 to October Week 4 2013&gt;<BR/>
<BR/>1 (preventable adverse drug or medication related adverse event?).ti. [Screen all] (3)<BR/>2 (Medication errors or Inappropriate Prescribing).ti,ab,id. (344)<BR/>3 (medication safety or medication incident? or medication error?).ti,ab. (341)<BR/>4 ((pharmacist? or prescrib$ or prescription? or dispens$ or dosing) adj2 (error? or mistake? or miscalculat$)).ti,ab. (102)<BR/>5 (medication? adj2 misadventure?).ti,ab. (4)<BR/>6 ((inappropriate adj3 (prescription? or medication?)) or ((appropriat$ or inappropriat$ or optimal) adj2 prescrib$)).ti,ab. (447)<BR/>7 effective prescribing practice?.ti,ab. (2)<BR/>8 (quality improv$ and (prescrib$ or prescript$ or dosing)).ti. (2)<BR/>9 ((drug? or medication? or medicine? or dose or dosage? or dosing) adj2 wrong$).ti,ab. (53)<BR/>10 (medication? adj2 (reconciliation? or audit? or quality improvement)).ti. (19)<BR/>11 (accident$ adj2 overdose?).ti,ab. (72)<BR/>12 (near miss or near misses).ti,ab. (246)<BR/>13 ((excess$ or inadequat$) adj2 (dosage? or dose? or dosing)).ti,ab. (169)<BR/>14 ("medication related" adj2 (problem? or issue? or hospitali?ation? or mortal$ or morbid$ or illness$ or condition?)).ti,ab. (53)<BR/>15 decision support systems/ and (prescrib*.ti,hw. or medication?.ti. or *drug therapy/) (21)<BR/>16 Electronic prescribing.ti,ab,id. and (safety or error? or improv$).ti. (4)<BR/>17 (prevent$ and (error? or (adverse adj2 event?))).ti. and (dosing or drug? or medication? or prescript$ or prescrib$).ti,hw. (12)<BR/>18 (((drug? or medication? or prescrib$) adj3 error?) and (prevent$ or reduce? or reducing)).ti. (18)<BR/>19 (drug therapy/ or exp drug administration routes/ or (drug administration schedule or drug delivery systems or drug dosage calculations or drug prescriptions or combination drug therapy or computer-assisted drug therapy).ti,ab,id.) and (error? or mistake or mistakes or prevent$ adverse).ti. (138)<BR/>20 (hospital medication systems or hospital pharmacy service).ti,ab,id. and ((error? or mistake or mistakes or prevent$ adverse).ti. or ((prevent$ or reduce? or reducing) adj2 (error? or adverse event? or adverse drug event? or medication related problem?)).ab.) (1)<BR/>21 medical errors.ti,ab,id. and (medication? or drug?).ti,ab. (49)<BR/>22 (drug therapy/ or exp drug administration routes/ or (pharmaceutical preparations or drug administration schedule or drug delivery systems or drug dosage calculations or drug prescriptions or combination drug therapy or computer-assisted drug therapy).ti,ab,id.) and medical errors.ti,ab,id. (12)<BR/>23 (prevent$ adverse drug or (causes adj2 (prescri$ error? or medication? error?)) or medication related adverse).ti,ab. (42)<BR/>24 or/2-23 [Med errors] (1524)<BR/>25 exp hospitals/ (14703)<BR/>26 (perioperative care or intraoperative care or postoperative care or perioperative period or intraoperative period or postoperative period or preoperative period or postoperative pain).ti,ab,id. (1175)<BR/>27 exp hospitalization/ (16534)<BR/>28 hospital personnel.ti,ab,id. (413)<BR/>29 hospital$.ti. or ("in hospital?" or hospitali$).ab. (48251)<BR/>30 or/25-29 [Hosptials, Hospitalization General] (63084)<BR/>31 (pediatric intensive care units or neonatal intensive care units or pediatric hospitals).ti,ab,id. or neonatal intensive care/ (781)<BR/>32 (Pediatric Nursing or Neonatal Nursing or Neonatology or Perinatology).ti,ab,id. (262)<BR/>33 ((p?ediatric? or children? or neonatal or infant?) adj3 (hospital? or ICU or intensive care or care unit or department?)).ti,ab. (4370)<BR/>34 or/31-33 [Pediatric Hospitals] (4722)<BR/>35 (child or adolescent).ti,ab,id. (249289)<BR/>36 (child or children or child? or newborn? or p?ediatric? or infant? or neonate? or teenager? or teens or adolescent? or baby or babies).ti,ab. (558383)<BR/>37 pediatrics/ or adolescent medicine.ti,ab,id. (12518)<BR/>38 (neonatology or perinatology).ti,ab,id. (126)<BR/>39 or/35-38 [Child/Pediatrics] (565768)<BR/>40 adults.ti,ab,id. (176810)<BR/>41 exp residential care institutions/ (28594)<BR/>42 (elderly or nursing home?).ti,ab. or geriatric?.ti,ab,hw. or adult?.ti. (116898)<BR/>43 or/40-42 [Adults, Elderly, Nursing Homes non-hospital facilities] (265885)<BR/>44 (cocaine or cannabis or marijauna or drug abuse or street drug?).ti,ab,hw. [Terms to exclude] (53408)<BR/>45 24 and 30 and 39 [Med Errors &amp; Hospitals &amp; Child/Pediatrics] (21)<BR/>46 (24 and 34) not 45 [Med Errors &amp; Pediatric Units/Hospitals] (11)<BR/>47 (24 and 30) not 43 not (or/45-46) [Med Errors &amp; Hospitals not Adults] (80)<BR/>48 (or/45-47) not 44 [Results before Filters--illicit drug terms excluded] (106)<BR/>49 double-blind.tw. (16397)<BR/>50 random$ assigned.tw. (21826)<BR/>51 control.tw. (283286)<BR/>52 or/49-51 [RCT Filter per J Clin Epidemiol. 2008 January; 61(1): 34&#8211;40] (309846)</P>
<P>
<BR/>53 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or doctor? or educational or family doctor? or family physician? or family practitioner? or financial or GP or general practice? or hospital? or impact? or improv$ or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or tailor$ or target$ or team$ or usual care)).ab. (75950)<BR/>54 (pre-intervention? or preintervention? or "pre intervention?" or post-intervention? or postintervention? or "post intervention?").ti,ab. [added 2.4] (4141)<BR/>55 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing or doctor?).ti,hw. (39422)<BR/>56 demonstration project?.ti,ab. (893)<BR/>57 (pre-post or "pre test$" or pretest$ or posttest$ or "post test$" or (pre adj5 post)).ti,ab. (32125)<BR/>58 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. (371)<BR/>59 trial.ti. or ((study adj3 aim?) or "our study").ab. (60657)<BR/>60 (before adj10 (after or during)).ti,ab. (45884)<BR/>61 ("quasi-experiment$" or quasiexperiment$ or "quasi random$" or quasirandom$ or "quasi control$" or quasicontrol$ or ((quasi$ or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. (39916)<BR/>62 ("time series" adj2 interrupt$).ti,ab,hw. (376)<BR/>63 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or hour? or day? or "more than")).ab. (1789)<BR/>64 pilot.ti. (9209)<BR/>65 (multicentre or multicenter or multi-centre or multi-center).ti. (1572)<BR/>66 random$.ti,ab. or controlled.ti. (118983)<BR/>67 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not (controlled clinical trial or randomized controlled trial).pt. (77108)<BR/>68 "comment on".cm. or review.ti,pt. or randomized controlled trial.pt. (97596)<BR/>69 review.ti. (97596)<BR/>70 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti. (96983)<BR/>71 (or/53-67) or experimental design/ or between groups design/ or quantitative methods/ or quasi experimental methods/ (409712)<BR/>72 exp animals/ or animal?.ti,id,hw. (271628)<BR/>73 71 not (or/69-70,72) [EPOC Methods Filter 2.4 PsycInfo] (373217)<BR/>74 48 and 52 [RCT Results] (9)<BR/>75 (48 and 73) not 74 [EPOC Filter Results] (43)</P>
<P>
<B>3 October 2013</B>
</P>
<P>74 48 and 52 [RCT Results] (10)<BR/>75 (48 and 73) not 74 [EPOC Filter Results] (51)<BR/>76 (201211$ or 201212$).up. or 2013$.up,dp. (189306)<BR/>77 (or/74-75) and 76 (9)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2015-02-17 09:39:57 -0500" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2014-12-02 13:44:36 -0500" MODIFIED_BY="Julia Worswick">ProQuest Dissertations &amp; Theses strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-17 09:39:57 -0500" MODIFIED_BY="[Empty name]">
<P>13 November 2012 Results: 175</P>
<P>3 October 2013: Results: 15<BR/>
<BR/>(ti,ab("medication safety" OR "medication incident?" OR "medication error?") OR ti,ab((pharmacist? OR prescrib* OR prescription? OR dispens* OR dosing) NEAR/2 (error? OR mistake? OR miscalculat*)) OR ti,ab((inappropriate NEAR/3 (prescription? OR medication?)) OR ((appropriat* OR inappropriat* OR optimal) NEAR/2 prescrib*)) OR ti,ab,if,su("Medication errors" OR "Inappropriate Prescribing") OR ti,ab,if,su("medication reconciliation") OR ti,ab((drug? OR medication? OR medicine? OR dose OR dosage? OR dosing) NEAR/2 wrong*) OR ti,ab(accident* NEAR/2 overdose?) OR ti,ab("near miss" OR "near misses") OR ti,ab((excess* OR inadequat*) NEAR/2 (dosage? OR dose? OR dosing)) OR ti,ab("medication related" NEAR/2 (problem? OR issue? OR hospitali?ation? OR mortal* OR morbid* OR illness* OR condition?)) OR (ti,ab,if,su("Electronic prescribing") AND ti(safety OR error? OR improv*)) OR (ti,ab,if,su("Pharmaceutical preparations" OR "Drug Therapy" OR "Drug Administration Routes" OR "Drug administration schedule" OR "drug delivery systems" OR "drug dosage calculations" OR "drug prescriptions" OR "drug therapy, Combination" OR "Drug Therapy, Computer-assisted") AND ti(error? OR mistake OR mistakes OR "prevent* adverse")) OR (ti,ab,if,su("Pharmaceutical preparations" OR "Drug Therapy" OR "Drug Administration Routes" OR "Drug administration schedule" OR "drug delivery systems" OR "drug dosage calculations" OR "drug prescriptions" OR "drug therapy, Combination" OR "Drug Therapy, Computer-assisted") AND ti,ab,if,su(Medical Errors))) AND ((child OR children OR toddler* OR adolescent OR adolescents OR pediatric* OR paediatric* OR neonat* OR perinatal* OR infant OR infants OR newborn*) NOT ti(nursing home OR nursing homes OR elderly OR "old* adults" OR "old* adult"))</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2015-02-17 09:40:58 -0500" MODIFIED_BY="[Empty name]" NO="7">
<TITLE MODIFIED="2015-02-17 09:40:21 -0500" MODIFIED_BY="[Empty name]">ProQuest Nursing &amp; Allied Health strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-17 09:40:58 -0500" MODIFIED_BY="[Empty name]">
<P>Please note: Other search strateigies were used in this database, but copies were not saved. However results from those searches yielded 515 citations gross; 233 after removal of duplicates. Searches were conducted 3 October 2013.</P>
<P>(intervention* or pre-intervention* or post-intervention* or team* or collaborat* or interdisciplin*) OR TITLE(chang* or impact or implement* or improv*) AND (((medication pre/3 error?) OR (medication? w/3 miscalculat*) or (drug? w/3 miscalculat*) or (dosing w/3 error?) or (dose w/3 error?) or (dosage w/3 error?)) OR (MESH(Medication errors))) AND (((child* or teen* or p?edatric? or infant* or infancy or adolescent?)) OR (MESH(child) or MESH(infant) or MESH(adolescent) or MESH(Infant, Premature) or MESH(Infant, Postmature))) [25 citations]<BR/>Database: ProQuest Nursing &amp; Allied Health Source<BR/>Look for terms in: citation and abstract<BR/>Publication type: all publication types</P>
<P>(random* or (before w/3 after) or (interrupted time series) or control* or quasiexperiment* or quasi-experiment* or experiment*) AND (((medication pre/3 error?) OR (medication? w/3 miscalculat*) or (drug? w/3 miscalculat*) or (dosing w/3 error?) or (dose w/3 error?) or (dosage w/3 error?)) OR (MESH(Medication errors))) AND (((child* or teen* or p?edatric? or infant* or infancy or adolescent?)) OR (MESH(child) or MESH(infant) or MESH(adolescent) or MESH(Infant, Premature) or MESH(Infant, Postmature))) [49 citations]<BR/>Database: ProQuest Nursing &amp; Allied Health Source<BR/>Look for terms in: citation and abstract<BR/>Publication type: all publication types</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-08" MODIFIED="2015-02-17 09:41:53 -0500" MODIFIED_BY="[Empty name]" NO="8">
<TITLE MODIFIED="2014-12-02 13:44:44 -0500" MODIFIED_BY="Julia Worswick">Web of Science strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-17 09:41:53 -0500" MODIFIED_BY="[Empty name]">
<P>We identified 337 (2012) + 64 (2013) citations in our searches of Web of Science databases, specifically Science Citation Index (SCI-EXPANDED); Conference Proceedings, Science (CPCI-S); Social Sciences Citation Index (SSCI); and Social Sciences Conference Proceedings Indices (CPCI-SSH). However, we do not have copies of the search strategies as run.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-09" MODIFIED="2015-02-17 09:42:53 -0500" MODIFIED_BY="[Empty name]" NO="9">
<TITLE MODIFIED="2013-05-05 12:41:31 -0400" MODIFIED_BY="Jolanda Maaskant">Other resources search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2015-02-17 09:42:53 -0500" MODIFIED_BY="[Empty name]">
<P/>
<TABLE COLS="2" ROWS="5">
<TR>
<TD COLSPAN="2">
<P>
<B>Open Grey </B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Date of search</P>
</TD>
<TD VALIGN="TOP">
<P>10 February 2013</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Search terms</P>
</TD>
<TD VALIGN="TOP">
<P>&#8220;medication safety&#8221; OR &#8220;ME*&#8221; OR &#8220;medication incident*&#8221; OR &#8220;drug safety&#8221; OR &#8221;drug error*&#8221; OR &#8220;drug incident*&#8221; OR &#8220;adverse drug event*&#8221;</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results of the search</P>
</TD>
<TD VALIGN="TOP">
<P>54</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results after screening titles (and abstracts)</P>
</TD>
<TD VALIGN="TOP">
<P>0</P>
</TD>
</TR>
</TABLE>
<TABLE COLS="2" ROWS="4">
<TR>
<TD COLSPAN="2">
<P>
<B>Grey literature report </B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Date of search</P>
</TD>
<TD VALIGN="TOP">
<P>10 February 2013</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Search terms:</P>
<P>results of the search</P>
</TD>
<TD VALIGN="TOP">
<P>&#8220;medication safety&#8221;, results of the search: 3</P>
<P>&#8220;ME(s)&#8221; , results of the search: 69 (69)</P>
<P>&#8220;medication incident(s)&#8221;, results of the search: 1 (1)</P>
<P>&#8220;drug safety&#8221; , results of the search: 18</P>
<P>&#8220;drug error(s)&#8221;, results of the search: 0 (0)</P>
<P>&#8220;drug incident(s)&#8221;, results of the search: 0 (0)</P>
<P>&#8220;adverse drug event(s)&#8221;, results of the search: 4 (4)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results after screening</P>
<P>titles (and abstracts)</P>
</TD>
<TD VALIGN="TOP">
<P>Results after screening titles (and abstracts): 0</P>
</TD>
</TR>
</TABLE>
<TABLE COLS="2" ROWS="5">
<TR>
<TD COLSPAN="2">
<P>
<B>AHRQ</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Date of search</P>
</TD>
<TD VALIGN="TOP">
<P>10 February 2013</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Search terms</P>
</TD>
<TD VALIGN="TOP">
<P>Advanced search &#8594; all in title</P>
<P>&#8220;medication safety&#8221; OR &#8220;ME*&#8221; OR &#8220;medication incident*&#8221; OR &#8220;drug safety&#8221; OR &#8221;drug error*&#8221; OR &#8220;drug incident*&#8221; OR &#8220;adverse drug event*&#8221;</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results of the search</P>
</TD>
<TD VALIGN="TOP">
<P>84</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results after screening titles (and abstracts)</P>
</TD>
<TD VALIGN="TOP">
<P>0</P>
</TD>
</TR>
</TABLE>
<TABLE COLS="2" ROWS="4">
<TR>
<TD COLSPAN="2">
<P>
<B>NRR</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Date of search</P>
</TD>
<TD VALIGN="TOP">
<P>31 January 2013</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Search terms:</P>
<P>results of the search</P>
</TD>
<TD VALIGN="TOP">
<P>Advanced search &#8594; the exact phrase</P>
<P>medication safety, results of the search: 1</P>
<P>ME(s), results of the search: 0 (1)</P>
<P>medication incident(s), results of the search: 0 (1)</P>
<P>drug safety, results of the search: 4</P>
<P>drug error(s), results of the search: 0 (0)</P>
<P>drug incident(s), results of the search: 0 (0)</P>
<P>adverse drug event(s), results of the search: 6 (0)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results after screening</P>
<P>titles (and abstracts)</P>
</TD>
<TD VALIGN="TOP">
<P>0</P>
</TD>
</TR>
</TABLE>
<TABLE COLS="2" ROWS="4">
<TR>
<TD COLSPAN="2">
<P>
<B>Joanna Briggs Institute</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Date of search</P>
</TD>
<TD VALIGN="TOP">
<P>10 February 2013</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Search terms:</P>
<P>results of the search</P>
</TD>
<TD VALIGN="TOP">
<P>medication safety, results of the search: 1</P>
<P>ME(s) , results of the search: 0 (1)</P>
<P>medication incident(s), results of the search: 0 (1)</P>
<P>drug safety , results of the search: 0</P>
<P>drug error(s), results of the search: 0 (0)</P>
<P>drug incident(s), results of the search: 0 (0)</P>
<P>adverse drug event(s), results of the search: 0 (0)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results after screening</P>
<P>titles (and abstracts)</P>
</TD>
<TD VALIGN="TOP">
<P>0</P>
</TD>
</TR>
</TABLE>
<TABLE COLS="2" ROWS="5">
<TR>
<TD COLSPAN="2">
<P>
<B>NICE</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Date of search</P>
</TD>
<TD VALIGN="TOP">
<P>31 January 2013</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Search terms</P>
</TD>
<TD VALIGN="TOP">
<P>&#8220;medication safety&#8221; OR &#8220;ME*&#8221; OR &#8220;medication incident*&#8221; OR &#8220;drug safety&#8221; OR &#8221;drug error*&#8221; OR &#8220;drug incident*&#8221; OR &#8220;adverse drug event*&#8221;</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results of the search</P>
</TD>
<TD VALIGN="TOP">
<P>11</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results after screening titles (and abstracts)</P>
</TD>
<TD VALIGN="TOP">
<P>0</P>
</TD>
</TR>
</TABLE>
<TABLE COLS="2" ROWS="5">
<TR>
<TD COLSPAN="2">
<P>
<B>ICTRP (WHO)</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Date of search</P>
</TD>
<TD VALIGN="TOP">
<P>31 January 2013</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Search terms</P>
</TD>
<TD VALIGN="TOP">
<P>Search for trials, advanced search: clinical trials in children</P>
<P>Search terms: medication safety OR ME OR medication incident OR drug safety OR</P>
<P>drug error OR drug incident OR adverse drug event</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results of the search</P>
</TD>
<TD VALIGN="TOP">
<P>4</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results after screening</P>
<P>titles (and abstracts)</P>
</TD>
<TD VALIGN="TOP">
<P>1</P>
</TD>
</TR>
</TABLE>
<TABLE COLS="2" ROWS="5">
<TR>
<TD COLSPAN="2">
<P>
<B>Clinical Trials</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Date of search</P>
</TD>
<TD VALIGN="TOP">
<P>31 January 2013</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Search terms</P>
</TD>
<TD VALIGN="TOP">
<P>Advanced search: search terms met additional criteria child (0-17)</P>
<P>Search terms: &#8220;medication safety&#8221; OR &#8220;ME*&#8221; OR &#8220;medication incident*&#8221; OR &#8220;drug safety&#8221; OR &#8221;drug error*&#8221; OR &#8220;drug incident*&#8221; OR &#8220;adverse drug event*&#8221;</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results of the search</P>
</TD>
<TD VALIGN="TOP">
<P>129</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Results after screening titles (and abstracts)</P>
</TD>
<TD VALIGN="TOP">
<P>1</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="AFF_15812_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="15812">
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>Academic Medical Centre, University of Amsterdam</ORGANISATION>
<ADDRESS_1>Meibergdreef 9</ADDRESS_1>
<ADDRESS_2>PO Box 22660</ADDRESS_2>
<CITY>Amsterdam</CITY>
<ZIP>1100 DD</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 20 5661170</PHONE_1>
<PHONE_2/>
<FAX_1>+31 20 6914858</FAX_1>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>